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ABSTRACT
A synthetic multivulva phenotype results from mutations in interacting genes that
negatively regulate the ras-mediated intercellular signaling system of Caenorhabditis
elegans vulval induction. The interaction of two synthetic multivulva mutations in two
different classes of genes, class A and class B, is required to produce the multivulva
phenotype in which all six vulval precursor cells adopt vulval fates thereby forming
ectopic vulval tissue in addition to a normal vulva. Mutations in either class alone do not
cause a vulval phenotype.
To further characterize these pathways, mutations in both classes of synthetic
multivulva genes were isolated. A total of 49 mutations were isolated and characterized.
The analysis of some of these mutations and some previously isolated mutations allowed
the identification of five new class B genes and one new class A gene.
The class B gene lin-36 was characterized in greater detail. lin-36 mutations
alone did not cause vulval lineage fate transformations, but in conjunction with a class A
mutation, caused all vulval precursor cells to adopt vulval fates. lin-36 was cloned and
shown to encode a novel protein. Genetic mosaic analysis suggests that lin-36 is required
cell autonomously, and a lin-36 reporter is expressed in the nuclei of vulval precursor
cells. The interaction between synthetic multivulva genes and genes that positively
regulate the ras-mediated signaling system was studied.
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Chapter 1
Antagonistic Signals in the Control of Development and Cell Proliferation
Jeffrey H. Thomas
Howard Hughes Medical Institute, Massachusetts Institute of Technology
Cambridge, MA 02139
Summary
Many complex biological processes are regulated by both positive and negative
signals which act antagonistically with respect to each other. Positive and negative inputs
allow a cell to effectively respond to its environmental context. The synthetic multivulva
genes act antagonistically to the anchor cell signal in Caenorhabditis elegans vulval fate
specification. A number of other examples of signals that act antagonistically to regulate
development and cell proliferation are now known. These signals interact by a variety of
different mechanisms.
Antagonistic signals can provide information effectively in complex processes
Many complex biological processes are controlled by multiple signals. These
signals may act in concert and reinforce each other or they may act in opposition and
antagonize each other. In both cases, multiple signals can provide more information to a
cell about its environment than a single signal, allowing the cell to respond to
environmental conditions more effectively. Often the environment of the cell is defined
by the time and place of the cell in development. The proper interpretation of its
developmental context by a cell is crucial to its adoption of the proper fate, be it in terms
of identity, relative spatial position, growth, or role in further development. In highly
complex biological processes such as development, there is a requirement for highly
specific information. Highly specific information is readily produced by multiple signals,
each of which provide only some of the information needed, but together provide all of
the information needed.
In some respects, accurate information about the environmental context of a cell
can be more readily provided by antagonistic signals rather than by cooperative signals.
Inhibitory information can be provided directly, rather than through the absence of
additional stimulatory information. This point can be illustrated by several simple
scenarios. In the case of two positive signals acting to regulate a biological process, a
threshold of response is necessary to distinguish between receiving both positive signals
versus receiving just one. Alternatively, each positive signal may be distinct; neither one
type nor the other is sufficient to elicit the proper response. In this case, both types of
signal must be received and must be distinguished. In the case of a positive signal and
purely inhibitory signal, no threshold is required. The positive signal need merely be
received in the absence of the inhibitory signal, which would negate it or act to prevent its
reception. Thus situations can be imagined whereby antagonistic signals provide
information more effectively and parsimoniously than cooperative signals.
Potential mechanisms of positive and negative signal interaction
A negative signaling system can act in a variety of ways to antagonize the action
of a positive signaling system. The cases documented here are all cases in which
negative regulation is exerted through a distinct signaling system. Only examples of
negative regulation that clearly involve both a negative and a positive signaling system
are described. This negative signaling system may exert its effect at any of several levels.
It may negatively regulate the positive signal upstream of the positive signal transduction
system, it may directly regulate the signal transduction apparatus of the positive signal, or
it may act in the nucleus, downstream of positive signal transduction.
An inhibitory signal that acts upstream of the stimulatory signal transduction
apparatus may act via several mechanisms. It may directly inhibit the cell that secretes
the stimulatory signal from either producing the positive signal or secreting it. The
negative system may prevent the transcription of the stimulatory ligand or the molecules
necessary for producing it. The negative signal may prevent the proper processing of the
stimulatory ligand or its secretion. The inhibitory signal may titrate out the stimulatory
signal by binding it and rendering it inoperative. The negative signal may be a
competitive inhibitory ligand which prevents the positive signal from binding its receptor
by occupying, and thus blocking access to, the ligand binding domain of the receptor.
The inhibitory signal may exert its negative regulation by directly modulating the
activity of the signal transduction system that transduces the positive signal within the
responding cell. The possible mechanisms for this type of regulation are numerous. The
negative signal may prevent receptor dimerization by binding to the extracellular domain
of the receptor and altering its conformation or by occluding receptor association. It may
also prevent receptor dimerization by activating a competing receptor subunit which
prevents propagation of a signal, or by means of an intracellular factor which occludes
dimerization or alters receptor conformation. The negative signal may activate a
phosphatase that dephosphorylates the receptor or a downstream target of a kinase. The
negative signal may activate another enzymatic activity that counters one found in the
positive signal's transduction system. An example of such an activity is a GTPase
activating protein (GAP) activity in a Ras-mediated pathway. The negative signal may
stimulate a kinase which phosphorylates a negative regulatory site on a signal
transduction protein. The negative signal may activate an inhibitory protein which binds
an essential signal transduction substrate and inhibits its activity or thwarts its ability to
bind to its target or form an active complex. These are some of the many conceivable
ways to inhibit a signal transduction pathway.
The negative signaling system may exert its influence in the nucleus. It may
activate a molecule that prevents the transport of a signal transduction molecule such as
mitogen-activated protein (MAP) kinase into the nucleus. It may activate a nuclear
protein that binds to a transcription factor activated by the positive signaling pathway and
prevent its binding to DNA,or prevent it from interacting with an essential cofactor. The
negative signaling system may activate a DNA-binding factor that blocks the binding site
of a transcription factor activated by the positive signal, thereby preventing its action.
Transcription factors activated by the negative signal may simply bind promotor
regulatory sites that act in opposition to those promotor regulatory sites upon which
transcription factors stimulated by the positive signal bind. The negative signal may also
inhibit the transcription of necessary components of the positive signal trasnsduction
system if these components are limiting and their production is positively controlled by
the activation of the positive signaling system (a positive feedback loop). Of course, it is
possible that the negative signal activates the transcription of an inhibitory protein that
acts in any of the myriad ways described previously in this section.
As described later in this chapter, many of these mechanisms have been found to
act in various regulatory schemes in different biological processes. In this chapter,
examples of these interacting positive and negative systems are described in detail. These
systems provide a framework to think about how a group of negative regulatory genes
may act in Caenorhabditis elegans vulval development act.
Antagonistic signaling systems in the specification of cell fates during Caenorhabditis
elegans vulval development
The focus of this work is on the antagonistic signaling systems that determine the
cellular fates of the vulval equivalence group of Caenorhabditis elegans. These signaling
systems provide information to each member of this group of equipotent cells. This
information is integrated by the cells and each responds according to the information it
receives by adopting a specific fate. Antagonistic signals allow cell fates to be specified
in the proper spatial pattern, allowing development of the vulva to be coordinated with
the development of the uterus and the hypodermis.
The vulval equivalence group, P(3-8).p, is a set of six cells that have the potential
to adopt either one of two vulval fates (10 or 20) characterized by a distinctive division
pattern and morphology, or a nonvulval hypodermal fate (30) (Sulston and White, 1980;
Kimble, 1981; Sternberg and Horvitz, 1986). In wild type, the hermaphrodite vulva of C.
elegans is formed from the descendents of three hypodermal blast cells, P(5,6,7).p.
Specifically, P5.p and P7.p adopt 20 cell fates in mirror image symmetry about P6.p,
which adopts a 1° cell fate. P(3,4,8).p adopt 30 cell fates such that they produce
component nuclei of the hypodermal syncytium (Sulston and Horvitz, 1977).
These cell fates are specified by several cell interactions (for review, see Horvitz
and Sternberg, 1991; Eisenmann and Kim, 1994; Sundaram and Han, 1996). The gonadal
anchor cell signals the nearest Pn.p cells to adopt vulval fates. This signal has a limited
range, and cannot act over the entire field of the vulval equivalence group. A signal from
the anchor cell is at least partly responsible for establishing the proper pattern of vulval
fates (Kimble, 1981; Sternberg and Horvitz, 1986; Thomas et al., 1990; Simske and Kim,
1995; Katz et al., 1995). In the absence of the anchor cell, no vulval tissue is formed in
wild-type animals (Sulston and White 1980; Kimble, 1981). In addition to the influence
of the gonadal anchor cell signal on the pattern of vulval cell fates, another signal is
propagated amongst the induced Pn.p cells to prevent the formation of adjacent primary
cells. This serves to reinforce the proper (2O-1o-2o) pattern (Sternberg, 1988).
Many genes have been identified and shown to encode proteins implicated in the
transduction of the inductive signal from the anchor cell. These genes include: lin-3, an
EGF-like molecule (Hill and Sternberg, 1992), let-23, a receptor tyrosine kinase (Arioan
et al., 1990), sem-5, an adaptor molecule (Clark et al., 1992a), let-60, a ras GTPase (Han
and Sternberg, 1990, Beitel et al., 1990), lin-45, a raf serine/threonine kinase (Han et al.,
1993), mek-2, a mitogen activated protein (MAP) kinase kinase (Kornfeld et al., 1995a,
Wu et al., 1995), mpk-1/sur-1, a MAP kinase (Lackner et al., 1994, Wu and Han, 1994),
and ksr-1, a protein kinase (Kornfeld et al., 1995b). These genes constitute the core of
the anchor cell-mediated signaling pathway. Other genes have been identified, some of
which act in an auxillary role to positively regulate the anchor cell signaling pathway.
These include lin-2, lin-7 and lin-lO, genes which have been implicated in the
localization of the LET-23 receptor to the Pn.p cell junction (Ferguson et al., 1987; Kim
and Horvitz, 1990; Hoskins et al., 1996; Simske et al., 1996).
Another group of genes acts in opposition to the genes described above. These
genes likely encode the components of a signaling system since some have been shown to
act cell nonautonomously. The hypodermal syncytium postulated to be the source of this
signal since it is the tissue that most clearly fits criteria of an anatomical focus of activity
suggested by the genetic mosaic data (Herman and Hedgecock, 1990). This is a negative
signal, acting antagonistically to the positive signal propagated from the anchor cell. This
signal, as discussed below, is probably not a single signal but rather a pair of functionally
redundant signaling systems, either of which is sufficient to mediate the negative
regulation of vulva cell fates in wild type (Ferguson and Horvitz, 1989). Note that this
case the "negative signal" probably consists of two functionally redundant signaling
systems which are both responsible for negative regulation. It is likely that the anchor
cell overrides this inhibitory signal to induce the vulva from the cells nearest to the
uterus.
Several multivulva (Muv) strains have been identified which disrupt these
negative signaling systems. The Muv phenotype of these mutant strains results from the
interaction of two different mutations (Horvitz and Sulston, 1980; Sulston and Horvitz,
1981; Ferguson and Horvitz, 1985; 1989). The mutations that interact to produce such a
synthetic multivulva (synMuv) phenotype fall into two classes: A and B. Animals
carrying both a class A and a class B mutation have a Muv phenotype. Animals which
carry mutations in a single class have a wild-type vulval phenotype. Ferguson and
Horvitz (1989) have proposed that the synMuv genes encode the components of two
functionally redundant pathways which negatively regulate vulval development. Four
class A genes (lin-8, lin-15 A, lin-38 and lin-56) and ten class B genes (lin-9, lin-15 B,
lin-35, lin-36, lin-37, lin-51, lin-52, lin-53, lin-54, lin-55) have been identified (Horvitz
and Sulston, 1980; Ferguson and Horvitz, 1989; Chapter 2). Of these genes, lin-15 is
particularly notable in that it is a complex locus with genetically separable class A and
class B activities encoded by two nonoverlapping transcripts (Ferguson and Horvitz,
1989; Clark et al., 1994; Huang et al., 1994). Four genes, lin-15 A, lin-15 B, lin-9 and
lin-36 have been cloned and shown to encode novel proteins (Clark et al., 1994; Huang et
al., 1994; Beitel and Horvitz, in preparation; Chapter 3).
SynMuv mutants in which the anchor cell has been ablated, thereby eliminating
the positive signal, still display a Muv phenotype (Ferguson et al., 1987; Chapter 3). This
suggests that in the absence of synMuv gene activity, the Pn.p cells do not require the
anchor cell signal to adopt vulval cell fates. Thus the anchor cell is not absolutely
required for the specification of vulval cell fates, but is required for the proper pattern and
localization of cell fates in the vulval field.
Genetic mosaic analyses suggest that both lin-15 AB and lin-37 act cell non-
autonomously. Loss of lin-15 AB activity in either the AB or P lineages can result in a
Muv phenotype. Loss in either lineage is sufficient to produce a phenotype. This
suggests that lin-15 AB acts cell nonautonomously since lin-15 AB activity is required in
both AB and P 1. The only tissue that both AB and P1 lineages give rise to is the
syncytial hypodermis. This is likely to be the focus of lin-15 AB activity. Loss of lin-37
activity in AB, but not in its daughter cell, AB.p, which gives rise to the Pn.p cells
infrequently produces a Muv phenotype. Thus, lin-37 acts cell nonautonomously. This
result, though different from the lin-15 AB result, is consistent with a hypodermal focus
for lin-37 activity. The difference in these results is probably a result of a differing dose
requirements for these genes (Herman and Hedgecock, 1990; Hedgecock and Herman,
1995). The non-autonomous focus of these genes suggests that the synMuv genes encode
the components of signaling systems that inhibit the adoption of vulval fates by the Pn.p
cells. Genetic mosaic analysis of lin-36 suggests that this gene acts cell autonomously in
the Pn.p cells (Chapter 3). Thus, for the class B pathway, the negative signaling system
has components within the responding cells, eliminating models which involve a negative
ligand binding the extracellular domain of the LET-23 receptor and exerting its influence
directly.
Reduction-of-function mutations in genes known to be involved in inductive
signal transduction, let-23, sem-5, let-60 ras, and lin-45 raf, are epistatic to synMuv
mutations (Ferguson et al., 1987; Beitel et al., 1990; Han et al., 1990, Clark et al., 1992;
Han et al., 1993; Huang et al., 1994; Chapter 3). These results suggest that the inductive
signal transduction system is required for the adoption of the Muv phenotype in the
absence of inhibitory synMuv gene activity even though the anchor cell signal itself is
not. The phenotype of mutations in the lin-2, lin-7 and lin-lO receptor localization
system and the synMuv phenotype are coexpressed in triple mutants (Ferguson et al.,
1987; Chapter 3). Pn.p cells can still adopt vulval cell fates in animals in which the
anchor cell signal, the negative signaling systems and the localization of the receptor have
been eliminated but the positive signal transduction cascade is intact (Chapter 3). This
suggests that the unstimulated activity of the let-23 pathway is necessary for the adoption
of vulval fates.
Together, these data suggest the following model. The six equipotent vulval
precursors are predisposed to adopt vulval fates by virtue of the unstimulated activity of
the let-23 signal transduction pathway. In the absence of this pathway, the cells are
incapable of adopting vulval fates. This predisposition to adopt vulval fates is inhibited
through the action of two functionally redundant signaling pathways from the
hypodermis. These pathways act to downregulate the unstimulated activity of the let-23
signal transduction pathway. This changes the cells' inherent tendency to adopt vulval
cell fates to a tendency to adopt nonvulval cell fates. The inductive signal from the
anchor cell stimulates the let-23 pathway in the cells nearest it, leading them to adopt a
vulval cell fate. It is likely that this stimulation acts by overriding the effect of the two
inhibitory pathways but may act by relieving the Pn.p cells of inhibition by the synMuv
genes. These possibilities differ in the means by which inhibition is overcome. The
signal transduction system may override the negative regulation of the synMuv genes by
being activated so strongly that the inhibitory activity of the synMuv genes is insufficient
to reduce the activity of the fully activated pathway below the threshold for a response.
Alternatively, activation of the inductive signaling pathway may activate a secondary
pathway which inhibits the activity of the synMuv genes thereby relieving the inhibition
exerted by the synMuv genes. At present, there are no compelling observations that
allow these two possibilities to be distinguished.
Examples of antagonistic signals are found in other biological processes
A number of biological processes are known in which antagonistic signaling
pathways function. In each of these examples, a "positive" signaling system activates a
process such as specification of a certain cell fate. This process is modulated by a second
signaling system that operates in opposition to the first; this signaling pathway is referred
to as the "negative" signaling system. The information delivered by positive and negative
signals is then integrated by the responding cell.
Several examples of such antagonistic signaling systems are described in the
following sections. In each case, negative regulation has been shown to involve signaling
between cells rather than cell-intrinsic negative regulation. Only examples in which this
is known to be the case are described in the following sections. The examples are
primarily drawn from studies of cell growth and development where biological control
must be exerted precisely. In many cases, a molecular mechanism for the negative
regulation is known. In some of these examples, similar molecular mechanisms are used
to effect negative regulation of the positive signaling system in different processes. In
other examples, very different mechanisms are used. These processes and their modes of
negative regulation provide a framework to think about negative regulation of vulval
development by the synMuv genes.
The mating pheromone signal transduction pathway acts to inhibit cell proliferation
in Saccharomyces cerevisiae
Antagonistic signals act to control cell proliferation in the yeast Saccharomyces
cerevisiae. Nutrients serve as a positive signal for cell growth. Mating pheromone serves
as a negative signal, preventing cell division and allowing the cell to mate. Mating
pheromone exerts its negative influence through the inhibition of the cell cycle (Table 1).
Cell division and growth in S. cerevisiae are regulated by nutrient avalability and
by the presence or absence of mating factor for haploid cells. The availability of
sufficient nutrients acts as a positive signal to begin cell division. This is assessed at
"Start," the major control point of the yeast cell cycle which occurs at the end of G1. If
the cell passes Start, it is committed to divide. This entails several processes which can
be defined mutationally. The gene CDC28 has been found to perform an essential role at
Start and is required for all the different processes involved in cell division (Hartwell et
al., 1974; Reed, 1980; Hartwell and Pringle, 1981).
In addition to CDC28, several cyclin homologues have been isolated. These
cyclin genes, CLN1, CLN2 and CLN3 were identified and shown by loss-of-function and
gain-of-function mutations to control cell proliferation (Hadwiger et al., 1989). Other
dominant mutations define a third cyclin homologue, CLN3 (DAF1/WHI1). CLN3
apparently acts as an activator of Start (Cross, 1988; Nash et al., 1988). These three
cyclins are redundant (Richardson et al., 1989). As expected for cyclins, CLN1 and
CLN2 mRNAs oscillate throughout the cell cycle as do the proteins they encode. CLN3,
however, does not oscillate throughout the cell cycle (Nash et al., 1988; Cross, 1990;
Wittenberg et al., 1990; Tyers et al., 1993). Immunoprecipitation experiments have
shown that these cyclins can associate with Cdc28; these complexes have kinase activity
(Wittenberg et al., 1990; Tyers et al., 1992; 1993). Tyers et al. (1993) have proposed that
CLN3 acts as an upstream positive regulator of the other G1 cyclins. Both CDC28 and
the CLN genes are necessary for the accumulation of CLN1 and CLN2 mRNAs in a
positive feedback loop (Cross and Tinkelenberg, 1991; Dirick and Nasmyth, 1991).
Mating pheromone acts as a negative signal; cell division is arrested upon
exposure of the haploid cells to mating pheromone. The effect of mating pheromone is
mediated by a distinct signal transduction system within the responding cell (Marsh et al.,
1991). Mating pheromone is one of the signals that is integrated by the cell at Start and
has been thought to interact with components of the cell cycle machinery (Hartwell et al.,
1974; Cross, 1988; Nash et al., 1988; Richardson et al., 1989; Wittenberg et al., 1990;
Marsh et al., 1991). This negative signaling system is activated by a-factor in a cells and
a-factor in a cells. In each case, a specific (a or a) seven transmembrane domain
receptor binds the appropriate peptide mating factor. A heterotrimeric G protein
transduces this signal (Marsh et al., 1991). Downstream of the G protein, the components
of a MAP kinase signaling cascade have been identified (Elion et al., 1990; Marsh et al.,
1991; Cairns et al., 1992; Gartner et al., 1992; Stevenson et al., 1992; Errede et al., 1993).
Deletion of FUS3, a MAP kinase homologue, causes a failure to arrest in G 1. This
disruption of cell division control can be suppressed by a cln3 mutation, suggesting that
FUS3 regulates CLN3 (Elion et al., 1990). In addition to negatively regulating CLN1 and
CLN2 through its negative regulation of CLN3, FUS3 downregulates CLNJ and CLN2
transcript levels independently of CLN3. Thus FUS3 acts to cause cell cycle arrest in G1
by negatively regulating all three of the G1 cyclins (Elion et al., 1991). However, it is not
the direct action of FUS3 that is responsible for the negative regulation of the yeast cell
cycle.
FUS3 does not seem to act directly on the cyclins but rather through another gene,
FAR]. farl mutants have been isolated in screens for mutants that grow in the presence
of a-factor and transcribe lacZ from a FUS1 promotor (Chang and Herskowitz, 1990) and
in a multicopy suppressor screen of fus3 mutants (Elion et al., 1993). farl null mutants
fail to arrest in response to mating pheromone; although they show some physiological
changes reminescent of mating, they fail to mate and continue to divide (Chang and
Herskowitz, 1990). FAR] encodes a novel 780 amino acid protein. Its expression is
elevated four- to five-fold in the presence of pheromone (Chang and Herskowitz, 1990).
cln2 loss-of-function mutants suppress thefarl defect, but not completely. Together cln2
and cln3 mutations suppress thefarl defect, allowing arrest at physiological a-factor
concentrations (Chang and Herskowitz, 1990). FAR] has been shown to be necessary for
the negative regulation of CLN1 and CLN2 transcript levels in response to a-factor
(Valivieso et al., 1993). However, the effect of FAR] is not mediated solely through the
downregulation of message levels; it is also mediated post-transcriptionally. Both Clnl
and Cln2 protein levels are regulated by FAR] independently of its effect on transcription
(Valdivieso et al., 1993).
As alluded to in the previous paragraph, FUS3 is necessary for phosphorylation of
FAR1 which, in turn, is necessary for FAR] activity. FAR] is phosporylated in response
to o-factor. Thus, FAR] is controlled by the mating pheromone signal transduction
pathway (Chang and Herskowitz, 1992). FAR] is not phosphorylated in deletion mutants
of pheromone signal transduction components. Fus3 immunoprecipitated from cells
exposed to oa pheromone can phosphorylate the N terminal domain of Farl in vitro,
whereas Fus3 isolated from untreated cells cannot (Elion et al., 1993; Errede et al., 1993;
Peter and Herskowitz, 1993). Thus, FAR] is positively regulated by the MAP kinase
cascade controlled by mating pheromone.
Farl has also been shown to form a complex with Cdc28 and each of the cyclins,
Cln 1, Cln2 and Cln3. These associations, shown by coimmunoprecipitation experiments,
are a-factor dependent and require the phosphorylation of Farl by Fus3. It is noteworthy
that the ability of truncations of the Farl protein to bind the Cdc28-Cln2 complex
correlate with the ability of these truncated products to mediate Gi arrest in response to ax
pheromone stimulation (Peter et al., 1993; Tyers and Futcher, 1993). Peter and
Herskowitz (1994) argue that Farl binding to the Cln-Cdc28 complex is necessary for
inhibition. In ax-factor treated cells, immunoprecipitated complexes have reduced histone
H1 kinase ability compared to untreated, dividing cells. This reduction of kinase activity
is dependent on FAR] activity as shown by the observation that complexes isolated from
farl cells treated with a-factor have levels of histone H kinase activity similar to those
observed in untreated cells. An inducible constitutively active form of Farl stimulated
the kinase activity of Cdc28-Cln 1 and Cdc28-Cln2 complexes in a dose-dependent
manner whereas a weakly binding Farl mutant protein could inhibit kinase activity only
at very high doses. These results suggest that the binding of Farl to the Cdc28-Cln
complexes is necessary to inhibit the activity of these complexes and thereby prevent cell
division (Peter and Herskowitz, 1994). Thus, the negative regulation of cell division in
yeast by mating pheromone is mediated through a cyclin-kinase inhibitor protein
activated by the pheromone signal transduction cascade (Figure 1).
A notable characteristic of mating pheromone inhibition of cell growth is that the
neagtive signal is received and propagated via its own signal transduction system. This
nagativeregulatory pathway of yeast cell division consists of a complete signal
transduction apparatus. The mechanism of inhibition is also noteworthy. A protein is
activated by the negative signaling system which directly binds and inhibits a complex
essential for cell cycling. Thus, inhibition occurs directly on the molecules necessary for
cell growth, the cell cycle machinery, the same molecules stimulated by the positive
signaling system.
TGF- 3 acts to inhibit mitogen-stimulated cell proliferation in some types of
mammalian cells
Antagonistic signals also control proliferation of mammalian cells. Various
mitogens, the positive signal, stimulate cell division. TGF- P, in many cases, acts as an
anti-mitogenic signal. TGF-P, like yeast mating pheromone, exerts its effects on the cell
cycle machinery (Table 1).
Mammalian cells are subject to regulation of proliferation in the Gi phase of the
cell cycle. Mitogens are activators of the cell cycle; they promote cell proliferation.
These growth signals are transduced into the cell where they act to positively regulate the
components of the cell cycle machinery to cause cycling. Such mitogens include
epidermal growth factor (EGF), fibroblast growth factor (FGF), platelet-derived growth
factor (PDGF), insulin, and insulin-like growth factor I (IGF-I). Often, several mitogens
are required at different subphases of the Gi phase to activate the cell cycle (Pardee,
1989; Aaronson, 1991).
Transforming growth factor- P (TGF-f) has been shown to inhibit the proliferation
of a wide variety of mammalian cell types. Picomolar quantities have been shown to
inhibit the proliferation of many melanoma, lung carcinoma and breast carinoma cell
lines. Often TGF- 3 acts antagonistically to EGF, which has a proliferative effect.
However, it is notable that in the same cell line, under different growth conditions, TGB-
p can act as an antagonist of EGF for proliferation (anchorage-independent conditions) or
act synergistically with EGF or PDGF to promote proliferation (anchorage-dependent
conditions) (Roberts et al., 1995). TGF-P has been shown to inhibit growth and DNA
synthesis in non-transformed cells in a dose-dependent manner(Masui et al., 1986). The
inhibitory effect of TGF-f has also been shown in situ. Ethylene vinyl acetate copolymer
implants which allow the slow release of TGF- 1 can completely inhibit the growth of
normal mammary gland tissue when implanted in the mammary end buds of pre-adult
mice. Removal of the implants restores growth (Silberstein and Daniel, 1987). This
indicates that TGF-3 can play a role in the inhibition of normal developmental growth as
well as in tumorigenic growth. TGF- 1 signaling is mediated through a heterodimeric
receptor complex (Carcamo et al., 1994, Wrana et al., 1994). Thus, it, like yeast mating
pheromone, has its own signal transduction system.
Evidence suggests that cyclins and cyclin-dependent protein kinases (cdks), which
are required for progress through the cell cycle and tumor proliferation, are targets for the
TGF- P-mediated signal transduction system. It is the cyclins and Cdks that specifically
act in the GI phase of the cell cycle to control progress into the S phase that are subject to
negative regulation. These are the cyclin E-Cdk2 complex and the Cyclin D-Cdk4
complex. These complexes are active when their components are associated and display
a histone Hi kinase activity when purified from cycling cells (Pardee, 1989; Sherr, 1993;
Matushime et al. 1994). The cyclin D-Cdk4 and cyclin E-Cdk2 complexes regulate the
retinoblastoma (Rb) protein which acts at the restriction point of GI to regulate the cell's
decision to divide or remain quiescent. The cyclin D-Cdk4,6 and cyclin E-Cdk2
complexes are responsible for the hyperphosphorylation of Rb seen in proliferating cells
(Sherr, 1993; Weinberg, 1995). The addition of TGF-3 to cycling cells inhibits Rb
activity and prevents its hyperphosphorylation (Laiho et al., 1990). Thus, TGF- 3 acts by
inhibiting the activation of the cell cycle at the cyclin-cdk level by means of cyclin kinase
dependent inhibitory proteins.
Studies in MvlLu cells, human keratinocyte cell lines, and non-immortal cultured
breast epithelial cells have revealed that cyclin-Cdk complexes are a target of TGF-3
inhibition (Ewen et al., 1993; Geng and Weinberg, 1993; Koff et al., 1993; Slingerland et
al., 1994). Cyclin E mRNA levels as well as Cdk2 and Cdk4, but not cyclin D1, D2, or
D3, mRNA levels are reduced in response to TGF-0 (Ewen et al., 1993; Geng and
Weinberg, 1993; Slingerland et al., 1994). MvlLu cells that continuously express Cdk4,
but not cells that continuously express Cdk2, can bypass the TGF-3 induced arrest.
However, entry into S phase is still somewhat delayed, suggesting that TGF-3 inhibition
relies on mechanisms other than just control of the transcription of genes encoding the
cyclins and Cdks (Ewen et al., 1993).
Cyclin E and Cdk2 associate in a complex as shown by co-immunoprecipitation
from MvlLu cells. As these cells pass through the GI phase, Cdk2 protein is
increasingly phosphorylated. This phosphorylation is associated with cyclin E-Cdk2
histone H1 kinase activity. Addition of TGF-3 prevents the accumulation of the
phosphorylated form of Cdk2, the formation of cyclin E-Cdk2 complexes and cyclin E
associated kinase activity. No reduction in protein levels of cyclin E or Cdk2 were
observed (Ewen et al., 1993; Koff et al., 1993; Slingerland et al., 1994).
In the Gi phase, the cyclin D-Cdk and cyclin E-Cdk complexes regulate the
decision whether to divide or not. These complexes are regulated by a group of
molecules known as the cdk inhibitors. These molecules are the likely means by which
TGF- P exerts its negative influence on cell proliferation.
The cdk inhibitory protein 1 (CIP1) which encodes a novel 21 kDa protein with a
cysteine-rich region and a nuclear localization sequencewas identified as a molecule that
interacts with Cdk2 and cyclin D (El-Deiry et al., 1993; Gu et al., 1993; Harper et al.,
1993; Xiong et al, 1993). Overexpression of the cipl gene suppresses growth of several
cell lines (El-Deiry et al., 1993; Xiong et al., 1993). p21 has been shown to directly
associate with various cyclin-Cdk complexes in vitro, including cyclin D-Cdk4 and
cyclin E-Cdk2 complexes. The association of p21 with these complexes inhibits their
histone Hi and retinoblastoma (Rb) kinase activity (Gu et al., 1993; Harper et al., 1993;
Xiong et al., 1993). Addition of TGF- P to the human keratinocyte cell line HaCaT leads
to the rapid induction of cip] transcription independent of p53. Correlated with transcript
increase is the association of p21 with Cdk2 and cyclin D as shown by
immunoprecipitation experiments (Datto et al., 1995). These data suggest that p21 is a
promiscuous cyclin-Cdk inhibitor that acts in response to TGF- P.
The cdk inhibitory protein 1 (Kip ) was identified as a 27 kDa protein, similar to
CIPI, which associates with the cyclin E-Cdk2 and the cyclin D-Cdk4 complex (Polyak
et al., 1994a; 1994b, Toyoshima and Hunter, 1994). p27Kipl can bind cyclins D1, D2,
D3, and Cdk4 strongly, and cyclin E and Cdk2 less strongly (Polyak et al, 1994a,
Toyoshima and Hunter, 1994). In in vitro assays, p27 can inhibit the histone H1 kinase
and Rb kinase activities of cyclin E-Cdk2 and cyclin D-Cdk4 (Polyak et al., 1994a;
1994b; Toyoshima and Hunter, 1994). Overexpression of p2 7 Kipl leads to cellular arrest
in the GI phase. However, mRNA levels of Kip are equivalent in both arrested and
proliferating cells, suggesting that p27 acts post-transcriptionally to inhibit cell
proliferation (Polyak et al., 1994b; Toyoshima and Hunter, 1994). In extracts from
inhibited cells, addition of cyclin D2-Cdk4 complexes, including ones with an inactive
Cdk4, restore the activity of cyclin E-Cdk2 complexes. This may indicate a role for
cyclin D2-Cdk4 in regulating p27-induced inhibition of cyclin E-Cdk2 (Polyak et al.,
1994a).
Another class of inhibitory molecule has been found which associates with Cdk4.
Serrano et al. (1993) isolated a gene which encodes a 16 kDa inhibitor of cdk4 (Ink4).
This novel protein immunoprecipitates with Cdk4 in a 1:1 molar ratio, but does not
associate with Cdk2. The addition of p16 to cyclinD-Cdk4 inhibits complex
phosphorylation of Rb. However, p 16 does not inhibit cyclinD-Cdk2 phosphorylation of
Rb (Serrano et al. 1993). Injection of p16 mRNA into normal breast epithelial cells and
fibroblasts leads to growth arrest. Injection into normal fibroblasts from Rb-/Rb- mice
did not produce any effect, suggesting that p16 acts to promote cell cycle arrest through
an Rb-dependent mechanism (Lukas et al., 1995b; Medema et al., 1995). Hannon and
Beach (1994) observed that the immunoprecipitation of Cdk4 and closely related Cdk6
from TGF- P-arrested keratinocytes pulls down a 15 kDa protein as well as p 16. The
pl 5Ink4b protein shows similarity to p 6Ink4a . In vitro binding studies reveal an
association with Cdk4 and Cdk6 but not with Cdc2, Cdk2 or Cdk5. p15, like p16, can
inhibit the kinase activity of cyclin D-Cdk4 and cyclin D-Cdk6 complexes. Addition of
TGF- P to HaCaT (a human keratinocyte derived cell line) leads to a large increase in
ink4b mRNA levels as well as an increase in Cdk4 and Cdk6 association with p15. This
occurs in the absence of a reduction in Cdk4 protein and mRNA levels (Hannon and
Beach, 1994).
Reynisdottir et al. (1995) have proposed a model in which the concerted action of
Kipl/Cipl proteins and Ink4 proteins mediates the TGF-1-induced arrest of cell
proliferation. They show that for both MvlLu cells and HaCaT cells there is a complete
loss of Cdk2 activity shortly after treatment with TGF-3. This treatment also leads to the
rapid loss of p27-Cdk4 and p27-Cdk6 association. In MvlLu cells, this corresponds to an
increase of Cdk2-bound p27. A rapid increase in p15 mRNA levels is also observed in
both MvlLu and HaCaT cells. A rapid induction of cipl mRNA, independent of p53
activity, is seen in HaCaT cells and is correlated with a rise in p21-Cdk2 association as
well as Cdk activity inhibition. No increase in p27-Cdk2 complexes is observed in these
cells (Reynisdottir et al., 1995). Reynisdottir et al. (1995) propose that in MvlLu cells
TGF- 1 treatment increases transcription of pl5 Ink4b which, when transcribed, binds
Cdk4. This binding displaces cyclin D from Cdk4 thereby rendering the cyclin D-Cdk4
complex inactive and liberating p27 from the now defunct complex The liberated p27
binds to the cyclin E-Cdk2 complex, inactivating it. The process is similar in HaCaT
cells, except that the displaced p27 does not bind cyclin E-Cdk2. Instead, a rapid rise in
cipl mRNA levels leads to the association of p21 with cyclin E-Cdk2, inactivating the
complex. Thus, TGF- P-induced cell proliferation arrest is strongly correlated with the
inhibition of the activities of various classes of cdk inhibitors (Figure 2).
As expected for the components of a signaling pathway that acts negatively on
mammalian cell proliferation, mutations in these components have been observed in
various tumors. These, again as expected, tend to be of the tumor suppressor variety.
Loss of TGF-3 expression has been observed in mouse skin carcinomas (Glick et al.,
1993). Lack of, or defects in, the TGF-13 receptors have been noted in gastric cancer cell
lines, lymphomas, and certain colon cancer cell lines (Park et al., 1994; Kadin et al.,
1994; Markowitz et al., 1994). Several melanomas have been found to carry a mutant
version of Cdk4. These mutations involve a change in arginine 24 such that the mutant
Cdk4 protein cannot form stable complexes with p16 Ink4a or p15 Ink4b nor can these
cyclin-dependent kinase inhibitors inhibit the mutant Cdk4 protein. This effect is
specific; mutant Cdk4 protein can form active complexes with cyclin D1 and can be
inhibited by p21 and p27 (Wolfel et al., 1995). A number of melanomas, breast tumors,
leukemias, and non-small cell lung tumors have been shown to carry deletions in human
chromosomal region 9p21, the region in which the genes encoding the Ink4 proteins p15
and p16 are located. Melanoma cell lines often carry point mutations in the p16 Ink4a_
encoding gene (Hannon and Beach, 1994; Kamb et al., 1994; Nobori et al., 1994). Rb
mutations are, of course, common in several tumor types. These include retinoblastomas,
small lung cell carinoma cell lines, bladder carcinoma, and breast carcinoma cell lines
(Horowitz et al., 1990; Weinberg, 1990).
TGF- 3-mediated inhibition involves a negative signal transduction cascade like
yeast mating pheromone and acts on the cell cycle machinery as does yeast mating
pheromone signaling. The mechanism of inhibition is similar as well: inhibitory factors
bind cyclin-kinase complexes. The activation of p27 inhibitor by TGF- P is post-
transcriptional, as is the activation of Farl by yeast mating pheromone. However, the
activation of the p21 and p15 inhibitors requires the transcription of the genes encoding
these proteins. Thus TGF- P inhibition requires the transduction of the negative signal to
the nucleus of the responding cell to activate the transcription of molecules that inhibit
the biologuical process. This provides an example of another variation of negative
signaling that may serve as a mechanism for the action of the synMuv genes.
Antagonistic signaling systems are involved in Xenopus dorso-ventral pattern
formation
Antagonistic signals act to specify dorso-ventral polarity in Xenopus laevis.
BMP-4 acts as a ventralizing factor and has arbitrarily been designated the "positive
signal." Chordin and Noggin act as dorsalizing factors and have been designated
"negative signals." These negative signals act directly on the positive signal without
requiring signal transduction cascades to mediate their effect (Table 1).
Bone morpogenetic protein-4 (BMP-4), a secreted member of the TGF- 3 family
was found in searches for known activin related molecules involved in Xenopus
development (Koster et al., 1991, Dale et al., 1992). BMP-4 was found to be expressed
in the gastrula; expression progressively extends through the ventral marginal zone to
include all of the equatorial region with the exception of the dorsal marinal zone: an
expression pattern complementary to that of goosecoid, a dorsal marker. Later, the BMP-
4 transcripts are excluded from the presumptive neural plate ectoderm, and finally are
found only at the ventral side of the slit blastopore and in a ventral anterior patch (Cho et
al., 1991; Fainsod et al., 1994; Schmidt et al., 1995b).
BMP-4 can act as a ventralizing factor. Injection of BMP-4 RNA can ventralize
both embryos and explanted tissue (Koster et al., 1991; Dale et al., 1992; Jones et al.,
1992; Schmidt et al., 1995b). Thus the addition of ventralizing BMP-4 signal can
override the endogenous dorsalizing activity. Ectopic expression of a dominant negative
BMP-4 receptor construct dorsalized Xenopus embryos (Graff et al., 1994; Suzuki et al.,
1994; Schmidt et al., 1995b). Antisense BMP-4 RNA can also dorsalize embryos
(Steinbiesser et al., 1995) as can dominant negative BMP-4 ligands that cannot be
cleaved to form an active dimer (Hawley et al., 1995). BMP-4 can alter the expression of
genes involved in patterning and positively autoregulate itself (Fainsod et al., 1994; Jones
et al., 1992; Schmidt et al., 1995b). BMP-4 can block the neuralization of dissociated
animal cap cells in vitro (Wilson and Hemmati-Brivanlou, 1995). Likewise, dominant
negative BMP-4 ligand expression induces neural tissue (Hawley et al., 1995). Thus
BMP-4 has been implicated in the ventralization of embryonic mesoderm and the
epidermalization of the ectoderm. It plays an active role as a positive signal. These
results are further supported by observations that in mice in which BMP-4 has been
knocked out, defects occur in the formation of posterior and ventral mesoderm (Hogan et
al., 1994).
noggin was isolated as a clone with dorsalizing activity from LiCl-treated
dorsalized Xenopus gastrulae (Smith and Harland, 1992). noggin encodes a novel protein
that is secreted and acts as a dimer (Smith and Harland, 1992; Smith et al., 1993).
Dorsalizing activity has been demonstrated in both uv-treated ventralized embryos and
normal embryos. Zygotic transcription of noggin occurs in the dorsal lip region of the
Spemann organizer, a region responsible for neural induction and capable of dorsalizing
ventral mesoderm. noggin-conditioned media can dorsalize gastrula stage ventral
marginal zone mesoderm in explant. This activity is predicted of a mesoderm dorsalizing
agent from the Spemann organizer (Smith and Harland, 1992; Smith et al., 1993). noggin
also fulfills another function of the Spemann organizer, neural induction. Purified
Noggin protein can induce neural markers in blastula to mid-gastrula stage animal cap
ectoderm explants cultured in vitro. It can induce neural tissue without first inducing
mesodermal tissue, implying that it directly, rather than indirectly through the agency of
mesoderm, induces neural tissue (Lamb et al., 1993). These results are all consistent with
a role for noggin as a dorsalizing agent for mesoderm and a neural inducer from the
Spemann organizer in Xenopus.
BMP-4 and noggin act antagonistically to pattern the mesoderm. Re'em-Kalma et
al. (1995) have proposed a model that involves a competition between BMP-4 and noggin
to regulate the dorsalization of marginal zone mesoderm. Noggin emanating from the
Spemann organizer acts to turn off or inhibit BMP-4 in nearby marginal zone mesoderm
allowing dorsalization. BMP-4 is present in more ventral domains in high enough
concentration to inhibit the expansion of the dorsalization process while allowing ventral
mesoderm formation. The authors provide several lines of evidence to support this
model. BMP-4 RNA injections induce an increase of ventral mesodermal markers in
animal caps and reduce the ability of treated Spemann organizer to induce muscle from
ventral marginal mesoderm. BMP-4 can also inhibit noggin-mediated dorsalization of
mesoderm in a concentration-dependent manner (Re'em-Kalma et al.,1995). All of these
data point to a BMP-4-Noggin antagonistic interaction
The work of Zimmerman et al. (1996) elucidates the molecular mechanism of the
noggin-BMP-4 antagonism. They show that noggin can block BMP-4 induced alkaline
phosphatase activity of a murine bone marrow stromal cell line in a 1:1 molar ratio. They
show that Noggin specifically binds BMP-4 directly with high affinity (higher than the
affinity of BMP-4 to its own receptor). Noggin-BMP-4 complexes cannot bind BMP-4
receptor types I or II. Similarly, antibodies that block Noggin activity also block Noggin-
BMP-4 binding. From this evidence, the authors propose that Noggin mediates the
Spemann organizer function by blocking ventralizing BMP-4 signaling by directly
binding and titrating out BMP-4 (Zimmerman et al., 1996) (Figure 3).
In vivo evidence from a heterologous system complements the biochemical
evidence for a direct negative regulation of BMP-4 by noggin. Injection of noggin
mRNA can block dorsal fates and promote ventral fates in a dose-dependent manner in
dorsalized Drosophila embryos just as injected BMP-4 mRNA can dorsalize lateralized
embryos (Padgett et al., 1993; Holley et al., 1996). Note that the dorsal and ventral axes
are reversed in arthropods relative to mammals. Despite the reversal of axis orientation,
the mechanisms and characteristics of the dorso-ventral pattern are similar (DeRobertis
and Sasai, 1996; Holley et al., 1996). Coinjection experiments of noggin mRNA with
decapentaplegic (a Drosophila TGF-P-like dorsalizing agent, see below), BMP-4,
activated thick veins (type I receptor) or wild-type punt (type II receptor) showed that
noggin can block the dorsalizing activity of decapentaplegic or BMP-4 ligands but not
the activities of the injected receptor RNA. This suggests that noggin acts upstream of
the receptor (Holley et al., 1996).
Thus noggin acts by binding TGF- p-like molecules and thereby preventing the
binding of these TGF- P-like molecules to their receptors. Another gene, chordin,
behaves similarly. The role of these other molecules suggests that the dorso-ventral
patterning system may be highly redundant or specific.
Chordin, another molecule implicated in the action of the Spemann organizer, acts
as an antagonistic signal. chordin (chd) was identified as a clone enriched in dorsalized
Xenopus embryos in a differential cDNA screen. It encodes a novel secreted protein
(Sasai et al., 1994; Piccolo et al., 1996). chordin is expressed in the Spemann organizer
of the dorsal marginal zone just before and at early gastrula stages (Sasai et al., 1994) and
in the mesodermal mantle which lies under the presumptive neural plate at the gastrula
stage (Sasai et al., 1995). The expression of chd and the expression of noggin in the
dorsal lip is probably regulated differently (Cho et al., 1991; Sasai et al., 1994; Taira et
al., 1994).
Chordin is capable of dorsalizing mesoderm. chd mRNA can dorsalize embryos
and explanted ventralized mesoderm but cannot induce mesoderm (Sasai et al., 1994). In
explant experiments, chd mRNA can induce neural tissue in the absences of mesodermal
tissue (Sasai et al., 1995). Thus, Chordin dorsalizes, but does not induce, mesoderm and
induces neural tissue.
BMP-4 is capable of antagonizing chd-induced dorsalization of mesoderm when
the two mRNAs are injected into different cells suggesting that this antagonism is cell-
nonautonomous. BMP-4 also acts to eliminate chd-mediated neuralization of ectoderm,
but cannot act to eliminate the neuralization caused by injection of mRNA encoding a
dominant negative BMP-4 receptor. A similar antagonism between BMP-4 and Chd is
seen in in vitro explant experiments (Sasai et al., 1995; Piccolo et al., 1996).
Biochemical work has shown that chd can inhibit the alkaline phosphatase activity of the
10T1/2 cell line induced by BMP-4 but not that induced by retinoic acid. A direct
physical interaction is suggested by observations that Chordin is capable of competing
BMP-4 away from its receptors and of immunoprecipitating BMP-4. Chd appears to bind
BMP-4 in a 1:1 Chd to BMP-4 dimer ratio with high affinity (Piccolo et al., 1996)
(Figure 3).
noggin and chordin play similar, and probably somewhat redundant, roles in
mesoderm dorsalization and neural induction in Xenopus. The molecules are unrelated
and differ greatly in size; noggin is much smaller than chordin (Harland and Smith, 1992;
Sasai et al., 1994). noggin expression and chordin expression are under different
controls. chd is active at similar concentrations in both dorsalization and neuralization
whereas noggin is a more potent dorsalizer that neuralizer. These two molecules may act
synergistically in subtly different ways to antagonize BMP-4 and thus finely control
dorsalization and neuralization in the developing Xenopus embryo.
Anti-dorsalizing morphogenetic protein (ADMP), another TGF- 3 family member,
has been identified in Xenopus embryos. ADMP is expressed in the Spemann organizer
and later forms a gradient of expression through the neuroectoderm extending anteriorly.
The expression of this gene is reduced in uv-irradiated ventralized embryos and increased
in LiCl-treated dorsalized embryos as expected for a gene expressed in the organizer.
Paradoxically, the injection of ADMP mRNA into dorsal blastomeres inhibits axis
formation, most particularly the formation of the most anterio-dorsal structures (Moos et
al., 1995). This result is similar to that seen in experiments in which BMP-4 mRNA is
injected dorsally resulting in the decrease of noggin and goosecoid expression (Fainsod et
al., 1994). Moos et al. (1995) argue that ADMP serves to modulate the dorsalizing
activity of the Spemann organizer. Presumably, ADMP acts through the same
mechanism as BMP-4 and seems to more finely regulate the distribution of active
dorsalizing molecules since it acts at the source of these dorsalizing molecules. ADMP
may act as a negative regulator of the negative (dorsalizing) signal.
The antagonisticinteractions involved in Xenopus dorso-ventral polarity
specification are noteworthy in two particiulars. The positive and negative signals are
mutually antagonistic; either can override the other depending on relative dose. This is
likely a necessary function of polarity specification in which gradients define polarity.
Such gradients are discussed in the next section. The other notable characteristic is the
mechanism. The negative signal titrates out the positive signal. The inhibition of the
positive signal by the negative signal occurs upstream of the positive signal transduction
apparatus. The negative signal has no signal transduction system to mediate its
antagonistic effect; it acts directly on the positive signal itself. This may be a possible
mechanism of action for the class A synMuv genes for which there is no evidence for cell
autonomous action.
Antagonistic signals act in the establishment of dorso-ventral polarity in Drosophila
embryos
The determination of dorso-ventral polarity in the Drosophila melanogaster
embryo is similar to that in Xenopus, only the axes are reversed. The work in Drosophila
more clearly illustrates the regulation of activity gradients in antagonistic systems. The
general mechanism is the same, and the molecules involved are homologues (Table 1).
In Drosophila, decapentaplegic (dpp) null mutations produce a ventralized
embryo. dpp acts strictly zygotically and the null allele is haploinsufficient for lethality
(Irish and Gelbart, 1987). dpp encodes a member of the TGF- 3 peptide growth factor
family (Padgett et al., 1987) that is closely related to BMP-4 (Gelbart, 1989). Expression
studies using probe from the two-exon haploinsufficient region that is present in all dpp
transcripts show embryonic expression just after nuclear division 11, reaching its peak at
the early cellular blastoderm stage. This initial expression is seen in the dorsal-most 40
% of the embryo (St. Johnston and Gelbart, 1987). The early dorsal expression is
eliminated in embryos from mutant mothers carrying the maternal ventralizing alleles of
Toll (TI), easter, and cactus. In dorsalized embryos produced by dorsal (dl) mothers, dpp
expression is expanded throughout the entire dorso-ventral axis of the embryo (Ray et al.,
1991).
The dpp ventralized phenotype is incompletely epistatic to the maternal dorsalized
phenotype produced by dorsalizing alleles of TI, dl and pelle (pll). Double mutants
(homozygous dpp animals derived from mothers homozygous for the maternal effect
mutation) with dl and pll were lateralized whereas double mutants with the weaker Tl
allele were ventralized (Irish and Gelbart, 1987). Zygotic ventralizing mutations,
however, do not affect the initial dpp espression pattern (Ray et al., 1991). These results
suggest that dpp expression is regulated by the maternal localization gradient of dl (Roth
et al, 1989; Ray et al., 1991). The observation that dpp mutations produce the strongest
ventralized phenotype of any of the zygotic ventralizing mutations, and the observation
that these other mutations cannot enhance the dpp phenotype, suggest that dpp is the
primary determinant of dorsal pattern in the Drosophila embryo (Irish and Gelbart, 1987;
Ray et al., 1991; Arora and Nusslein-Volhard, 1992).
dpp acts in a graded fashion to specify dorso-ventral polarity. dpp loss-of-
function and reduction-of-function mutations form a single allelic series in which the
extent of polarity defects correlates with the extent of embryonic lethality. The dorsal-
most structures are lost in mutants carrying the weakest alleles whereas defects in
increasingly ventral tissues are seen in strains carrying stronger alleles. This suggests that
the dpp gradient specifies amnioserosa at its highest activity level, and dorsal epidermis
and ventral epidermis at decreasing activity levels (Arora and Nusslein-Volhard, 1992;
Wharton et al., 1993). Dosage studies can be conducted with duplications carrying dpp+.
Increasing the dpp+ dose in wild type increases the extent of amnioserosa, the dorsal-
most tissue (Wharton et al., 1993). Increasing the dose of dpp+ in animals carrying
mutations in the zygotically acting ventralizing genes can bypass the ventralizing effect
of these mutations (Ferguson and Anderson, 1992b). However, these effects are seen
only in the dorsal and lateral regions of the embryo. In the absence of ventralizing
activity in dl embryos, increased dpp+ dose can lead to the expansion of the amnioserosa
to encompass the entire circumference of the embryo (Wharton et al., 1993).
In addition to these genetic data, RNA microinjection data support the contention
that dpp acts in a graded fashion to specify dorsal fates. Ferguson and Anderson (1992a)
report that small amounts of dpp+ RNA injected into the ventral side of a syncytial
embryo can expand the dorsal domain and that large amounts can lead to the formation of
amnioserosa along the entire dorso-ventral axis except the ventral mesodermal region.
Injection of dpp+ RNA into lateralized embryos, which do not express zygotic dorso-
ventral genes, from snake (snk) T1 mothers show that dpp+ RNA can cause a dose-
sensitive dorsalization of the embryo. dpp+ RNA can organize elements of the dorso-
ventral pattern at the site of the injection, pattern the dorsoventral axis from amnioserosa
to ventral epidermis, and allow germband extension to occur (Ferguson and Anderson,
1992a). Since dpp is expressed at uniform concentrations in the dorsal-most 40 % of the
embryo (St. Johnston and Gelbart, 1987), it is likely that the dpp gradient is post-
transcriptional; that is, based on its activity rather than expression (Ferguson and
Anderson, 1992a; Wharton et al., 1993).
Several gene products seem to enhance the activity of dpp. screw (scw) and
tolloid (tid) mutations lead to ventralization of Drosophila embryos but do not result in as
severe a phenotype as do dpp null mutations (Ray et al., 1991; Arora and Nusslein-
Volhard, 1992). Allelic series of scw and tid mutations show increasing loss of
amnioserosa with increasing allele strength (Arora and Nusselein-Volhard, 1992;
Ferguson and Anderson, 1992; Arora et al., 1994). Thus, allelic series of these genes are
similar to the dpp allelic series, though not as severe. scw and tld mutations enhance each
other but even together do not produce a phenotype as strong as that produced by strong
dpp alleles (Arora and Nusslein-Volhard, 1992). Increased doses of dpp+ can at least
partially bypass the requirement for scw and tid (Ferguson and Anderson, 1992b; Arora et
al., 1994).
scw is expressed along the entire dorsoventral axis at the same level just before
gastrulation, but expression of scw + under the control of a tld promotor which expresses
only in the dorsal region is sufficient to rescue the scw phenotype. scw has been cloned
and shown to encode a TGF- 1 homologue and has been hypothesized to act as a
heterodimer with Dpp to control the formation of the dorsal-most amnioserosa cells
(Arora et al., 1994). tld, like dpp, has antimorphic alleles that are stronger than
deficiencies. Elevated dpp+ expression can partially bypass tld but elevated tld+ activity
cannot bypass dpp, suggesting that tid acts to elevate the level of dpp activity (Ferguson
and Anderson, 1992b). tld is expressed at peak levels during early cellularization stages
in the dorsal-most 50 % of the embryo, overlapping the dpp expression domain (Shimell
et al., 1991). tld encodes a protein similar to bone morphogenetic protein-i (BMP-1), a
protease that copurifies with the TGF- f-like BMPs and has bone morphogenetic activity
(Wozney et al., 1988; Shimell et al., 1991). It has been postulated that the binding ability
and protease activity of tld act to enhance the activity of dpp and scw (Shimell et al.,
1991; Arora et al., 1994; Childs and O'Connor, 1994). Thus the dpp gradient is positively
modulated by other, secreted proteins.
short gastrulation (sog) mutants were originally characterized as having a weak
ventralized phenotype similar to that of the weakest dpp alleles (Zusman et al., 1988; Ray
et al., 1991; Wharton et al., 1993). Germline mosaic results demonstrate that sog acts
strictly zygotically (Zusman et al., 1988). sog does not affect the ventral expression of
dpp but eliminates the later refinement of the dpp, tld and zen expression patterns.
Ventral genes are unaffected (Ray et al., 1991; Fracoise et al., 1994). A closer inspection
of the phenotype of null alleles of sog reveals that the primary defect in sog mutants is the
failure to subdivide the dorsal region into amnioserosa and dorsal ectoderm domains
(Francoise et al., 1994). Mosaic analysis of sog gynandromorphs suggests that sog is
required in the ventral region of the embryo (Zusman et al., 1988). This coincides with
the expression domain of sog as determined by in situ hybridization; sog is expressed at
early cellularization in the ventral region of the embryo. Transcripts are found in the
apical regions of cells and their expression pattern is not altered in zygotic ventralization
mutants. The domain of sog expression is directly adjacent to the domain of dpp
expression as seen in co-staining experiments (Francoise et al., 1994).
sog acts antagonistically to the dorsalizing activity of dpp and tld. Heterozygous
sog can suppress antimorphic alleles of tld and the haploinsufficiency of strong dpp
alleles (Ferguson and Anderson, 1992b; Francoise et al., 1994). Duplications which
increase the dose of dpp+ in sog mutants enhance the sog phenotype. The neurogenic
pattern is altered and fates shift to more ventral positions; i.e. the embryo becomes more
dorsalized. Thus, sog appears to inhibit dpp activity in the neurogenic ectoderm and in
the ventral domain (Ferguson and Anderson, 1992b; Biehs et al., 1996). Results from
experiments involving the dorsal injection of sog mRNA support this conclusion. Such
injections block amnioserosa formation and ventralize embryos (Holley et al., 1995).
Recent evidence suggests that dpp is epistatic to sog. sog; dpp double mutants
show marker expression similar to that of dpp mutants (Biehs et al., 1996). Biehs et al.
(1996) have shown that the range at which sog can affect the expression of dorsal
markers varies directly with the dose of sog + activity. These results provide additional
support to the evidence presented above by Zusman et al. (1988) and Francoise et al.
(1994) that sog acts over a distance to modulate cell fate specification. These results lend
support to the model of Ferguson and Anderson (1992b), that sog acts in an inhibitory
manner to define the dpp activity gradient (Figure 3).
As has been noted above, the Drosophila dorso-ventral patterning system has
many mechanistic parallels to the Xenopus dorso-ventral patterning system. The general
patterning mechanism in which at least one TGF- P-like molecule defines one pole and an
antagonistic signaling mechanism defines the other pole with respect to the first signal is
similar in both organisms. The secreted signaling molecules that act as antagonists,
chordin and sog, are homologous (Francois and Bier, 1995). Many of the molecules in
these two organisms have been shown to be functionally interchangable. (Padgett et al.,
1993; Holley et al., 1995; Schmidt et al., 1995a; Holley et al., 1996). However,
dpp/BMP-4 acts in ventral specification in Xenopus and dorsal specification in
Drosophila whereas soglchd and noggin act in dorsal specification in Xenopus and
ventral specification in Drosophila. Thus, the poles of these axes seem to be reversed
despite the conservation of the mechanisms of specification. Several workers have
proposed that these results support the contention of Etienne Geoffrey Saint-Hilaire that
the dorso-ventral axis of arthropods and chordates are homologous, but inverted with
respect to each other (Holley et al., 1995; DeRobertis and Sasai, 1996; Ferguson, 1996).
Thus, the vertebrate and arthropod dorso-ventral patterning systems seem to be
homologous. In light of the similarity between these two systems, the conclusions drawn
from Drosphila dorso-ventral polarity can be considered to be the same as those drawn
from the studies of Xenopus dorso-ventral polarity determination. The Drosophila work
does serve to point out the sophisticated regulation of activity gradients possible in
antagonistic signaling systems.
clr-i acts antagonistically to egl-15 in C. elegans development
Antagonistic signaling systems may directly inhibit the transduction of the
positive signal within the cytoplasm of the responding cell. In the case of egl-15 and clr-
1 in C. elegans developnent, this is not known to be the case, but is the simplest model.
The EGL-15 receptor propagates the positive signal whereas the CLR-1 receptor
propagates the negative signal. CLR-1 is postulated to directly inhibit EGL-15-mediated
signal transduction (Table 1).
In addition to a role in sex myoblast migration, egl-15 (egg-laying defective)
mediates an essential function in C. elegans development. Complete loss-of-function
alleles in egl-15 lead to developmental arrest in early L1 larvae, shortly after hatching.
Many Egl- 15 larvae die shortly after this cessation of development (Stern and Horvitz,
1991; DeVore et al., 1995). egl-15 encodes a fibroblast growth factor (FGF) receptor,
suggesting that it acts to transduce a signal that is necessary for continued development of
the L1 larva (DeVore et al., 1995).
The clr-1 (clear) gene has also been shown to play a role in early larval
development. Mutations in clr-1 produce a Clear phenotype that is characterized by a
fluid-filled pseudocoelom. Scrawny, dumpy, uncoordinated, sterile and lethal phenotypes
are also produced by mutations in the gene (Hedgecock et al., 1990; Clark et al. 1992a;
1992b; DeVore et al., 1995). clr-1 can suppress the egl-15 lethal phenotype and egl-15
can suppress the clr-1 lethal, clear and other phenotypes (Clark et al., 1992b; DeVore et
al., 1995). This mutual suppression constitutes genetic evidence for an antagonistic
interaction between these genes in early larval development.
clr-1 has been cloned and found to encode a receptor tyrosine phosphatase. The
extracellular domain has been found to be required for rescue, suggesting that CLR-1
may respond to a signal. This has led to the proposal that CLR-1 dephosphorylates some
component of the egl-15 FGF receptor signal transduction pathway, possibly Egl-15
itself, in response to the antagonistic signal. This dephosphorylation negatively regulates
the egl-15 pathway (M. Kokel and M. Stern, personnal communication). Although the
exact developmental process that these genes regulate is not well defined, it is clear that it
is mediated by opposing signaling systems (Figure 4).
The model for egl-15 and clr-1 antagonism is noteworthy for several reasons.
First, the effect of the negative signal is mediated by a short signal transduction system,
the receptor itself. No further signal transduction need occur. Second, the negative
signal acts by directly inhibiting the transduction of the positive signal within the
responding cell. Third, the postulated biochemical mechanism is intriguing. The
negative signaling system undoes the the activating phosphorylation of a molecule caused
by the positive signal. Thus, this system serves as an example of direct negative
regulation of the positive signal transduction system itself. The variations on this theme
are enormous and well suited for a mechanism of synMuv gene activity.
Antagonistic signals act to specify cell fates in Drosophila ommatidia
Antagonistic signals act in the specification of ommatidial cell fates in the
developing eye of Drosophila. The positive signal is Spitz, the ligand of the Drosophila
EGF receptor at this time in the developing eye. It is countered by the negative signal
Argos. This system provides another example of a regulatory system that acts upstream
of the signal transduction system, albeit in a different manner (Table 1).
Drosophila eye development provides an excellent system for the analysis of cell
signaling mechanisms. The eye is composed of a crystalline array of self-contained,
identical ommatidia. Each ommatidium is composed primarily of an outer group of
pigment cells which surround a group of four cone cells, which in turn surround a cluster
of eight photoreceptors and two "mystery cells." These photoreceptors differentiate in a
set sequence: R8, R2 and R5, R3 and R4, R1 and R6, and finally, R7 (reviewed by
Tomlinson, 1988). In particular, the determination of the R7 cell has been intensively
studied. R7 determination is primarily directed by the sevenless (sev) receptor tyrosine
kinase and a ligand encoded by bride ofsevenless (boss). Genetic analysis has revealed
that a ras -mediated signal transduction pathway transduces the sev signal (reviewed by
Simon, 1994). This signal transduction pathway is required for the development of all
photoreceptors, not just R7 (Simon et al., 1991; Fortini et al., 1992). The phenotypes
caused by mutations in these signal transduction genes resemble those caused by
Drosophila EGF receptor (DER) mutations in adults (Diaz-Benjumea and Hafen, 1994).
Ellipse (Elp) mutations provided evidence for the involvement of DER in
Drosophila eye development. The eyes of Elp flies are irregular and have few
ommatidia. To the extent tested, Elp acts as a hypermorph. Revertants of Elp mutations
fail to complement faint little ball (flb) mutations in the Egfr, demonstrating that Elp
mutations are alleles of Egfr, the gene encoding the DER. In x-ray-induced mosaic
clones of recessive revertant alleles andflb alleles, the mutant cells did not survive. This
suggests that Egfr plays a role in eye disc cell proliferation and ommatidial formation
(Baker and Rubin, 1989). In situ expression data in which the Egfr is found uniformly
expressed throughout the eye disc is consistent with this model (Schejter et al., 1986).
Viable torpedo (top) alleles of Egfr as homozygotes and trans-heterozygotes with
null alleles did not affect the number or spacing of ommatidia but led to the development
of eyes containing ommatidia with aberrant morphology or fewer photoreceptors than
wild type. These results suggest that DER may be playing multiple roles in eye
development (Baker and Rubin, 1992). Genetic mosaic analysis using the FLP/FRT
system enabled Xu and Rubin (1993) to analyze the role of Egfr in eye development more
precisely. They confirmed the role of Egfr in eye disc cell proliferation in early third
instar larval eye discs. Clones induced posterior to the morphogenetic furrow contained
cells which did not differentiate into photoreceptors as judged by basal nuclei and lack of
expression of neuronal markers. This result suggested a role in photoreceptor
determination in addition to the role seen in earlier cell proliferation (Xu and Rubin,
1993). These results were further extended through the use of dominant negative DER
constructs under various promotors. Expression of the dominant negative receptor in
cells behind the morphogenetic furrow blocked the determination of photoreceptors other
than R8 and R2/5. Heat shock-controllable promotors allowed the production of
ommatidia in which the photoreceptors being recruited at the time of the heat shock are
not found. Later heat shock produced the same result for cone cells and pigment cells. It
was also noted that R7 determination required DER activity (Freeman, 1996).
The role of the DER in the determination of photoreceptor identity is mediated by
the gene spitz (spi). spitz encodes a molecule with a signal sequence, a transmembrane
domain, a dibasic proteolytic clavage site, and a single EGF domain. In this sense, it is
similar to TGF-ct, which has only a single EGF repeat (Rutledge, et al., 1992). In vitro
experiments in Schneider S2 cells show that secreted Spi can lead to the
autophosphorylation of DER whereas the membrane-bound form of Spi cannot
(Schweitzer et al., 1995b). These authors suggest that Star and rhomboid play a role in
processing the Spi ligand (Schweitzer et al., 1995b). Weak, viable, partial loss-of-
function alleles of spi show a reduced number of photoreceptor cells (Tio et al., 1994).
Genetic mosaic analysis reveals that spitz is required for most photoreceptor
determination. R8 absolutely requires spi activity in order to lead to the formation of
additional photoreceptors. If R8 lacks spi activity, the ommatidium fails to form. spitz
activity in R8 is sufficient to lead to photoreceptor development. R2/5 show a strong, but
not absolute, requirement for spitz activity. This mosaic analysis shows that spitz is
required for photoreceptor determination but not precursor cell proliferation. These
results suggest that R8 does not require spitz activity to be determined but that all other
photoreceptors do. The current model holds that R8 secretes Spitz protein which
determines R2/5 photoreceptors which also secrete Spitz protein. The secreted Spitz
protein induces the other photoreceptors in sequence. Clonal analysis suggests that the
spitz activity range is quite limited in that it can act within an ommatidial precursor but
not between ommatidial precusors in photoreceptor determination (Freeman, 1994b; Tio
et al., 1994; Tio and Moses, 1997). Preliminary expression data for spitz is consistent
with this interpretation (Tio et al., 1994; Tio and Moses, 1997).
Another gene, argos (aos), mediates an inhibitory signaling pathway for
photoreceptor development. argos mutants have rough eyes, reduced viability, and one
or two extra photoreceptor cells in many of their ommatidia (Freeman et al., 1992;
Kretschmar et al., 1992; Okano et al., 1992). The so-called "mystery cells," whose
ultimate fate in the developed eye is as yet unknown, differentiate as photoreceptors in
argos mutants. Later defects are also observed in the developing eye. More cone cells
form (an average of nine compared with four in wild type), as do more primary pigment
cells (an average of five rather than two). Thus the Argos gene product appears to inhibit
the adoption of successive cell fates in the ommatidia (Freeman et al., 1992). Complete
loss-of-function alleles are lethal, but mosaic clones of these alleles in the developing eye
show defects similar to those of weaker alleles (Freeman et al., 1992; Kretzschmar et al.,
1992). This mosaic analysis suggests that argos acts cell non-autonomously. The extra
cells in ommatidia need not be mutant. Small or narrow clones have few defects and
ommatidia on the border of large mutant clones are often wild-type. These defects
suggest that argos activity has a range of 1-2 ommatidia (Freeman et al., 1992).
Overexpression of argos under the control of a heat shock promotor in early pupae leads
to missing photoreceptors, fewer cone cells, and fewer primary pigment cells in anterior
to posterior positions, respectively, suggesting that the time of overexpression of argos is
important to the production of the mutant phenotypes in these cells (Freeman, 1994a).
argos has been shown to interact genetically with many alleles of genes involved
in the DER signaling pathway. Reduction-of-function argos phenotypes are suppressed
by heterozygous loss-of-function mutations of DER signaling pathway components and
of spitz. The increased activity of argos by heat shock overexpression is enhanced in the
genetic backgrounds described above which suppress argos reduction-of-function
phenotypes. In early development, Egfr hypomorphic phenotypes are similar to
phenotypes caused by overexpression of argos while reduction-of function alleles of
argos produce a phenotype similar to that produced by Elp gain-of-function alleles of
Egfr. Notably, the phenotypes produced by overexpression of argos and Elp alleles of
Egfr mutually supress each other. These genetic interactions support a model in which
argos acts as an inhibitor of the Egfr signaling pathway (Schweitzer et al., 1995a).
argos encodes a novel 444 amino acid protein with a signal sequence, but no
transmembrane domain. It also contains a single six cysteine domain with some
similarity to the concensus EGF repeat (Freeman et al., 1992; Kretschmar et al., 1992;
Okano et al., 1992). One loop in particular is larger than that seen in other EGF motifs
(Schweitzer et al., 1995a). argos can be expressed in cultured cells which secrete Argos
protein into the media, thus suggesting that Argos acts as a secreted protein (Freeman,
1994a). lacZ expression studies were conducted using an enhancer trap line in which
lacZ is under the transcriptional control of the argos promotor. These expression studies
show expression behind the morphogenetic furrow. lacZ is expressed strongly in all
developing photoreceptors in order of differentiation: R8, R2/5, R3/4, R1/6, R7. The
mystery cells only express lacZ weakly.
Argos has been shown to directly inhibit the DER pathway. Argos acts as a
competitive inhibitor of DER activation by Spitz protein in experiments in which the
autophosphorylation activity of DER expressed in S2 cells is assayed. Preincubation of
these cells with Argos prevents activation by Spitz (Schweitzer et al., 1995a). The
observation that Argos can rapidly reduce the ligand-independent autophosphorylation
activity of overexpressed DER suggests that Argos does not act to titrate out Spitz but
acts on the receiving cell itself, presumably directly binding to the receptor in a fashion
similar to Spitz protein. In this regard, it is notable that both Argos and Spitz contain a
single EGF-like domain (Schweitzer et al., 1995a) (Figure 5).
These results have led to the proposal of a model for the sequential determination
of photoreceptors, cone cells, and pigment cells in the developing ommatidia. Spitz is
produced by the first photoreceptor R8 and subsequently by R2 and R5. The Spitz ligand
activates DER in the other presumptive photoreceptor cells in sequence. It also activates
Argos expression (Freeman, 1996; 1997). Golembo et al., (1996) showed that DER
activity was necessary for argos expression both in vivo and in cell culture experiments.
Argos then inhibits the induction of more distant cells since its range is significantly
greater than that of Spitz. Higher levels of Spitz can overcome Argos-mediated inhibition
of DER. After the photoreceptors are determined in sequence, the cone cells , which are
radially more distant from the initially determined R8 cell of the ommatidium, are
formed. Later still, the primary pigment cells are induced, followed by the secondary and
tertiary pigment cells. Thus the Freeman model involves remote inhibition, and the
limitation of the spreading of Spitz. This reduction of Spitz activity spread coupled with
a postulated clock that determines cell competence to adopt different fates permits the
proper determination of ommatidial components and radial pattern (Freeman, 1996;
1997).
The Spitz/Argos system provides an example of a simple mechanism of
inhibition. The positive and negative signals each bind to the same receptor. The
receptor acts to propagate the positive signal. However, the negative signal can bind to
the receptor ligand binding site but cannot activate the receptor. By blocking the access
of the positive ligand to the receptor, the negative ligand inhibits the positive signaling
system. The negative ligand presumably acts as a competitive inhibitor of the positive
ligand. This mechanism is more fully developed in the folloing section. This example
demonstrates how a positively acting receptor can be negatively regulated directly. Other
variations are possible, such as a negative signal molecule binding to the receptor at a site
other than the positive ligand binding site and preventing receptor dimerization or the
conformation changes necessary for signal transduction. In these cases, the negative
signal would be expected to act as a noncompetitive inhibitor. These mechanisms of
negative regulation of a positively acting receptor are good possibilities for the class A
synMuv genes since few molecules are required to effect negative regulation in this
manner.
Inhibition of IL-1 receptor activity by a negative regulatory ligand
The mechanism by which Argos acts as an antagonist of DER may be similar to
the mechanism by which the interleukin-1 receptor antagonist (IL-1ra) acts on the
interleukin- 1 (IL- 1) receptor. A detailed biochemical analysis of the mechanism of Argos
inhibition of DER has not yet been conducted. However, more detailed biochemical data
on the negative regulation of the IL-1 receptor by an inhibitory ligand are available. This
data provides some insight into a possible mechanism of Argos action.
IL-1ra was purified from media conditioned by IgG-stimulated monocytes which
also secrete IL- I a and IL- 1 3, the stimulatory ligands of the IL- receptor. IL- ra was
cloned and shown to encode a small protein containing a signal sequence with a limited
similarity to IL-1 a (26 %) and IL-I P (19 %). IL-lra fails to stimulate the IL-I receptor
even at high concentrations. IL-1ra was shown to not bind IL-1, but to bind the IL-i
receptor. Binding studies indicate that IL-lra binds to the IL-1 receptor with an affinity
similar to that of IL-1 a and IL- 1 3, and that it acts as a competitive inhibitor of IL-I
binding to receptor (Carter et al., 1990; Eisenberg et al., 1990; Hannum et al., 1990). It is
noteworthy that the same cell type secrets both the stimulatory ligand and the antagonist,
but that the mRNA encoding IL-1ra does not include the potential RNA stability motifs
found in the mRNAs encoding IL-1 a and IL-1 P. The differential stability of the positive
and negative ligands may play a role in the modulation of IL-I receptor activation by the
stimulatory cell (Carter et al., 1990; Eisenberg et al., 1990).
Recent results reveal more about the mechanism of antagonistic action by IL- Ira.
Co-crystallization of IL- 1P and IL- receptor extracellular domain and co-crystalization
of IL- ra and IL- receptor extracellular domain have allowed the nature of the binding
of these ligands to receptor to be determined at a high level of resolution. IL- Ira does not
interact with one of the receptor sites that IL- 13 does. IL-i receptors in which this site
has been deleted bind IL-1 a and P with much reduced affinity but continue to bind IL-1ra
with high affinity (Schreuder et al., 1997; Vigers et al., 1997). These results suggest that
an antagonist that acts as a competitive inhibitor prevents binding of the stimulatory
ligand to the receptor by binding to the ligand interaction site but not interacting with site
necessary to stimulate activity by the receptor. Presumably, Argos acts in a similar
manner on the DER (Figure 5).
Different mechanisms are used to antagonize stimulatory signals
The preceeding examples illustrate not only the great diversity of different
processes in which antagonistic signals act, but also the great diversity of mechanisms by
which these signaling systems exert their effects. Many of these antagonistic regulatory
pathways act directly on the positive signaling system to inhibit or modulate the activity
of the stimulatory pathway. In these cases, the antagonism manifests itself as a
downregulation or a complete inhibition of the stimulatory pathway.
Direct action on the stimulatory signaling system can either be mediated upsteam
of the signal transduction cascade or on the signal transduction cascade itself. Examples
of inhibitory regulators acting upstream of the stimulatory signal transduction pathway
are chordin and noggin, sog, argos, and IL- ra. Chordin, Noggin and Sog exert their
effects by directly binding the stimulatory ligand and rendering it incapable of activating
its receptor. Thus, these molecules act to titrate out the positive signal. Argos and IL-lra
act as inhibitory ligands for the receptor of the stimulatory ligand. These inhibitory
ligands compete for the ligand binding domain, preventing the stimulatory ligand from
binding. The bound inhibitory ligand precludes stimulatory ligand binding of the
receptor, but does not activate the receptor itself.
Other antagonistic signaling systems act directly on the stimulatory signal
transduction system. These include the TGF- P-mediated and yeast mating pheromone-
mediated negative regulation of cell proliferation and the clr-1 negative regulation of
larval developmental progression in C. elegans. The cell proliferation inhibitory
pathways consist of a receptor and signal transduction cascade which transduce the
negative signal in the responding cells . These systems activate a molecule or molecules,
cdk inhibitors in mammals or Far 1 in yeast, which directly inhibit the cell cycle
machinery activated by the stimulatory pathway. In these cases, the stimulatory and
inhibitory signals are transduced to a common target for regulation. The other example
cited of a mediator of a stimulatory signal transduction cascade involves the Clr-1
receptor phosphatase. Although its target is unknown, it likely acts by dephosphorylating
the stimulatory Egl-15 receptor, or another downstream molecule in the Egl-15 signal
transduction cascade. This downregulates Egl-15-mediated signaling.
Although there are no examples presented in which the negative regulatory
pathway acts indirectly at the level of transcriptional control, this is theoretically possible.
In this scenario, the stimulatory and inhibitory signals are transduced to the nucleus of the
responding cell. There, they control the transcription of genes necessary for the process
which is being regulated. The inhibitory system may negatively regulate transcription
factors stimulated by the positive signaling system or may stimulate negatively acting
transcription factors which would interact with positive transcription factors at the
promotor. Such a scenario does not differ conceptually from the positive and negative
regulation of cyclin-cdk complexes. In this case, the targets of the positive and negative
signaling systems are the promotors of genes necessary for the process being regulated
rather than a cyclin-cdk complex. Since lin-36 may encode a nuclear protein, it is
possible that the class B synMuv genes negatively regulate vulval development at the
promotor level or by modulating the activity of transcription factors involved in this
process.
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Table 1. Examples cited of biological processes which involve antagonistic signaling
systems are listed. Biological process, biological process regulated by antagonistic
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arbitrary. Mechanism of negative regulation, mechanism, if known, by which the
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Figure 1. Antagonistic signals controlling yeast cell division. (A) Nutrients act as a
positive signal to activate a Cln-Cdc28 complex which allows cell division. (B) Mating
pheromone acts through a distinct signal transduction cascade to activate Farl via
phosphorylation. Phosphorylated Farl binds to the Cln-Cdc28 complex, inhibiting it and
thereby inhibiting cell division.
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Figure 2. Antagonistic signals controlling mammalian cell division. (A) Mitogen
signaling activates Cyclin E-Cdk2 and Cyclin D-Cdk4 complexes which
hyperphosphorylate Rb allowing cell division. (B) TGF- 1-mediated inhibition in MvlLu
cells. TGF- 1 signaling causes p27 to bind Cdk2 and inhibit cyclin-Cdk2 complex
activity. ink4 transcription is activated, leading to the production of p15 which associates
with Cdk4 thereby inhibiting the cyclin D-Cdk4 complex. Rb is not hyperphosphorylated
and cell division is prevented. (C) TGF-3-mediated inhibition in HaCaT cells. TGF-3
signaling activates the transcription of ink4b and cipl. The protein products, p15 and
p21, bind to Cdk-4 and Cdk2, respectively, inhibiting the cyclin-Cdk complexes. This
prevents Rb hyperphosphorylation and cell division.
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Figure 3. Negative regulation of a signal transduction system by a negative signal that
titrates out the positive signal. Xenopus and Drosophila dorso-ventral polarity
specification use this process. (A) In the absence of negative signal, the positive signal
binds and activates the receptor. (B) In the presence of negative signal, the positive
signal is bound by the negative signal molecule and is thereby prevented from binding
and activating the receptor. Molecules depicted are from Xenopus dorso-ventral polarity





Figure 4. C. elegans larval development regulatory system involving antagonistic signals
mediated by the EGL-15 and CLR-I proteins. (A) In the absence of a negative signal
mediated by the CLR-1 receptor, the positive signal activates the EGL-15 receptor which
leads to the phosphorylation of a molecule necessary for signal transduction. (B) In the
presence of a CLR-1 ligand, CLR-1 dephosphorylates the signal transduction molecule
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Figure 5. Antagonistic signaling by means of a negative ligand for the receptor of the
positive signal. (A) In the absence of negative signal, the ligand (positive signal)
activates the receptor. In the specification of ommatidial cell fates in the Drosophila eye,
Spitz is the ligand and DER is the receptor. In IL-I signaling, IL-i is the positive ligand
that binds the IL-i receptor. (B) Negative regulation is mediated by a negative ligand
molecule which can bind the receptor without activating it and prevent postitive ligand
binding. The negative ligand acts as a competitive inhibitor. In Drosophila ommatidial
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Summary
Previous studies have shown that a synthetic multivulva phenotype results from
mutations in interacting genes that negatively regulate the ras-mediated intercellular
signaling system of Caenorhabditis elegans vulval induction. The interaction of
synthetic multivulva mutations in two different classes of genes, class A and class B, is
required to produce the multivulva phenotype. The multivulva phenotype is produced by
the formation of ectopic vulval tissue by vulval precursor cells which in wild type do not
form vulval tissue. Mutations in either class alone do not cause a vulval phenotype. In
this paper, we describe the isolation and characterization of 49 synthetic multivulva
mutations and the identification of six new synthetic multivulva loci.
Introduction
A receptor tyrosine kinase and Ras-mediated signal transduction pathway is
essential to the specification of vulval cell fates in the development of the hermaphrodite
vulva of Caenorhabditis elegans. This signal transduction cascade has been implicated in
the development and growth of other organisms and in oncogenesis. However, little is
known about the negative regulation of this signal transduction pathway. In oncogenesis
such negative regulators act as tumor suppressor genes. The synthetic Multivulva
(synMuv) genes perform this role in C. elegans vulval development. Thus, these genes
provide an opportunity to study the negative regulation of a receptor tyrosine kinase and
Ras-mediated signal transduction pathway in a genetically tractable model system.
The hermaphrodite vulva of Caenorhabditis elegans is formed from the
descendents of three hypodermal blast cells, P(5,6,7).p (Sulston and Horvitz, 1977).
These cells are part of the vulval equivalence group, P(3-8).p, a set of six cells which
have the potential to adopt either one of two vulval fates (10 or 20) or a nonvulval fate (3°)
(Sulston and White, 1980; Kimble, 1981; Sternberg and Horvitz, 1986). These cell fates
are specified by several cell interactions (for review, see Horvitz and Sternberg, 1991;
Eisenmann and Kim, 1994; Sundaram and Han, 1996). The gonadal anchor cell signals
the nearest Pn.p cells to adopt vulval fates. A signal from the anchor cell is at least partly
responsible for establishing the proper pattern of vulval fates (Kimble, 1981; Sternberg
and Horvitz, 1986; Thomas et al., 1990; Simske and Kim, 1995; Katz et al., 1995). In
addition to the influence of the gonadal anchor cell signal on the pattern of vulval cell
fates, another signal is propagated amongst the induced Pn.p cells to prevent the
formation of adjacent primary cells (Sternberg, 1988). Another signal, presumably
emanating from the hypodermal syncytium, inhibits the adoption of vulval fates (Herman
and Hedgecock, 1990). It is likely that the anchor cell signal overrides this inhibitory
signal to induce the cells nearest to the uterus to adopt vulval fates.
Genetic dissection of vulval development has led to the identification and
characterization of numerous genes involved in different aspects of this process (for
review, see Horvitz and Sternberg, 1991; Eisenmann and Kim, 1994; Sundaram and Han,
1996). Many of these genes encode proteins implicated in signal transduction. Among
those involved in the transduction of the inductive signal from the anchor cell are: lin-3,
an EGF-like molecule (Hill and Sternberg, 1992), let-23, a receptor tyrosine kinase
(Arioan et al., 1990), sem-5, an adaptor molecule (Clark et al., 1992), let-60, a ras
GTPase (Han and Sternberg, 1990; Beitel et al., 1990), lin-45, a rafserine/threonine
kinase (Han et al., 1993), mek-2, a mitogen-activated protein (MAP) kinase kinase
(Kornfeld et al., 1995a; Wu et al., 1995), mpk-1/sur-1, a MAP kinase (Lackner et al.,
1994, Wu and Han, 1994), and ksr-1, a protein kinase (Kornfeld et al., 1995b).
Many loss-of-function mutations in the genes described above result in a
vulvaless (Vul) phenotype in which the vulva is not formed. Mutations in some other
genes result in a multivulva (Muv) phenotype in which ectopic vulva tissue is produced.
The multivulva (Muv) phenotype of certain mutant strains results from the interaction of
two different mutations (Horvitz and Sulston, 1980; Sulston and Horvitz, 1981; Ferguson
and Horvitz, 1985; 1989). The mutations that interact to produce such a synthetic
multivulva (synMuv) phenotype fall into two classes: A and B. Animals carrying both a
class A and a class B mutation have a Muv phenotype. Animals that carry mutations in a
single class have a wild-type vulval phenotype. Ferguson and Horvitz (1989) have
proposed that the synMuv genes encode the components of two functionally redundant
pathways that negatively regulate vulval development.
SynMuv mutants were discovered in the first screen for mutations that produced
lineage defects. The mutant strain CB 1322 had a Muv phenotype that was found to
require the presence of two unlinked mutations, lin-8(n111) and lin-9(n112). Neither of
these mutations caused a vulval phenotype when alone (Horvitz and Sulston, 1980;
Sulston and Horvitz, 1981). Systematic mutagenesis of strains carrying either lin-8(nl 11)
or lin-9(n112) and the mutagenesis of another strain carrying a previously undetected
class A synMuv mutation in the background allowed the identification of additional
mutations that behaved like lin-8(nl 11) (class A) or lin-9(n112) (class B). Several of
these mutations failed to complement lin-15 for either a class A or a class B activity
(Ferguson and Horvitz, 1989). lin-15 had been previously identified by alleles that
produced a Muv phenotype (Ferguson and Horvitz, 1985). These genetic analyses
suggested that lin-15 is a complex locus that contained genetically separable class A and
class B activities (Ferguson and Horvitz, 1989). Subsequent molecular analyses of lin-15
revealed that lin-15 encodes two nonoverlapping transcripts that encode the A and B
activities (Clark et al., 1994; Huang et al., 1994). These genetic analyses resulted in the
identification and characterization of three class A genes (lin-8, lin-38 and lin-15 A) and
five class B genes (lin-9, lin-35, lin-36, lin-37 and lin-15 B). Three additional class B
mutations were identified and found to complement mutations in the five class B genes
and to complement each other, but were not further characterized (Horvitz and Sulston,
1980; Sulston and Horvitz, 1981; Ferguson and Horvitz, 1989).
SynMuv mutants in which the anchor cell has been ablated still display a Muv
phenotype (Ferguson et al., 1987). This result suggests that in the absence of synMuv
gene activity, the Pn.p cells do not require the anchor cell signal to adopt vulval cell fates.
Genetic mosaic analyses indicate that both lin-15 AB and lin-37 act cell non-
autonomously and most likely in the hypodermal syncytium (Herman and Hedgecock,
1990; Hedgecock and Herman, 1995). These data suggest that the synMuv genes encode
the components of two redundant signaling systems that inhibit the adoption of vulval
fates by the Pn.p cells. Loss-of-function mutations in genes known to be involved
inductive signal transduction, let-23, sem-5, let-60 ras, and lin-45 raf are epistatic to lin-
15 AB mutations (Ferguson et al., 1987; Beitel et al., 1990; Han et al., 1990, Clark et al.,
1992; Han et al., 1993; Huang et al., 1994). Thus, the inductive signal transduction
system, but not the anchor cell signal itself, is required for the adoption of vulval cell
fates by Pn.p cells in the absence of inhibitory synMuv gene activity.
The molecular nature of the inhibitory signals encoded by the synMuv genes is
unknown. Three genes, lin-15 A, lin-15 B and lin-9 have been cloned and shown to
encode novel proteins (Clark et al., 1994; Huang et al., 1994; G. Beitel and H. R. Horvitz,
in preparation).
The synMuv genes provide an opportunity to study the negative regulation of
receptor tyrosine kinase and Ras-mediated signal transduction pathways. Very little is
known about the negative regulation of this signal transduction pathway. To provide the
necessary reagents for an extensive study of the negative regulation of signal transduction
in C. elegans, we conducted several screens to isolate more synMuv mutants. These
mutants provide new alleles of previously identified synMuv genes which will facilitate
the genetic and molecular analysis of these known genes. The screens also provided
alleles that define new genes involved in the synMuv pathways.
In this paper, we identify and characterize 49 additional synMuv mutations. We
define six new synMuv loci, including three which had been previously isolated by
Ferguson and Horvitz (1989), but not completely characterized. These six loci include
five class B loci and one class A locus which are demonstrated to be synMuv loci.
Materials and Methods
Strains and general techniques
Caenorhabditis elegans var. Bristol strain N2 was used as the wild-type strain and
parent of all of the mutants used in this study. The alleles used in this study have been
described by Hodgkin et al. (1988) unless otherwise noted.
LGI: bli-3(e767); sup-11(n403); dpy-5(e61); lin-35(n745) (Ferguson and Horvitz,
1989); unc-29(e1072); dpy-14(e188); unc-13(el091); lin-11(n566); unc-75(e950); unc-
101(ml); unc-54(e1092) (Waterston et al., 1980).
LGII: lin-8(nlll) (Horvitz and Sulston, 1980; Sulston and Horvitz, 1981;
Ferguson and Horvitz, 1985; 1989); unc-85(e1414); bli-2(e768); dpy-10(e128); rol-
6(e187); let-23(n1045, mn23, mn216) (Herman, 1978; Sigurdson et al., 1984; Ferguson
and Horvitz, 1985); let-240(mn209); unc-4(e]20); unc-53(e569); rol-1(e91); lin-38(n751)
(Ferguson and Horvitz, 1989); unc-52(e444); mnDf67 (Sigurdson et al., 1984); mnDJ85
(Sigurdson et al., 1984); mnDf46 (Sigurdson et al., 1984); mnDf71 (Sigurdson et al.,
1984); mnC1 dpy-10(e128) unc-52(e444).
LGIII: dpy-1(el); daf-2(e1370); unc-93(e1500); dpy-27(y57) (Plenefisch et al.,
1989); unc-79(e1068); dpy-17(e164); lon-](e185); sma-3(e491); lin-37(n758) (Ferguson
and Horvitz, 1989); egl-5(n945); lin-36(n766) (Ferguson and Horvitz, 1989); unc-
36(e251); dpy-19(e1259); lin-9(n1l2) (Horvitz and Sulston, 1980; Sulston and Horvitz,
1981; Ferguson and Horvitz, 1985; 1989); unc-32(e189); unc-16(e109); unc-69(e587);
unc-25(e156); unc-49(e382); dpy-18(e364); qCl (Austin and Kimble, 1989; Graham and
Kimble, 1993).
LGIV: dpy-9(el2); egl-18(n162); unc-17(e245); unc-5(e53); dpy-20(e1282); unc-
22(e66); unc-30(el91); lev-1(x22); ced-3(n717); unc-26(e205); dpy-4(e1166).
LGV: unc-34(e566); dpy-11(e224); unc-51(e369).
LGX: lon-2(e678); unc-3(e151); lin-15(n433, n744, n765, n767) (Ferguson and
Horvitz, 1985; 1989).
Methods for the culture and genetic manipulation of C. elegans have been
described by Brenner (1974).
Genetic nomenclature used conforms to the standardized C. elegans nomenclature
established by Horvitz et al. (1979). The assignment of lin (lineage abnormal) gene
names to new synthetic Multivulva genes and other nomenclature used to describe
synthetic Multivulva strains has been established (Ferguson and Horvitz, 1989).
Mutagenesis of class A and class B mutants
Screens for new synthetic Multivulva strains were conducted essentially as
described by Ferguson and Horvitz (1989). To isolate mutations in one class, L4
hermaphrodites carrying a single mutation of the other class were mutagenized with ethyl
methanesulfonate (EMS). Two P0 hermaphrodites were placed on a single plate and
allowed to lay eggs. A total of 40 F 1 eggs was selected from each plate and picked, 20
per plate, to two plates. The F2 generation was screened for the presence of Muv
animals. These Muv animals were picked individually to plates and allowed to self-
fertilize to generate a mutant strain. Only one Muv strain was selected from each pair of
plates for subsequent analysis to ensure each mutation was independently derived. N2
males were crossed into the Muv strains and the F2 progeny were scored for the Muv
phenotype. Those that segregated 1/16 or less were selected as candidate synMuv strains.
None of the Muv strains in which the original mutation was autosomal resulted from a
synthetic interaction with a second mutation on the same linkage group. In mutagenesis
experiments in which the original mutation was lin-15, strains that segregated 1/4 or less
were also retained for further analysis. All candidate synMuv strains were backcrossed to
their strain of origin two to five times.
To isolate class B mutations, a lin-8(n 11) homozygous strain and a lin-15(n433)
homozygous strain were mutagenized. Ferguson and Horvitz (1989) had previously
mutagenized lin-8(nlll) and lin-15(n767) to isolate class B mutations. In the
mutagengenesis of lin-8(n 111) described in this paper, approximately 6000 haploid
genomes were screened and 15 synMuv strains were isolated. In the mutagenesis of lin-
15(n433), approximately 10,000 haploid genomes were screened and 15 synMuv strains
were isolated. To isolate class A mutations, a lin-36(n766) homozygous strain and a lin-
15(n744) homozygous strain were mutagenized. Ferguson and Horvitz (1989) had
previously mutagenized lin-9(n112) to isolate class A mutations. In the mutagengenesis
of lin-36(n766), approximately 10,000 haploid genomes were screened and 5 synMuv
strains were isolated. In the mutagenesis of lin-15(n744), approximately 13,000 haploid
genomes were screened and 15 synMuv strains were isolated.
Analysis of lin-15 AB lesions
Genomic DNA was purified, essentially using standard methods, from lin-15 AB
strains isolated in the mutageneses of lin-15(n744) and lin-15(n433) (Sulston and
Hodgkin, 1988). DNA was digested by EcoRI, separated by agarose gel electrophoresis,
and probed with 3 2 p-labeled lin-15 plasmid DNA (Sambrook et al., 1989; Clark et al.,
1994). Some samples of genomic DNA which showed a lesion were digested with
EcoR1 and either EagI, SacI, MscI, BglI, MluI or NruI, and probed with 3 2 P-labeled lin-
15 plasmid DNA.
Nomarski observation and Pn.p cell lineage analysis of lin-54 animals
P(3-8).p cells and their descendents in lin-8(n]11); lin-54(n2231) animals were
observed using Nomarski optics at different times during vulval development. P(3-8).p
cell lineages were observed using Nomarski optics as described by Sulston and Horvitz
(1977). The nomenclature and criteria described by Sternberg and Horvitz (1986, 1989)
were used to assign 1', 2' and 3" cell fates.
Construction of strains homozygous for isolated new synMuv mutations
Chromosomes carrying the synMuv mutation to be isolated and homozygosed in
the absence of another synMuv mutation were balanced by recessive markers that
mapped very close to the synMuv mutation to be isolated. Males of genotype r/+, where
r is one or more linked recessive markers, were crossed into synMuv strains of genotype
a; b, where a is the mutation to be isolated and b is the original mutation. Progeny of
genotype a +/+ r; b/+ were isolated by picking L4 larvae that were non-Muv as adults
and segregated R progeny, where R is the phenotype of strains of r/r genotype. Progeny
of phenotype non-Muv non-R were picked individually to plates. The non-Muv progeny
of animals that segregated 1/4 R and did not segregate Muv (genotype: a +/+ r, +/+)
were picked individually to plates. Those that did not segregate R animals were of
putative genotype a/a. This was confirmed by mating males of genotype b/b into the a/a
candidates, picking at least 12 L4 larvae individually to plates and observing the
segregation of Muv animals from each animal. In these experiments, unc-79 dpy-27
balanced lin-51(n770), unc-69 balanced lin-52(n771), unc-29 balanced lin-53(n833), unc-
22 ced-3 unc-26 balanced lin-54(n2231), and rol-6 unc-4 balanced both lin-55(n2994)
and lin-56(n2728).
Construction of unlinked synMuv double mutants
Class A; class B double mutants were constructed by crossing male lin-8(nll])
and male lin-15(n767) animals into strains homozygous for a class B mutation (lin-
51(n770), lin-52(n771), lin-53(n833), lin-54(n2231), and lin-55(n2994)) or male lin-
15(n744) animals into a strain homozygous for a class A mutation (lin-56(n2728)). F2
Muv progeny isolated were of genotype a/a; b/b.
To construct class A; class A or class B; class B double mutants carrying a new
mutation and a lin-15 mutation of the same class, N2 males were crossed into a strain of
genotype bl rl; lin-15a where bl is the new mutation (either class A or class B), rl is a
tightly linked recessive marker in cis, and lin-15a is a lin-15 mutation of the opposite
class of bl. Male progeny of genotype bl rl/+ +; lin-15a/O were crossed into animals of
genotype lin-15b where lin-15b is a lin-15 mutation of the same class as bl. Male
progeny of this cross, half of which were of genotype bl rl/+ +; lin-15b/0 were crossed
into animals of genotype lin-15b. Some progeny of this cross segregated R1 animals
which were of putative genotype bl rl; lin-15b. To ensure that a strain was isolated in
which mutations were not lost by recombination, several independent lines were isolated
for each strain.
To construct class A; class A or class B; class B double mutants carrying a new
mutation and an autosomal mutation of the same class, N2 males were crossed into a
strain of genotype h1 rl; lin-15a. Male progeny of genotype bl rl/+ +; lin-15a/0 were
crossed into animals of genotype b2 r2 where b2 is an autosomal mutation of the same
class as bl. Male progeny of this cross, half of which were of genotype bl rl/+ +; b2
r2/+ +; +/0 were crossed into animals of genotype b2 r2. Some R2 progeny of this cross
segregated R1 R2 animals which were of putative genotype bl rl; b2 r2. To ensure that
a strain was isolated in which mutations were not lost by recombination, several
independent lines were isolated for each strain.
In these constructions, lin-15(n767) and lin-15(n744) were used as the class A and
class B lin-15 alleles respectively. The autosomal class B mutation used was lin-
36(n766). This allele was marked in cis by unc-32. The following markers were linked
in cis to the new mutations: unc-32 to lin-51(n770), unc-32 to lin-52(n771), dpy-5 to lin-
53(n833), dpy-20 to lin-54(n2231), rol-6 to lin-55(n2994), and rol-6 to lin-56(n2728).
Construction of linked synMuv double mutants
The lin-8 lin-55(n2994) class A class B double mutant strain was isolated by
crossing lin-8 males to lin-8 unc-85 dpy-10 hermaphrodites, picking male progeny and
mating these males to animals of genotype lin-55 and isolating heterozygotes of genotype
lin-8 unc-85 dpy-l0 +/+ + + lin-55. Unc non-Dpy recombinant progeny were picked
and allowed to segregate 1/4 Unc Muv animals of genotype lin-8 unc-85 lin-55.
To construct a class B class B double between lin-51(n770) and lin-36, N2 males
were crossed into an egl-5 lin-36; lin-15 A strain. Progeny males were mated to
hermaphrodites of genotype lin-51 unc-32; lin-15 A, non-Unc progeny which segregated
Egl animals were selected. These animals were of putative genotype lin-51 + + unc-32/+
egl-5 +; lin-15 A. The frequency of recombination between lin-51 and egl-5 is greater
than that between lin-36 and unc-32 and much greater than that between egl-5 and lin-36.
Muv non-Unc recombinant progeny of putative genotype lin-51 egl-5 lin-36 +/lin-51 + +
unc-32; lin-15 A were isolated. These recombinants segregated Muv, Muv Unc and Egl
Muv animals. N2 males were crossed to the the Egl Muv animals of putative genotype
lin-51 egl-5 lin-36; lin-15 A and Egl non-Muv F2 animals were isolated and picked to
individual plates. Animals that did not segregate Muv progeny were of putative genotype
lin-51 egl-5 lin-36. This genotype was confirmed by crossing N2 males into these
animals and then crossing the male progeny into lin-15 A. Half of the male progeny of
this cross were of putative genotype lin-51 egl-5 lin-36/+ + +; lin-15 A/O. These males
were used in complementation tests with lin-51 and with lin-36 to show that the strain
contained both class B mutations.
A class B class B double between lin-36 and lin-52(n771) was constructed in a
manner similar to that for the construction of the double between lin-51 and lin-36.
Males of genotype lin-36 unc-36/+ +; lin-15 A were mated to sma-3 lin-52; lin-15 A
hermaphrodites to generate heterozygotes of putative genotype + lin-36 unc-36 +/sma-3
+ + lin-52; lin-15 A. The frequency of recombination between unc-36 and lin-52 is
greater than that between sma-3 and lin-36 and much greater than that between lin-36 and
unc-36. Muv non-Sma recombinant progeny of putative genotype + lin-36 unc-36 lin -
52/sma-3 + + lin-52; lin-15 A were isolated. These animals segregated Muv, Sma Muv
and Unc Muv progeny which were of putative genotype lin-36 unc-36 lin-52; lin-15 A.
N2 males were mated to these animals and F2 Unc non-Muv animals which did not
segregate Muv animals were selected. These animals were of putative genotype lin-36
unc-36 lin-52. This genotype was confirmed by crossing male heterozygotes through lin-
15 A and using the male F2 progeny in complementation tests with lin-36 and with lin-
52. These tests showed that the isolated strain was of genotype lin-36 unc-36 lin-52.
To construct a class A class A double between lin-8 and lin-56(n2728), lin-8
males were mated to hermaphrodites of genotype lin-8 unc-85 dpy-10; lin-9, and non-
Unc non-Dpy cross progeny of genotype lin-8 + + +/lin-8 unc-85 dpy-10; lin-9/+ were
isolated. Unc Dpy non-Muv animals which did not segregate Muv animals were of
genotype lin-8 unc-85 dpy-10. Males of lin-8 genotype were mated to these animals to
generate males of genotype lin-8 unc-85 dpy-1O/lin-8 + + which were crossed to
hermaphrodites of genotype rol-6 lin-56; lin-15 B. Cross progeny (non-Rol) which
segregated Unc Dpy animals were of genotype lin-8 unc-85 dpy-10 + +/+ + + rol-6 lin-
56; lin-15 B/+. Unc non-Dpy non-Muv recombinant animals which did not segregate
Muv progeny were isolated; these were of putative genotype lin-8 unc-85 + rol-6 lin-
56/lin-8 unc-85 dpy-10 + +. Rol Unc segregants were of putative genotype lin-8 unc-85
rol-6 lin-56. To confirm the presence of lin-8, N2 males were mated to these animals and
the progeny heterozygous males were mated to lin-8 unc-85 dpy-10; lin-9
hermaphrodites. Unc non-Dpy progeny were allowed to self-fertilize and Unc Muv
animals of putative genotype lin-8 unc-85 + rol-6 lin-56/lin-8 unc-85 dpy-10 + +; lin-9
were picked individually to plates. This genotype was confirmed by the segregation of
Unc Muv, Dpy Unc Muv and Unc Rol Muv progeny. The presence of lin-56 was
confirmed by crossing the heterozygous males to rol-6 lin-56; lin-15 B hermaphrodites
and allowing the Rol nonMuv progeny to self-fertilize. Rol Muv progeny, 2/3 of which
were of putative genotype lin-8 unc-85 rol-6 lin-56/+ + rol-6 lin-56; lin-15 B, were
picked individually to plates. This genotype was confirmed by the segregation of Rol
Muv and Unc Rol Muv.
Results
Isolation of strains containing new class A and new class B mutations
We sought to identify new synthetic Multivulva mutations using the protocol of
Ferguson and Horvitz (1989). To identify new class A mutations, we mutagenized lin-
36(n766) and lin-15(n744) homozygotes, which display wild-type vulval development.
Class A mutations interact with these class B mutations to produce a synthetic Multivulva
phenotype (Ferguson and Horvitz, 1989). The morphology of synMuv strains can be
readily distinguished from the morphology of Muv strains mutant in lin-1 and lin-31.
Muv strains that segregated as two unlinked loci when crossed with wild type males were
candidates for being synMuv strains. Certain strains obtained in a lin-15 background that
did not fit this criteria were also possible candidates (see below). We obtained five
synMuv strains from the mutagenesis of lin-36(n766) and 14 synMuv strains from the
mutagenesis of lin-15(n744). A total of 19 new class A mutations were identified in
these screens (Table 1).
To identify new class B mutations, we mutagenized animals homozygous for the
class A mutations lin-8(nl 11) and lin-15(n433). Muv strains were tested for segregation
of two loci as described for the isolation of class A mutations. We obtained 15 synMuv
strains from the mutagenesis of lin-8(n 111) and 15 synMuv strains from the mutagenesis
of lin-15(n433). A total of 30 new class B mutations were identified (Table 1).
Linkage and complementation
SynMuv mutations were expected to display linkage to two loci: the parental
locus and the new locus (Ferguson and Horvitz, 1989). Mutations caused by most of the
candidate synMuv strains displayed linkage to the parental mutation and to another
linkage group. A few lin-15 strains, discussed below, did not display linkage to a new
location (Table 1).
The newly isolated synMuv strains were tested for complementation with the
known synMuv genes: lin-8, lin-9, lin-15 A, lin-15 B, lin-35, lin-36, lin-37, and lin-38
(Ferguson and Horvitz, 1989). Mutations that complemented all of these genes were
tested against lin(n770), lin(n771), and lin(n833), three previously identified but not
extensively characterized mutations (Ferguson and Horvitz, 1989). Mutations that did
not fall into these complementation groups were tested against each other after strains
carrying identical parental mutations of the opposite class were constructed.
Mutations were assigned to the same complementation group only if
hermaphrodites of genotype a; bl/b2, where a is the background mutation required for
the synthetic interaction and bl and b2 are the two mutations being tested, were Muv and
segregated only Muv progeny. As described by Ferguson and Horvitz (1989), this
approach was necessary to distinguish intragenic noncomplementation from the
intergenic noncomplementation observed in some doubly heterozygous synMuv strains.
Several combinations of genotype a; bl/+; b2/+ displayed intergenic
noncomplementation; in most cases, the penetrance and expressivity of the Muv
phenotype produced by intergenic noncomplementation was lower than that produced by
homozygosity at either of the two loci which displayed intergenic noncomplementation.
Thus, animals lacking the activity of one class of synMuv genes and having reduced
doses of two genes of the other class as well as no maternal activity from one of these
genes are occasionally Muv. This suggests that the synMuv genes are dose-sensitive and
may not be completely redundant. lin-53(n833) was notable in that it showed very strong
intergenic noncomplementation with other class B mutations. It is likely that lin-53
mutations act differnetly from the other class B synMuv mutations. lin-53 activity may
be very sensitive to dosage reduction or lin-53 mutations may have an interfering activity
that is enhanced in a background of reduced class B gene dosage.
A total of 38 mutations failed to complement defined synMuv genes. These
included eight lin-8 alleles, eight lin-15 A alleles, 10 lin-15 B alleles, six lin-35 alleles,
three lin-36 alleles, one lin-37 allele, and two lin-38 alleles. Another six mutations failed
to complement lin-51(n770) and lin-53(n833), mutations that had previously been
isolated but not extensively characterized. These include five lin-51 alleles and one lin-
53 allele. Another four mutations defined three new complementation groups: lin-54, lin-
55, and lin-56. There were two lin-54 alleles, one lin-55 allele, and one lin-56 allele
(Table 1).
Identification of lin-15 AB double mutants
The mutations of several Muv strains isolated in a lin-15 background did not
segregate as two loci, yet displayed a Muv phenotype similar to that displayed by other
synMuv strains. These included five strains isolated in a lin-15(n433) background and
seven strains isolated in a lin-15(n744) background. These strains showed linkage only
to unc-3 X which marked the parental lin-15 mutation, and failed to complement lin-
15(n765), a lin-15 allele defective in both class A and class B activities. Thus, the new
strains are defective in both lin-15 A and lin-15 B activities.
lin-15 is a complex locus which contains genetically separable class A and class B
activities (Ferguson and Horvitz 1989). This locus has been cloned and shown to encode
two nonoverlapping transcription units under the control of the same promotor. One of
these genes encodes the LIN-15 A protein and the other encodes the LIN-15 B protein
(Clark et al., 1994; Huang et al., 1994). All lin-15 Muv mutants that have been analyzed,
except lin-15(n765), have gross mutations that disrupt both of the lin-15 transcripts
(Clark et al., 1994; Huang et al., 1994). lin-15(n765) is a deletion in the class B transcript
and presumably a second point mutation in the A transcript. Several lin-15 A and lin-15
B mutations have been analyzed; none of these is a gross mutation that affect both
transcription units (Clark et al., 1994).
To determine whether the Muv phenotype of the each of the lin-15 AB mutants
isolated in these screens is the result of only the newly induced mutation or the result of
an interaction between the newly induced mutation and the parental mutation, we used
Southern hybridization to analyze the lin-15 locus in these strains. Four mutant strains
show polymorphisms; three of these four are confined to only the A region or the B
region. The lin-15(n2993 n433) strain has a polymorphism: the loss of an EcoRI site in
the B region of lin-15. This is consistent with a second mutation affecting only the B
locus; the Muv phenotype likely results from the interaction of this new mutation with the
parental mutation. The lin-15(n744 n2733) strain has a small deletion of 0.3 kb in the A
region of lin-15. The lin-15(n744 n2735) strain has a larger deletion of several kilobases
in the A region. The Muv phenotype of these strains is also likely to result from the
interaction of the new mutation, a deletion in only in one transcript region, with the
parental mutation of the other class.
The lin-15(n744 n2726) strain has a deletion of about 0.9 kb in an EcoRI SacI
restriction fragment containing both A and B sequences. This region includes both the
start of the class A transcript and the end of the class B transcript. It is likely that the
deletion eliminates the 5' end of the class A transcriptional unit. It is possible that some
of the 3' end of the class B transcriptional unit is also eliminated. This may be sufficient
to give a class B defect. Thus the Muv phenotype in this strain may result entirely from
the new mutation.
Polymorphisms were not detected in the other strains. Since the parental mutation
of these strains is either a lin-15 A or a lin-15 B point mutation, and EMS produces
predominantly point mutations, it is likely that the Muv phenotype of most, if not all,
these lin-15 AB strains is the result of an interaction between class A and class B point
mutations.
Phenotypes of newly isolated synMuv strains
Many of the newly isolated synMuv strains display a temperature-sensitive effect
on vulval development such that the penetrance of the Muv defect increases at higher
temperatures (Table 2). Similar observations were made by Ferguson and Horvitz
(1989). The synMuv strains often show temperature-sensitive growth characteristics.
Many strains show a reduced growth rate, or in some cases, lethality at 25' (Table 2).
Similar observations were made on synMuv strains isolated by Ferguson and Horvitz
(1989). Although there are some differences between strains in strain growth at 200, the
differences between these strains are much greater at 150 and 25'. Rare animals display a
protruding excretory pore. Some animals rupture at the vulva, or rarely at a pseudovulval
protrusion, as adults. Strains isolated in the screen in which lin-15(n744) was used as the
parental mutation have a fairly high percentage of rupture, often exceeding 50% of adults.
Strains carrying lin-54 mutations differ from other synMuv strains in that a
greater proportion of these animals have a ventral protrusion that is more posterior to the
vulva than is the case in most synMuv mutants. A number of these strains have two
ventral protrusions posterior to the vulva, a rare occurrence in synMuv strains. This
phenomenon is observed in both alleles of lin-54. In lin-8(n1 I); lin-54(n2231), 13% of
the animals have a relatively far posterior ventral protrusion and 11% of the animals have
two posterior ventral protrusions (n=126). In lin-54(n2231); lin-15(n767), 26% of
animals have a far ventral protrusion and 19% of animals have two ventral protrusions
(n=75). For lin-54(n2990); lin-15(n433) animals, 13% have a far ventral protrusion and
10% have two ventral protrusions (n= 112).
Observation of the Pn.p cells and their descendents and lineage analysis of the
Pn.p cells of lin-8(nl l); lin-54(n2231) animals confirmed that the vulval equivalence
group is composed of P(3-8).p, as in the wild type. Thus, the vulval equivalence group
was not expanded to include P9.p as it is in certain mutants which enhance the lin-15
Muv phenotype (Clark, 1992). Lineage analysis shows that the vulva is sometimes
formed from P(4-6).p rather than P(5-7).p (Data not shown). This phenomenon has been
observed in other synMuv strains, but is rare (Ferguson et al., 1987; Chapter 3). In these
animals, both P7.p and P8.p are posterior to the developing vulva. These cells adopt
vulval fates in the mutant animals and form either two posterior pseudovulvae or one
posterior pseudovulva that has a greater relative distance from the misplaced vulva than
does a pseudovulva formed from only P8.p relative to a properly positioned vulva. In one
case, the vulva was observed to form from P5.p, P6.p and part of P7.p. Some
descendents of P7.p formed a pseudovulva with some P8.p descendents whereas other
P8.p descendents formed a second posterior pseudovulva.
New complementation groups define synMuv genes
This study has resulted in the identification and characterization of six new
synMuv genes: lin-51, lin-52, lin-53, lin-54, lin-55 and lin-56. Mutations in three of
these genes, lin-51(n770), lin-52(n771) and lin-53(n833) were isolated previously
(Ferguson and Horvitz 1989). The results from multiple-factor crosses and deficiency
tests (Table 3) were used to position these six genes on their linkage groups (Figure 1).
lin-55 maps to the same interval as let-23, which encodes a receptor tyrosine
kinase involved in inductive vulval signaling (Arioan et al. 1990). To determine if lin -
55(n2994) is allelic to let-23, we performed complementation tests against let-23(mn23),
let-23(mn216) and let-23(n1045). lin-55(n2994) complemented let-23 for all phenotypes:
Muv, Vul, hyperinduced (Hin) in which Pn.p cells adjacent to the developing vulva also
adopt vulval fates, and lethal (Let). The allele used in these tests, lin-55(n2994), is
predicted to fail to complement a loss-of-function allele for the synMuv phenotype, since
lin-55(n2994)/mnDf67, lin-15 A animals are Muv (Table 3).
Two of the newly isolated synMuv genes, one class A gene and one class B gene,
are represented by only one mutant allele. To test whether the phenotypes produced by
these alleles are weaker than that expected from a null phenotype, these mutations were
each tested in trans to a deficiency (Table 3). Animals of genotype lin-
56(n2728)/mnDf71; lin-15(n744) had a Muv phenotype indistinguishable from that of
animals of genotype lin-56(n2728); lin-15(n744). The trans-deficiency heterozygotes
were fertile and healthy. These results suggest that lin-56(n2728) is not a weak allele of a
locus that has a stronger null phenotype. Animals of genotype lin-55(n2994)/mnDf67;
lin-15(n433) had a Muv phenotype and an incidence of sterility similar to that of animals
of genotype lin-55(n2994); lin-15(n433) when both are progeny of a mother of genotype
lin-55(n2994)/mnDf67; lin-15(n433). However, the fertile animals of genotype lin-
55(n2994)/mnDf67; lin-15(n433) had a much greater incidence of maternal effect
lethality than did in animals of genotype lin-55(n2994); lin-15(n433) when both are
progeny of a mother of genotype lin-55(n2994)/mnDf67; lin-15(n433). Animals of both
of these genotypes have a stronger Muv phenotype and are less fertile than animals of
genotype lin-55(n2994); lin-15(n433) when descended from animals of genotype lin-
55(n2994); lin-15(n433). These results suggest that lin-55(n2994) is a weak allele of a
locus that has a stronger, possibly sterile, null phenotype.
To formally demonstrate that the newly defined synMuv genes are synMuv genes,
we conducted tests similar to those used by Ferguson and Horvitz (1989). First, we
isolated an allele of each gene from its parental mutation and showed that strains that
carried only the isolated allele in homozygous condition displayed wild-type vulval
development at the level of resolution of the dissecting microscope (Table 4). Double
mutants were constructed between alleles of the new synMuv genes and alleles of
previously defined synMuv genes. Double mutants carrying class A and class B
mutations were Muv; double mutants carrying two class A mutations or two class B
mutations were wild-type for vulval development (Table 4).
Maternal rescue of the synMuv phenotype depends on both class A and class B
genes
Many of the new synMuv strains display maternal rescue of the Muv phenotype,
such that animals of genotype a; b descended from animals of genotype a/+; b/+ have
lower penetrance and reduced expressivity compared to animals of genotype a; b
descended from animals of a; b genotype (Table 5). Similar results have been shown for
other synMuv strains (Ferguson and Horvitz, 1989). To determine whether this maternal
rescue lay in only one of the two classes, we compared the Muv phenotype of animals of
genotype a; b descended from animals of genotype a/+; b/+ with the Muv phenotype of
animals of genotype a; b descended from animals of genotype a/a; b/+, and with the
Muv phenotype of animals of genotype a; b descended from animals of genotype a/+;
b/b. Several different combinations of synMuv mutations were tested. The maternal
rescue displayed in synMuv strains is the result of a synergistic interaction between genes
of the two classes rather than the result of the maternal contribution of the genes of just
one class (Table 5).
Discussion
In this paper, we describe the isolation of 49 synMuv mutants and their
phenotypes at different temperatures and show linkage of the Muv phenotype to two loci.
Six synMuv genes are mapped and described; these include five class B genes, lin-51,
lin-52, lin-53, lin-54, lin-55, and one class A gene, lin-56. We showed that the maternal
rescue of the synMuv phenotype is dependent on a synergistic interaction between the
wild type alleles of both classes.
This study has identified additional constituents of the two proposed redundant
signaling pathways controlled by the synMuv genes. The pathway defined by the class B
genes consists of at least ten genes, whereas that defined by the class A ganes consists of
at least four. The synMuv genes may not encode the components of two duplicated
pathways that perform the same biochemical function in the same manner. Instead, they
likely regulate vulval development via two distinct mechanisms. The biochemical
activities of the proteins encoded by the synMuv genes is, at present, unknown. The
mechanism by which the synMuvs negatively regulate vulval induction is also uncertain.
The null phenotype of each of the synMuv genes is not known. It is likely that
they do not all have the same null phenotypes. The class A mutation lin-15(n767) is a
possible null allele by molecular criteria. The mutation is a deletion with a small
insertion producing a frameshift in the class A transcript (Huang et al., 1994). lin-
15(n767) mutants behave as synMuvs (wild-type vulval development alone, Muv in
combination with a class B mutation), and are viable and fertile. Several lin-15 AB
mutations are double mutants for null alleles in both class A and class B transcripts. lin-
15(n309) and lin-15(el763) are deleted for most of the DNA of the locus (Clark et al.,
1994; Huang et al., 1994). These mutants are Muv, viable and fertile. Thus, the lin-15 A
and lin-15 B null phenotypes are not sterile. It is likely that the null phenotype of lin-9 is
sterile. A noncomplementation screen for lin-9 mutants allowed the isolation of lin-9
alleles which were sterile and behaved as synMuvs. The sterility was found to be
independent of the presence of a class A mutation (Ferguson and Horvitz, 1989). The
phenotype of animals carrying a strong lin-9 mutation differs from that of animals
carrying a null lin-15 AB (and thus a null lin-15 B) mutation.
The screens described in this paper were not designed to isolate synMuv alleles
that had lethal or sterile pleiotropies. Thus, complete loss-of-function alleles of loci that
have sterile or lethal null phenotypes were not isolated. Loci that are not readily mutated
to a viable synMuv phenotype may not have been identified. For example, no lin-9
alleles were isolated in this screen, even though a mutation similar to lin-9(n112) could
have been isolated. Since 39,000 genomes were screened, it is possible that reduction-of-
function mutations in loci with sterile or lethal complete loss-of-function phenotypes
were isolated. Mutations in complementation groups with few alleles are candidates for
such reduction-of-function mutations.
Two genes, the class A gene lin-56 and the class B gene lin-55, are each
represented by a single allele. To determine if these alleles are complete loss-of-function
mutations, these alleles were each tested in trans to a deficiency that spanned the locus.
Animals homozygous for lin-56(n2728) were indistinguishable from trans-heterozygotes
for a deficiency of the locus, consistent with the hypothesis that lin-56(n2728) is a loss-
of-function allele for the lin-56 locus. lin-55(n2994) mutants have a stronger Muv
phenotype, are less fertile, and have a greater incidence of maternal effect lethality when
they and their mothers are trans-heterozygotes for a deficiency of this locus. This
suggests that lin-55(n2994) is probably a reduction-of-function mutation rather than a
complete loss-of-function mutation.
With the exception of lin-15 alleles, no class A and class B mutations mapped to
the same site. This result, coupled with the result that lin-15 encodes two nonoverlapping
transcripts, one for each class, suggests that loci that are easily mutable to a synMuv A
phenotype and a synMuv B phenotype are rare or nonexistent. It is possible that certain
genes may be mutable to give a fertile synMuv phenotype in one class but not be mutable
to a fertile or viable Muv phenotype, or fertile or viable synMuv phenotype of the other
class. In such cases, these complex loci would not have been recognized.
The Muv phenotype of lin-13 is similar to that of synMuv double mutants
(Ferguson and Horvitz, 1985; 1989; Ferguson et al., 1987). This gene may be another
locus that has genetically separable class A and class B activities; lin-13(n387ts) is Muv
at 200 but acts as a class B synMuv at 150 (Ferguson and Horvitz, 1989). None of the
mutations isolated in this screen mapped to the lin-13 locus, so it is not clear whether it is
possible to obtain mutations in this locus that act as distinctly class A or class B synMuv
mutations.
Mutations in different complementation groups were isolated at different
frequencies. Class A mutations fell into either a frequently isolated group, lin-8 and lin -
15 A (eight alleles each), or an infrequently isolated group, lin-38 and lin-56 (one or two
alleles each). lin-38 was isolated at a higher frequency in previous screens (2 mutations
in 8000 haploid genomes versus 2 mutations in 23,000 haploid genomes), although the
sample size was much smaller (Ferguson and Horvitz, 1989). Class B mutations fell into
one of three groups: a frequently isolated group consisting of lin-15 B, lin-35 and lin-51
(five or more alleles each), an infrequently isolated group consisting of lin-36, lin-37, lin-
53, lin-54 and lin-55 (three or fewer alleles each), or a group in which no alleles were
isolated consisting of lin-9 and lin-52. Given the number of haploid genomes screened
and the expected frequency of mutation of the average C. elegans gene by EMS, 1/2000,
we expected to isolate five to eleven alleles of each gene (Brenner, 1974; Greenwald and
Horvitz, 1980).
There are several reasons why mutations may have been isolated at a lower
frequency than expected. Some of the genes may have a sterile loss-of-function
phenotype and only rare reduction-of-function mutations were isolated. This likely
explains the failure to isolate any lin-9 alleles. Since the only lin-55 allele appears to be a
reduction-of-function allele, lin-55 may also fall into this catagory. Such genes should be
easily isolated in screens that allow the isolation of sterile and lethal mutants. Other
genes may provide a small mutagenic target. Only one allele of lin-56 was isolated, yet
this allele appears to be a complete loss-of-function allele. Only one allele of lin-37 was
isolated in the screens described in this paper. This gene is physically small, and the
allele isolated is consistent by molecular criteria with its being a loss-of-function allele
(X. Lu, personal communication). We cannot rule out the possibility of bias due to the
parental mutation used in the screens. The mutations lin-8(n111) and lin-15(n433) used
to isolate class B mutations do not produce highly penetrant Muv phenotypes in
conjunction with some class B mutations. This may have resulted in a lower isolation
frequency of alleles of certain genes. Maternal rescue is unlikely to have played a
significant role since the parental mutation was homozygous.
Several other examples of functional redundancy during development have been
observed. In Drosophila, achaete and scute are functionally redundant for the
specification of larval sense organs even though individually they are required for the
specification of distinct groups of adult bristles (reviewed by Ghysen and Dambly-
Chaudiere, 1991). In C. elegans, lin-12 and glp-1 are molecularly similar and
functionally redundant for some aspects of development. Double mutants exhibit defects
not found in either single mutant (Lambie and Kimble, 1991). Partial functional
redundancy involving groups of genes or pathways is seen in the cell corpse engulfment
genes of C. elegans. These mutants fall into two classes; animals carrying mutations in
both classes have a more severe phenotype than animals carrying mutations in only one
class (Ellis et al., 1991).
The synMuv genes differ from these previous examples in that alone they do not
cause a vulval phenotype and they fall into two classes with multiple members. This
indicates that they encode two pathways, each of which is unnecessary in the presence of
the other for vulval development. Identifying other such redundant pathways by genetic
means is difficult because mutations in the genes of such pathways do not cause a
phenotype in the absence of a second site mutation. Because few examples are known,
most redundant processes in development are relatively inaccessible. The synMuvs
provide an excellent model for studying the role of redundant genetic systems in
metazoan development because they have been identified and placed in the context of a
well characterized developmental system.
The studies described in this paper have resulted in the identification of ten class
B synMuv genes and four class A synMuv genes. The number of genes constitutuing
each class is significantly different. This may indicate that genes of the two synMuv
classes do not encode duplicate pathways. If such is the case, it is likely that class A and
class B genes encode pathways which control different biochemical activities. Functional
redundancy at the genetic level implies that the two classes of genes exert the same
ultimate effect, i. e. the negative regulation of vulval induction. Genetic redundancy does
not imply that the two classes act via the same mechanism, only that only one is required
for negative regulation. For example, class A synMuv genes may encode proteins
necessary for the secretion and processing of a negative ligand that inhibits the LET-23
receptor tyrosine kinase which mediates vulval induction. This mechanism would require
few genes. Note that since the two classes of synMuv genes are redundant, a let-23
mutation only needs to be epistatic to one class of synMuv genes in order to produce a
Vul phenotype. Thus, class B synMuv genes may be postulated to negatively regulate a
component downstream of LET-23, thereby requiring a more elaborate signal
transduction cascade within the Pn.p cells. In such an example, different biochemical
mechanisms can be used to effect negative regulation; either is sufficient for negative
regulation.
In addition to the opportunity provided to study the role of redundant genetic
systems in development, the synMuv genes afford the opportunity to study the negative
regulation of receptor tyrosine kinase and Ras-mediated signal transduction pathways.
The synMuv genes encode the components of two signaling pathways involved in the
negative regulation of a process regulated by a Ras signal transduction cascade. The
further study of the synMuv genes may reveal how Ras signaling pathways are regulated
and at what steps in the pathway hierarchy they are subject to negative regulation. It is
likely that the synMuv genes are conserved in other organisms and may negatively
regulate receptor tyrosine kinase and Ras signaling in mammals.
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Table 1: The mutations causing the Muv phenotype of candidate synMuv strains were
mapped to linkage groups in a manner similar to that described previously (Ferguson and
Horvitz, 1989). Males carrying both the original mutation and the new mutation were
crossed to strains of genotypes dpy-5 I; bli-2 II; unc-32 III, unc-5 IV; dpy-11 V; lon-2 X
(Trent et al., 1983), and unc-3 X. If the mutation did not display linkage to two of the
markers, it was further tested against strains of the following genotypes: bli-3 I unc-54 I,
unc-85 II, mnC] II, unc-52 II; unc-25 III; dpy-4 IV, dpy-1 III; unc-34 V, dpy-9 IV, egl-18
IV, and unc-51 V. Muv animals were isolated from the F2 progeny of these crosses and
the frequency of marker segregation was scored. Markers linked to a mutation
responsible for producing the Muv phenotype are expected to segregate at a frequency of
2p where p is the recombination frequency between the mutation being assayed and the
linked marker. Unlinked markers are expected to segregate at a frequency of 2/3. The
markers that displayed linkage are noted in the table.
a The mutations in these strains displayed linkage only to unc-3 X. Linkage of the
new mutation to unc-3 X is assumed since the mutations in these strains segregated as
single locus Muv mutations and failed to complement lin-15(n765) X.
b The mutation in this strain failed to display linkage to any marker listed other
than unc-3 X. The mutations segregated as synMuv mutations and did not display
complete linkage to the X chromosome.
TABLE 1
Origins and chromosomal linkages of new synMuv strains
Genotype of F2 Muv hermaphrodites with
respect to the chromosomal marker linked to the:









































































































































































































Table 2: The penetrance of the Muv phenotype of each synMuv strain was determined at
15' and 200 after growth at the indicated temperature for two or more generations.
Several stains displayed a temperature dependent reduction in viability. This reduction in
viability was tested in a manner similar to that of Ferguson and Horvitz (1989) but
differed in that exactly 10 eggs laid by hermaphrodites of the indicated genotype grown at
20' were placed on each of the four assay plates (each with a 2 cm diameter lawn of
bacteria) used at each temperature. The plates were checked daily to determine when the
bacterial lawn was consumed. The data were described according to the following
criteria: at 15': WT: 8.5-14 days, Slow: 14-24 days, Very slow: 24-28 days, Inviable:
lethal or more than 28 days, at 200: WT: 5.5-9 days, Slow: 9-17 days, Very slow: 17-28
days, Inviable: lethal or more than 28 days, at 25": WT: 5-7.5 days, Slow: 7.5-15 days,
Very slow: 15-28 days, Inviable: lethal or more than 28 days. The last value of the range
described was included in that category. The data obtained from the wild type strain N2
was: 150: 10 days, 200: 6 days, 250: 5 days.
TABLE2
Phenotypes of new synthetic Multivulva strains
Penetrance of Muv phenotype Strain Growth





































































































































































































































































































Table 3: Two, three, and four factor crosses were performed as described previously
(Brenner, 1974, Ferguson and Horvitz, 1989). A second mutation of the opposite class of
the mutation being tested was present in the strain to allow the synMuv phenotype to be
scored. From heterozygotes of genotype rl r2/b r3; a, recombinant progeny of the
phenotypes RI non-R2, R2 non-Ri, Muv non-R3, and R3 non-Muv were isolated. The
progeny of each recombinant animal were scored for the presence of the the unselected
markers. Deficiency heterozygotes were constructed and the vulval phenotype scored.




Gene Genotype of heterozygote Segregants Map distance (p)




Three- and four-factor crosses
Phenotype of Genotype of selected
selected recombinants (with respect






lin-51 unc-32+ +/+ + unc-49 dpy-18; lin-15(n767)
+ lin-51 + unc-32/daf-2 + dpy-17 +; lin-15(n767)
+ + lin-51/unc-93 dpy-27 +; lin-15(n767)
+ lin-51 +/dpy-27 + unc-79; lin-15(n767)
+ + unc-32 lin-52/lon-1 sma-3 + +; lin-15(n767)
+ + lin-52/sma-3 unc-32; lin-15(n767)
+ lin-52 +/dpy-19 + unc-69; lin-15(n767)
+ lin-52 +/unc-16 + unc-49; lin-15(n767)
dpy-5 lin-53 + +/++ lin-ll unc-75; lin-15(n767)
+ lin-53 +/unc-29 + lin-11; lin-15(n767)
lin-8; + + lin-54/unc-22 unc-30 +
lin-8; + lin-54 +/unc-30 + dpy-4
lin-54 + +/+ lev-1 unc-26; lin-15(n433)
+ lin-55 +/dpy-lO + unc-53; lin-15(n433)
+ lin-55 +/rol-6 + unc-4; lin-15(n433)


































0/2 unc-49 dpy-18/+ +
7/7 lin-51 unc-32/+ +




5/5 daf-2 dpy-17/+ +
30/30 lin-51/+
8/12 lin-51/+









7/7 lin-11 unc-75/+ +
0/12 lin-ll unc-75/+ +
0/10 dpy-5 lin-53/+ +













+ + lin-56/unc-85 dpy-10 +; lin-15(n744)
+ lin-56 +/dpy-lO + unc-53; lin-15(n744)














Gene Genotype of heterozygote Phenotype of heterozygote
lin-55
dpy-10 lin-55(n2994) +/+ mnDf46 unc-4; lin-15(n433) wild type
dpy-10 lin-55(n2994) +/+ mnDf85 unc-4; lin-15(n433) wild type
dpy-10 lin-55(n2994) +/+ mnDf67 unc-4; lin-15(n433) Muv
lin-56
+ lin-56(n2728) unc-53/unc-4 mnDf71 +; lin-15(n744) Muv
lin-56
Table 4: Mutations in new genes were separated from the original mutation present in the
synMuv strain as described in Materials and Methods. Double mutants carrying
mutations in these new genes and mutations in class A and class B genes were
constructed as described in Materials and Methods. lin-51, lin-52 and lin-54 display a
weaker Muv phenotype in double mutants with lin-8(nlll) than with lin-15(n767). lin-
55 displays a weaker Muv phenotype in a lin-15(n433) background than in a lin-15(n767)
background.
TABLE 4
Phenotypes of single and double mutants
Double mutant with Class A Double mutant with Class B
New Mutation Single mutant lin-8(nlll) lin-15(n767) lin-36(n766) lin-15(n744)
Class A
lin-56(n2728) WT WT WT Muv Muv
Class B
lin-51(n770) WT Muv Muv WT WT
lin-52(n771) WT Muv Muv WT WT
lin-53(n833) WT Muv Muv WT WT
lin-54(n2231) WT Muv Muv WT WT
lin-55(n2994) WT Muv Muv WT WT
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Table 5: The contribution of class A and class B genes to the maternal rescue of the
synMuv phenotype of doubly homozygous animals descended from either singly or
doubly heterozygous mothers was determined by counting the number of Muv animals of
phenotype R, where R is the phenotype produced by the cis marker r. Doubly
heterozygous mothers were obtained by mating N2 males into marked doubly
homozygous animals. Singly heterozygous mothers were obtained by mating males
homozygous for one of the synMuv mutations into marked doubly homozygous animals.
A strain homozygous for lin-35 was obtained by the procedure used for the isolation of
strains homozygous for the synMuv mutations described in this study. dpy-14 was used
to balance lin-35. lin-8; lin-9 was marked with lon-1i. lin-35; lin-8 was marked with unc-
13. lin-8; lin-36 was marked with unc-32. lin-8; lin-37 was marked with lon-1. lin-38;
lin-9 was marked with unc-52. lin-51; lin-15(n767) was marked with unc-93 or unc-32.
lin-52; lin-15(n767) was marked with sma-3. lin-53; lin-15(n767) was marked with dpy-
5 or lin-11. lin-54; lin-15(n433) was marked with dpy-20. lin-55; lin-15(n433) was
marked with rol-6. lin-56; lin-15(n744) was marked with rol-6.
aThis datum was obtained by estimating the penetrance and the number of doubly
homozygous animals to be 1/4 of the R progeny.
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TABLE5
Maternal rescue of synMuv phenotype
Penetrance of the Muv phenotype in animals of a/a; b/b genotype
descended from animals of maternal genotype
Class A mutation Class B mutation a/+; b/+ a/+; b/b a/a; b/+
lin-8(nlll) lin-9(n112) 72% (n=57)a 83% (n=141)a 100% (n=183)
lin-8(n 11) lin-35(n745) 45% (n=65)a N. D. 97% (n=149)
lin-8(n 111) lin-36(n766) 14% (n=93)a 23% (n=216)a 84% (n=300)
lin-8(nll11) lin-37(n758) 31% (n=69)a 98% (n=133)a 85% (n=188)
lin-15(n433) lin-54(n2231) 9% (n=89) a  N. D. 21% (n=211)
lin-15(n767) lin-51(n770) 58% (n=64)a 97% (n=238)a 90% (n=220)
lin-15(n767) lin-52(n771) 83% (n=98)a 103% (n=225)a 90% (n=294)
lin-15(n767) lin-53(n833) 103% (n=76)a N. D. 100% (n=64)
lin-15(n433) lin-55(n2994) 11% (n=95)a 75% (n=125)a 50% (n=298)
lin-38(n751) lin-9(n12) 81% (n=65)a 100% (n=146) 99% (n=189)a
lin-56(n2728) lin-15(n744) 93% (n=92)a 99% (n=200) N. D.
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Figure 1: a. Partial genetic map of C. elegans showing the locations of newly identified or
characterized synMuv genes and the markers which were used to position these genes on
the map. New synMuv genes are shown above the line representing the linkage group;
marker genes are shown below the line. The cluster in linkage group II is depicted by a
filled box and is shown in detail in b. b. Detailed view of the cluster of linkage group II
extending roughly from dpy-10 to unc-53. Deficiencies are drawn below the line and
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Summary
Mutations in the Caenorhabditis elegans gene lin-36 do not cause an abnormal
phenotype alone but do cause a multivulva phenotype when combined with certain other
mutations. Such interacting genes, known as synthetic multivulva genes, fall into two
classes: A and B. Only a combination of a class A mutation and a class B mutation
results in the multivulva phenotype. The synthetic multivulva genes act as negative
regulators of the ras-mediated induction pathway of C. elegans. In this paper, we report
that lin-36 mutations do not cause vulval lineage defects alone, and that lin-36 encodes a
novel protein. We also report that lin-36 is required cell autonomously for the regulation
of vulval fate decisions and that a lin-36:: GFP is expressed in the nuclei of the cells that
decide whether to adopt vulval fates. We report that the synthetic multivulva genes act at




Receptor tyrosine kinease and Ras-mediated signal transduction pathways have
been implicated in the control of development in numerous organisms and in
oncogenesis. Although the signal transduction pathway itself is relatively well
understood, little is known about the negative regulation of the pathway in vivo. The
receptor tyrosine kinase and Ras-mediated signal transduction pathway in
Caenorhabsditis elegans provides a useful model for the analysis of this problem. A
well-defined biological context and genetically defined negative regulators of the
receptor tyrosine kinase signal transduction pathway are useful reagents for addressing
the mechanism of the negative regulation of signal transduction.
Vulval induction, the biological context of C. elegans receptor tyrosine kinase and
Ras-mediated signal transduction has been well defined. The hermaphrodite vulva of C.
elegans is formed from the descendents of three hypodermal blast cells, P(5,6,7).p
(Sulston and Horvitz, 1977). These cells are part of the vulval equivalence group, P(3-
8).p, a set of six cells which have the potential to adopt either one of two vulval fates (1°
or 20) or a nonvulval fate (3") (Sulston and White, 1980; Kimble, 1981; Sternberg and
Horvitz, 1986). Cell fates are specified by several cell interactions (for review, see
Horvitz and Sternberg, 1991; Eisenmann and Kim, 1994; Sundaram and Han, 1996). The
gonadal anchor cell signals the nearest Pn.p cells to adopt vulval fates and is at least
partly responsible for establishing the proper pattern of vulval fates (Kimble, 1981;
Sternberg and Horvitz, 1986; Sternberg, 1988; Thomas et al., 1990; Simske and Kim,
1995; Katz et al., 1995). The receptor tyrosine kinase signal transduction pathway is
activated by the anchor cell signal. Many of the components of this signaling system are
known (Arioan et al., 1990; Beitel et al., 1990; Han and Sternberg, 1990; Horvitz and
Sternberg, 1991; Clark et al., 1992; Hill and Sternberg, 1992; Han et al., 1993;
Eisenmann and Kim, 1994; Lackner et al., 1994; Wu and Han, 1994; Kornfeld et al.,
1995a, 1995b; Wu et al., 1995; Sundaram and Han, 1996).
A number of other genes have been identified that act as positive and negative
regulators of the receptor tyrosine kinase and Ras-mediated signal transduction pathway.
Mutations in the genes lin-2, lin-7 and l in-lO produce a vulvaless (Vul) phenotype similar
to that produced by reduction-of-function mutations in components of the let-60 ras
pathway. lin-2, lin-7 and lin-lO are not part of this signal transduction cascade, but rather
act as positive regulators of the cascade. They have been implicated in the localization of
the LET-23 receptor to the cell junction thereby upregulating the activity of the receptor
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tyrosine kinase pathway (Ferguson et al., 1987; Kim and Horvitz, 1990; Hoskins et al.,
1996; Simske et al., 1996).
Negative regulators of the receptor tyrosine kinase signaling pathway have also
been identified. A group of genes known as the synthetic Multivulva (synMuv) genes
have been shown to inhibit the adoption of vulval fates by Pn.p cells. The interaction of
two different synMuv mutations produce a multivulva (Muv) phenotype (Horvitz and
Sulston, 1980; Sulston and Horvitz, 1981; Ferguson and Horvitz, 1985; 1989). The
mutations that interact to produce such a synthetic multivulva (synMuv) phenotype fall
into two classes: A and B. Animals carrying both a class A and a class B mutation have a
Muv phenotype whereas animals which carry mutations in a single class have a wild-type
vulval phenotype. Ferguson and Horvitz (1989) have proposed that the synMuv genes
encode the components of two functionally redundant pathways which negatively
regulate vulval development. Four class A genes (lin-8, lin-15 A, lin-38 and lin-56) and
ten class B genes (lin-9, lin-15 B, lin-35, lin-36, lin-37, lin-51, lin-52, lin-53, lin-54, lin-
55) have been identified (Horvitz and Sulston, 1980; Ferguson and Horvitz, 1989;
Chapter 2). lin-15 is a complex locus with genetically separable class A and class B
activities encoded by two nonoverlapping transcripts (Ferguson and Horvitz, 1989; Clark
et al., 1994; Huang et al., 1994). Three of these genes, lin-15 A, lin-15 B and lin-9, have
been cloned and shown to encode novel proteins (Clark et al., 1994; Huang et al., 1994;
Beitel and Horvitz, in preparation).
SynMuv mutants in which the anchor cell has been ablated still display a Muv
phenotype, suggesting that in the absence of synMuv gene activity, the Pn.p cells do not
require the anchor cell signal to adopt vulval cell fates (Ferguson et al., 1987). However,
loss-of-function mutations in genes known to be involved inductive signal transduction,
let-23, sem-5, let-60 ras, and lin-45 raf are epistatic to lin-15 AB mutations (Ferguson et
al., 1987; Beitel et al., 1990; Han et al., 1990; Clark et al., 1992; Han et al., 1993; Huang
et al., 1994). These results suggest that the inductive signal transduction system is
required for the adoption of the Muv phenotype in the absence of inhibitory synMuv gene
activity even though the anchor cell signal itself is not. Genetic mosaic analyses suggest
that both lin-15 AB and lin-37 act cell non-autonomously and most likely in the
hypodermal syncytium suggesting that the synMuv genes encode the components of two
redundant signaling systems that negatively regulate vulval development (Herman and
Hedgecock, 1990; Hedgecock and Herman, 1995).
lin-36, a class B gene, was selected for further genetic and molecular analysis on
the basis of its map position and the observation that lin-36 seems to act only in vulval
development (Ferguson and Horvitz, 1989; Chapter 2). Here we describe the further
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genetic characterization of lin-36 mutants. The phenotype of lin-36 is analyzed at the
lineage level. We show that lin-36 encodes a novel protein and acts cell autonomously.
We show that lin-36 is likely expressed in the nuclei of the Pn.p cells. This result
suggests that negative regulation of vulval development by class B synMuv genes may be
mediated in the nucleus of the responding cell even though the inhibitory signal emanates
from another tissue. We also describe the genetic interaction between the synMuv genes
which negatively regulate the let-23 induction pathway and genes which positively
regulate the let-23 pathway.
Materials and Methods
General genetic methods and strains
Caenorhabditis elegans strains were maintained and genetically manipulated as
described by Brenner (1974) and were grown at 200 unless otherwise stated. Genetic
nomenclature used conforms to the standards established by Horvitz et al. (1979). N2
was used as the wild type strain and was the parent of all strains used in this study.
Unless otherwise noted, the mutations used in this study are described in Hodgkin et al.
(1988) and are listed below.
LGI: lin-35(n745) (Ferguson and Horvitz, 1989); lin-10(n299) (Ferguson and
Horvitz, 1985); lin-53(n833) (Ferguson and Horvitz, 1989; Chapter 2).
LGII: lin-8(nlll) (Horvitz and Sulston, 1980; Sulston and Horvitz, 1981;
Ferguson and Horvitz, 1985; Ferguson and Horvitz, 1989); let-23(sy97) (Aroian and
Sternberg, 1991); lin-55(n2994) (Chapter 2); rol-6(su1006); lin-7(e1413) (Ferguson and
Horvitz, 1985; Simske et al., 1995); mnC1 dpy-10(e128) unc-52(e444).
LGIII: lin-51(n770) (Ferguson and Horvitz, 1989; Chapter 2); dpy-17(e164); sma-
2(e502); sma-3(e491); egl-5(n945); egl-45(n999); ncl-1(e1865); lin-36(n747, n750, n766,
n772) (Ferguson and Horvitz, 1989) (n2235, n2240, n2243) (Chapter 2); unc-36(e251);
lin-9(n 12) (Horvitz and Sulston, 1980; Sulston and Horvitz, 1981; Ferguson and
Horvitz, 1985; Ferguson and Horvitz, 1989); unc-32(e189); lin-52(n771) (Ferguson and
Horvitz, 1989; Chapter 2); nDf20 (Finney et al., 1988); sDp3(f) (Rosenbluth et al., 1985).
LGX: lon-2(e678); xol-l(y70) (Miller et al., 1988); lin-2(n397) (Ferguson and
Horvitz, 1985; Hoskins et al., 1996); lin-15(el763, n767) (Ferguson and Horvitz, 1985;
Ferguson and Horvitz, 1989; Clark et al., 1994, Huang et al., 1994).
Noncomplementation screens for lin-36 alleles
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The 4,5',8-trimethylpsoralen (TMP) and ultraviolet radiation mutagenesis
technique of Yandell et al. (1994) was used to conduct a noncomplementation screen for
new lin-36 alleles. L4 males of genotype lin-8(nl 11) were mutagenized with TMP and
mated to hermaphrodites of genotype lin-8(n 11); sma-3(e491) lin-36(n766) unc-
32(e]89) and the phenotypically non-Sma non-Unc F 1 cross-progeny were screened for
Muv animals. A total of 23,666 haploid genomes were screened, and one Muv non-Sma
non-Unc animal was isolated. This mutant was made homozygous and backcrossed three
times with lin-8(n 11).
A second noncomplementation screen was conducted using ethyl
methanesulfonate (EMS) as a mutagen. L4 males of genotype lin-8(nl 11) were
mutagenized with EMS and mated to hermaphrodites of genotype lin-8(nl11); lin-
36(n766) unc-32(e]89); lon-2(e678) xol-1(y70) and the phenotypically non-Unc non-Lon
progeny were screened for Muv animals. A total of 21,003 haploid genomes were
screened and five Muv non-Unc non-Lon animals were isolated. These mutants were
made homozygous and then backcrossed three to four times by lin-8(n111).
Pn.p cell lineage analysis
P(3-8).p cell lineages were observed using Nomarski optics as described by
Sulston and Horvitz (1977). The nomenclature and criteria described by Sternberg and
Horvitz (1986, 1989) were used to assign 10, 20 and 3' cell fates.
General DNA manipulation
General DNA manipulations and analyses were essentially performed according
to the protocols of Sambrook et al. (1989). Subcloning was conducted using the
pBluescript SK and KS (+) and (-) vectors (Stratagene Cloning Systems, La Jolla CA)
and the pIBI20 vector (VWR Scientific, Boston, MA). The RNA filter used for Northern
blotting was a gift from L. Bloom.
Germline transformation
Germline transformation by microinjection was done according to Fire (1986) and
Mello et al. (1991). DNA for injection was purified using Qiagen columns (Qiagen Inc.,
Chatsworth, CA). Cosmids and plasmids for rescue experiments were injected at
concentrations of 20-80 gg/ml. The lin-36::gfp reporter was injected at 50 pgg/ml. pRF4,
a plasmid containing the rol-6(su1006) dominant allele was used as a coinjection marker
in all rescue experiments (Mello et al., 1991). Animals were raised and injected at 200.
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F1 Rol animals were placed individually on plates and scored for the Muv phenotype.
Transmitting lines were established from these isolates and scored at 20'.
Isolation of cDNAs and sequence determination
We screened the Barstead mixed stage cDNA library (Barstead and Waterston,
1989) with the 5.0 kb minimum rescuing fragment cloned in pJHT16 and isolated one
cDNA. Samples for sequencing were prepared from both strands using the limited Exo
III digestion procedure. Single-stranded template was prepared using M13 phage
according to Sambrook et al. (1989). The sequences of these templates were determined
using the dideoxy chain termination method and the Sequenase enzyme (U. S.
Biochemical, Cleveland, OH). A few regions required the use of the internal
oligonucleotide primers listed below:
pssEx 11: 5' CAAGAAACAAGAAGCAC





One region in the 3' untranslated region required the use of Taq polymerase at 950 to
sequence (Promega, Madison, WI). DNA sequences were assembled and analyzed using
the Geneworks program (Intelligenetics, Inc., Mountain View, CA).
Molecular analysis of lin-36 lesions
Genomic DNA was purified from N2 and strains carrying lin-36(n747, n750,
n766, n772, n2235, n2240, n2243, n3090, n3093, n3094, n3095, n3096, n3097)
mutations. lin-36(n3090) DNA was digested with SalIl and XbaI, NcoI, NcoI and XbaI,
EcoRV, and Hinfl and analyzed by Southern blot (Sambrook et al., 1989) using the
radiolabeled insert of pJHT16 as a probe. Four primer pairs were used to amplify the lin-
36 coding region and the regions of introns near the splice sites using PCR. These primer
pairs are listed below:
P 100: 5' ACTGTATTTTCTGTTTTTGTGCTC with:
R 1100: 5' CGAGCTAACATATTCATTCACAAG
P200: 5' CTTGTGAATGAATATGTTAGCTCG with:
R1501 A: 5' TTCACCAGATCCCATTGGAGCTTG
s9: 5' TCACCAACGAAAAAAGCCTACGTG with:
R1502: 5' ATCAATGACTTCTTCGACCATTTC
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P400: 5' AGACCGGTAAGTTTAATATATTAG with:
R1503C: 5' GGATAACTTCTGTGGATATAAAAC)
The DNA fragments were gel-purified in low melting temperature agarose. The agarose
was removed by digestion with B-agarase, and the DNA purified according to standard
protocols (Sambrook et al., 1989). The sequences of these PCR products were
determined using an automated ABI 373A cycle sequencer (Applied Biosystems, Foster
City, CA). In addition to seven of the eight primers (P100, R1100, P200, s9, R1501A,
P400, and R 1503C) used to generate the PCR fragments, the following primers were used






s 11: 5' GAGAACCAACAGTTTCACCAAATG
s13: 5' ATTCCTCTTTTACTTTGTAGCATG
s 15: 5' TCGCGAGATCTTTTGTTGCTGGAG
s 17: 5' ATCGTCTGAAGATGTTGCCACTTC
s19: 5' CAGGTGAGCCCATGGGAGGTCTAC
Genetic mosaic analysis
Genetic mosaic analysis of lin-36 was conducted using the method of free
duplication loss described by Herman (1984). We analyzed genetic mosaics using a
strain of genotype lin-8(nl 11); dpy-17(e]64) ncl-1(e1865) lin-36(n766) unc-36(e251);
sDp3(dpy-17(+) ncl-l(+) lin-36(+) unc-36(+)). These worms are phenotypically wild-
type. Most progeny are of two types: phenotypically wild-type progeny that carry the
free duplication and progeny that are Dpy Ncl Unc that have lost the duplication in the
maternal gametes or in the zygote. These Dpy Ncl Unc animals occur at a frequency of
31% (n=771). Rare progeny show a loss of the duplication mitotically, creating a mosaic
of mutant cells in an otherwise wild-type animal. Distinct phenotypes result from the loss
of the duplication in certain lineages in which the wild-type allele is required. unc-36 has
a focus in AB.p (Kenyon, 1986). dpy-17 apparently has has a hypodermal focus in AB.a,
AB.p and C (Yuan and Horvitz, 1990). ncl-i acts cell-autonomously and the enlarged
nucleolus of the mutant can be scored in many cells (Hedgecock and Herman, 1995).
Two strategies were adopted to find mosaic animals. In the first, mosaic animals
of the L3 and L4 larval stages (in addition to a few adults) were isolated on the basis of
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gross morphology and then observed using Nomarski optics to further define the cell
division at which duplication loss occurred. Unc non-Dpy animals result from
duplication loss in AB or AB.p. Dpy non-Unc animals result from loss in P 1, P2, or C.
In these animals, a P2 loss can be distinguished from a C loss by the segregation of all
Dpy Ncl Unc progeny. Semi-Unc non-Dpy animals are the result of a loss in either
AB.pl or AB.pr (Yuan and Horvitz, 1990). The second strategy was to examine
seemingly wild-type L3 and L4 larvae for the Ncl phenotype using Nomarski optics. A
total of 1515 animals were examined in this manner. This approach enabled us to
identify AB.a losses and losses in the AB.p lineages later than AB.pl/r. The Ncl
phenotype was scored primarily in neurons; it cannot be scored reliably in the Pn.p cells
themselves. From the P lineage, the pharyngeal neurons 14, 16, M1, M4 and M5, the tail
neurons PVR and DVC, and occasionally hypl 1 were scored for the Ncl phenotype.
From AB.p, the HSNs and the AB.p-derived neurons of the head and tail were scored.
The subset of AB.p-derived neurons with a Ncl phenotype and their lineage relationship
(Sulston and Horvitz, 1977; Sulston et al., 1983; White et al., 1986) allowed us to
determine the cell division at which duplication loss occurred. From AB.a, the BDUs,
ALMs, the pharyngeal neurons 15, MI, the M2s and the M3s, and the AB.a-derived
neurons of the head were scored.
To determine the maximum number of mosaic animals in which duplication loss
occurred in lineages leading to the anatomical focus of lin-36, we counted the penetrance
of the Muv phenotype in Dpy Ncl Unc animals. The penetrance of the Muv phenotype of
Dpy Ncl Unc animals derived from duplication-bearing mothers was 69% (n=240). The
penetrance of Muv non-Dpy non-Unc animals was 1.3% (n=531).
Construction of a lin-36:: GFP reporter
A lin-36::GFP reporter was constructed by ligating the 4.4 kb Sall SacI fragment
from pJHT16 to a linker fragment and Sall XmaI double digested pPD95.79. pPD95.79
is a vector containing a green fluorescent protein coding region with a C. elegans unc-54
3' end and a fluorescence enhancing S65C mutation (Chalfie et al., 1994; Heim et al.,
1994; 1995; A. Fire, personal communication). The linker fragment was constructed by
using the primers pG5F (5' AGAGCAATGGAAGACGC) and pG3W (5'
TCCCCCCGGGTTGTTGAGAATCCGATG) to amplify DNA from pJHT16. pG3W
anneals to the end of the lin-36 coding region including the last codon and adds an XmaI
site followed by four additional nucleotides. This linker was digested with XmaI and an
internal SacI site.
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Five lines were isolated from germline transformation experiments using a lin-
36(n766); lin-15(n767) animal as a host and rol-6(su]006) as a coinjection marker. The
reporter construct rescued the Muv phenotype of the strain in transformed lines. Animals
from two of these lines were exposed to 4100 rads of y-irradiation from a 60 Co source.
The progeny of 894 Fl animals were screened for lines that segregated only Rol animals.
Three such lines were isolated, but one had to be discarded because it had lost lin-36
rescue ability and GFP staining. Line 2H1 expressed strongly, but the animals were
sickly; line 3L26a was healthy and exhibited expression similar to the other transformants
and was used in the characterization of lin-36::GFP reporter expression. Reporter
expression in class B synMuv mutant backgrounds was analyzed in strains constructed by
crossing the reporter construct into the strain bearing a class B mutation and isolating
Muv Rol animals from the F2 generation.
Construction of strains for gene interaction studies
To constuct lin-36-containing triple mutants, N2 males were crossed into
Vulvaless(Vul) strains mutant in let-23, lin-2, lin-7, or lin-O10. Cross-progeny males were
crossed into lin-36; lin-15 hermaphrodites and cross progeny hermaphrodites were
isolated. These hermaphrodites were allowed to self-fertilize and Muv and Vul animals
were isolated. Progeny of the opposite phenotype (Vul segregants from Muv animals and
Muv segregants from Vul animals) were isolated as the triple mutants. This scheme is
essentially identical to that used previously (Ferguson et al., 1989). Double mutants
containing mutations resulting in a Vul phenotype and the lin-15(e1763) Muv mutation
were isolated in the same manner. In strains containing lin-2, a large number of animals
were used in the crosses to insure that recombinants between the linked mutations in lin-2
and lin-15 would be isolated. For all genes tested, either null alleles or the strongest
alleles known were used.
Laser microsurgery
Laser microsurgery was conducted essentially as described previously (Sulston
and White, 1980; Avery and Horvitz, 1987; Thomas et al., 1990). 60 mM sodium azide
was used as an anesthetic. Mock ablated animals were treated exactly as operated
animals with the exception of laser microsurgery. Three mock ablated animals were used
as an operation control in the lin-36(n766); lin-15(n767) experiment, and eight were used
as a control in lin-7(e1413); lin-36(n766); lin-15(n767) experiment.
Results
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Identification of new lin-36 alleles
lin-36 mutations had previously been identified in screens for class B synMuv
mutations (Ferguson and Horvitz, 1989; Chapter 2). To identify more mutations in this
locus, two noncomplementation screens were conducted in a lin-8(nl11) class A
background. In one screen, 4,5',8-trimethylpsoralen was used as a mutagen. One
mutation, lin-36(n3090) was isolated and shown to be associated with an EcoRV
polymorphism by Southern hybridization. This RFLP was produced by a point mutation
rather than a deletion. In the other screen, using EMS as a mutagen, five lin-36 mutations
(n3093, n3094, n3095, n3096, n3097) were isolated. This frequency of EMS-induced lin-
36 alleles, 2.4*10-4 per haploid genome is close to that expected for the average EMS-
induced loss-of-function mutation in C. elegans, 5*10 -4 (Brenner, 1974; Greenwald and
Horvitz, 1980).
The penetrance of the Muv phenotype of each of the mutant strains was
determined (Table 1). Three of the six strains, lin-8(nl11); lin-36(n3093), lin-8(nl11);
lin-36(n3095), lin-8(nl 11); lin-36(n3096) are phenotypically similar to two strains
carrying strong lin-36 alleles, lin-8(n] 11); lin-36(n747), lin-8(n 11); lin-36(n766)
(Ferguson and Horvitz, 1989). lin-8(n]11); lin-36(n3090) is phenotypically similar to
lin-8(nlll); lin-36(n2243); these mutations are missense mutations in adjacent residues
(Table 3, and Chapter 2).
The phenotypes of the strongest mutant alleles (n747, n766, n3093, n3095, n3096)
are essentially identical, suggesting that they may be complete loss-of-function alleles.
The frequency of isolation in a noncomplementation screen is not inconsistent with the
isolation of null alleles. We are not able to interpret the phenotype of animals carrying
both lin-36 alleles and deficiencies of the lin-36 region since the phenotype of deficiency
trans-heterozygotes is weaker than that of homozygotes. It is possible that a linked,
haplo-insufficient suppressor of the synMuv phenotype is uncovered by the deficiencies
or that the tested lin-36 alleles have some antimorphic character. The molecular natures
of the strong lesions are consistent with complete loss-of-function alleles;four out of five
are nonsense mutations (Table 3). Thus, much of the data is consistent with the
identification of loss-of-function alleles, but these data are not compelling.
Vulval lineage defects of lin-36
The vulval defect in strains carrying lin-36 mutations was analyzed at the lineage
level. Each of the three fates adopted by the cells of the vulval equivalence in wild-type
vulval development displays a characteristic and distinct cell division and morphology
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pattern. We observed the lineages of the P(3-8).p descendents in various strains carrying
synMuv mutations. Animals carrying only a strong lin-36 mutation, lin-36(n766),
displayed wild-type Pn.p cell lineages, as did animals carrying only the strong class A
mutation, lin-15(n767) (Table 2). Thus, animals homozygous for only a single,
representative synMuv mutation of either class A or class B, are wild-type for vulval
development at the lineage level. The members of the vulval equivalence group that are
not induced in wild type, P(3,4,8).p, are induced in animals of genotype lin-36(n766); lin-
15(n767). In ten animals examined, 29/30 of these cells were completely induced and the
remaining 1/30 showed partial induction. All but one of these cells that adopted 20 cell
fates (n=7 cells), adopted the same polarity as the cell that in wild type adopts the 20 cell
fate on the same side of the P6.p cell. 3/30 P(3,4,8).p cells adopted induced lineages
which did not meet the criteria for assignment as either a 1' or a 20 cell fate. One of these
included a P3.pap cell that adopted a hyp7-like nuclear morphology and fused with the
syncytium; otherwise, the lineage was consistent with a 10 cell fate (Table 2). Ectopic
vulval tissue from P3.p and P4.p formed invaginations consistent with the fates and
polarities of the cells which composed this tissue. In cases where ectopic 2' cell lineages
were adjacent to ectopic 10 lineages and their relative polarity was the same as that found
in the wild-type vulva, a single invagination was observed. In cases in which the 20
lineage polarity was opposite that of the wild-type vulva, two invaginations were
observed. In one case in which a P3.pap cell fused with the syncytium (described above),
three invaginations were observed (Table 2).
Cloning of lin-36
Previous data placed lin-36 between lin-13 and unc-36 on linkage group III
(Ferguson and Horvitz, 1989). We mapped lin-36 under nDJ20 and between egl-5 and
unc-36 (Figure 1 a) which had both been cloned and positioned on the physical map
(Coulson et al., 1986; Coulson et al., 1991; Wang et al., 1993; L. Lobel, personal
communication). We predicted the physical location of lin-36 based on the relative map
distances between lin-36 and egl-5 and unc-36, and selected cosmid pools from this
region (Figure lb). These pools of cosmids were injected into animals bearing a class A
synMuv mutation and a lin-36 mutation in germline transformation experiments. Cosmid
E02E3 was shown to rescue the Muv phenotype of both lin-8(nl 11); lin-36(n747) and
lin-36(n766); lin-15(n767) and was used to construct subclones. These experiments
defined a 5.0 kb XbaI SalIl minimum rescuing fragment, pJHT16 (Figure Ic)
The XbaI Sall insert of pJHT 16 was used as a probe to a Northern blot containing
poly-A+ RNA from mixed stage animals. This probe recognized a single band of
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approximately 3.5 kb. The same fragment was used as a probe to screen the Barstead
cDNA library (Barstead and Waterston, 1989) and isolate a single cDNA clone. The
3400 nucleotide cDNA included a poly-A tail and nine nucleotides of the SLI trans-
spliced leader, indicating that it was full length (Krause and Hirsh, 1987; Huang and
Hirsh, 1989). The sequence of the cDNA was compared to genomic sequence from the
region generated by the C. elegans genome sequencing project to define the exon and
intron structure of the gene (Wilson et al., 1994).
lin-36 encodes a novel protein
The coding sequence of lin-36 was determined from the cDNA clone (Figure 2).
Conceptual translation yields a novel gene product of 962 amino acids with a predicted
molecular weight of 108 kDa. The predicted protein product is highly hydrophilic and
has no hydrophobic stretches of significant length. There are few significant protein
motifs. Amino acids 428 to 532 are a potential nuclear localization sequence (for review,
see Goldfarb, 1989) and a poly-glutamine stretch at the C-terminus. The region between
residues 102 and 376 is cysteine- and histidine-rich; it contains 15 histidine and 14
cysteine residues. These residues are largely concentrated in the region between amino
acids 151 and 300; 12 histidine residues and 12 cysteine residues lie in this region. Only
two cysteine and two histidine residues fit zinc-finger spacing requirements (Rhodes and
Klug, 1986; Tautz et al., 1987). Given the large number of Cys and His residues, it is
unlikely that this region forms zinc fingers.
Molecular determination of lin-36 lesions
The polymerase chain reaction was used to amplify lin-36 DNA from mutants in
order to determine the sequence changes in these strains. Six mutations are missense
mutations, five are nonsense mutations, one is a splice site mutation, and one contains a
missense mutation as well as a putative novel splice donor (Table 3). The nonsense
mutations are expected to truncate the lin-36 product. Three of the ochre mutations, lin-
36(n766), lin-36(n3095) and lin-36(n3096) delete 167, 394 and 521 amino acids from the
962 amino acid coding sequence respectively. All produce a strong phenotype. Another
ochre mutation, lin-36(n2235) deletes 65 amino acids from the coding sequence and
produces a weaker phenotype. The amber mutation, lin-36(n3093) deletes 384 amino
acids from the protein. One mutant allele, n750, had two changes, one of which was
identical to the n2240 lesion. The other change is a silent glycine to glycine change but
may generate a novel splice donor site. The mutation produces a sequence that closely
conforms to the canonical C.elegans splice donor parameters (Fields, 1990). All of the
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EMS induced mutations are the expected G:C to A:T transitions (Coulondre and Miller,
1977), except for n766 which is a T:A to A:T transversion, a lesion rarely seen induced
by EMS (Table 3).
lin-36 acts cell autonomously
To determine the site of action of lin-36, we conducted a genetic mosaic analysis.
This analysis is commonly conducted in C. elegans by generating mutant clones in an
otherwise wild-type animal through the loss of a mitotically unstable free duplication
which complements the mutation of interest. By scoring the phenotypes of linked
markers that have known sites of action and are complemented by the free duplication,
and correlating these results with the known lineage of all C. elegans cells (Sulston and
Horvitz, 1977; Sulston et al., 1983), the site of action of a gene can be determined
(Herman, 1984).
A strain of genotype lin-8(nl11); dpy-17(e164) ncl-1(e]865) lin-36(n766) unc-
36(e251); sDp3(f) was used to generate genetic mosaics as described in Materials and
Methods. Genetic mosaics were identified and characterized as L3 and L4 larvae and
subsequently scored for the Muv phenotype upon reaching adulthood. Strains carrying
lin-36 exhibit maternal rescue of the Muv phenotype (Ferguson and Horvitz, 1989;
Chapter 2). The penetrance of the Muv phenotype of Dpy Ncl Unc animals homozygous
for lin-36 descended from duplication bearing mothers was determined to be 69%
(n=240). This number sets an upper limit on the fraction of Muv animals we expected
from a mitotic loss of the duplication in the lineage from which the cellular focus of lin -
36 is derived.
Loss in AB, AB.p, AB.pl, or AB.pr often produced Muv animals. Loss in P 1 or in
AB.a failed to result in Muv animals. These data are consistent with an anatomical focus
in both the AB.pl and AB.pr. lineages; the Pn.p cells derive from both of these lineages.
Note that P 1 makes the largest hyp7 contribution during embruogenesis. Note also that
AB.a makes a larger contribution to hyp7 that either AB.pl or AB.pr, yet losses in AB.pl
or AB.pr often result in a Muv phenotype whereas losses in AB.a or Pi do not (Figure 3).
Thus, the Pn.p cells, derived from AB.pl and AB.pr, are more likely candidates for the
focus of lin-36 activity than the hyp7 nuclei descended from thess lineages. As
discussed below, synMuv genes with a postulated focus in hyp7 show very different
clonal behavior. Three double losses were observed. One occurred in AB and MS/EMS
and resulted in a Muv phenotype, presumably because of the AB loss. Another occurred
in AB.pl and C resulting in a Muv phenotype, presumably because of the AB.pl loss. A
third occurred in AB.prapp and AB.a resulting in a Muv phenotype, presumably because
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of the AB.prapp loss. Thus, the phenotypes of mosaic animals with double losses could
be explained on the basis of one of the two losses.
The simplest interpretation of these results is that lin-36 acts cell autonomously in
the Pn.p cells, although it is possible that lin-36 is actually required in close relatives of
the Pn.p cells, possibly hyp7 cells derived from V3 or V5, in both the AB.pl and AB.pr
lineages.
These results are in marked contrast to the genetic mosaic analysis results of lin-
15 and lin-37. Loss of lin-15 activity in AB or AB.p lineages results in a Muv phenotype,
as does loss in AB.pl or AB.pr, albeit at a lower frequency. lin-15 mosaics differ from
lin-36 mosaics in that loss of lin-15 activity in P results in a Muv phenotype. The P 1
lineage does not give rise to Pn.p cells, yet lin-15 is required in this lineage as well as in
the AB lineage. These findings suggest that lin-15 is required in hyp7, which originates
from both of these lineages (Herman and Hedgecock, 1990). The lin-15 genetic mosaic
analysis was conducted using a lin-15 AB allele. Since lin-15 A and lin-15 B activities
are redundant, both activities must be lost simultaneously in their respective anatomical
foci in a mosaic analysis to produce a Muv phenotype. Since simultaneous loss of both
lin-15 A and lin-15 B activities in P 1 is sufficient to produce a Muv phenotype, lin-15 A
and lin-15 B are both required cell nonautonomously.
The lin-36 mosaic results differ from the lin-37 mosaic results. Only 3/23 animals
in which lin-37 was lost in AB had a Muv phenotype. Loss in AB.p was insufficient to
produce a Muv phenotype (n=24). Loss in P1 was also insufficient. Since loss in AB.p
did not produce a Muv phenotype, these results have been interpretted to mean that lin-37
activity is required cell nonautonomously. It has been proposed that the loss of lin-37
activity in P or AB.p lineages is insufficient to result in a Muv phenotype and that loss
in AB is only occasionally sufficient. This is probably because the AB lineage produces
almost all of the hyp7 nuclei in the animal. It is likely that lin-37 is provided in greater
excess than lin-15 activity and that this accounts for the differences in the mosaic animals
even though both are thought to act cell nonautonomously (Hedgecock and Herman,
1995). Thus, the requirements for lin-36 activity differ substantially from those of lin-15
and lin-37, and are consistent with a focus in the vulval precusor cells.
A lin-36::GFP reporter is expressed in the nuclei of Pn.p cells
To provide support for the evidence from the genetic mosaic analysis of lin-36,
we determined the expression pattern of a lin-36::GFP reporter construct. This construct
contains 1 kb of sequence 5' to the ATG start site and the entire lin-36 open reading frame
and all intervening sequences. GFP was fused, in frame, to the last amino acid residue of
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lin-36. The lin-36:: GFP reporter transgene rescued the Muv phenotype of a lin-36; lin-15
A strain. This implies that expression in at least a subset of the cells in which the fusion
protein is expressed is sufficient for normal lin-36 function. lin-36:: GFP is expressed in
Pn.p cells and their descendents during vulval cell determination, division, and
invagination (Figure 4). Similar observations have been made with an independently
constructed lin-36:: GFP reporter (Alex Hajnal, personal communication). This
expression pattern is consistent with the data obtained in the genetic mosaic analysis.
The Pn.p cell expression of lin-36:: GFP is not altered by mutations in other class B
genes. This was tested in lin-9, lin-15, lin-35, lin-51, lin-52, lin-53, and lin-55
backgrounds (Ferguson and Horvitz, 1987; Chapter 2).
Besides the Pn.p cells, many other cells express GFP in strains bearing the
reporter construct. Most notably, the neurons of the head, tail and ventral cord express
lin-36::GFP throughout development. Some staining has also been observed in the
gonad.
Interestingly, lin-36::GFP expression is observed in the nuclei of all cells in
which it is expressed. No expression in the cytoplasm has been detected. The GFP
reporter gene used in the construction of this reporter construct did not contain a nuclear
localization sequence, but as mentioned earlier, the lin-36 coding region contains a
potential nuclear localization sequence. This sequence appears to be sufficient to allow
localization of the LIN-36::GFP fusion protein to the nucleus. This data suggests that lin-
36 may act in the nucleus of the Pn.p cells to mediate its effect on vulval development.
The vulvaless phenotype of lin-2, lin-7, and lin-O10 is co-expressed with the
multivulva phenotype in triple mutants with synMuv mutations
To determine where the synMuv genes act in the regulatory hierarchy controlling
vulval induction, we constructed triple mutants using several vulvaless mutations and
synMuv mutations (Table 4). The Vul phenotype of mutations in the let-23 receptor
tyrosine kinase gene is epistatic to the lin-36; lin-15 A synMuv phenotype. Thus, let-23
activity is required for the adoption of vulval fates by Pn.p cells in synMuv mutants. The
let-23 receptor tyrosine kinase acts downstream of, or in parallel to, the synMuvs. This is
consistent with previous results using other synMuv mutations (Ferguson et al., 1987;
Huang et al., 1994).
lin-2, lin-7, and lin-lO positively regulate the let-23-mediated signal transduction
cascade presumably by localizing the LET-23 receptor to the Pn.p cell junctions (Simske
et al., 1995; Hoskins et al., 1996). In triple mutants with these mutations, the synMuv
phenotype and the Vul phenotype are co-expressed (Table 4). Neither is epistatic to the
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other. Animals are observed with either phenotype, a wild-type phenotype, or both
phenotypes such that animals are either bloated with eggs or are bags of worms, and have
ectopic ventral protrusions. This suggests that both groups of genes, the synMuv genes
and the lin-2, lin-7, lin-lO group, act at the same hierarchical level of regulation of the let-
23 pathway and that both sets of genes act independently of each other to regulate the let-
23 signal transduction pathway. The unusual distribution of phenotypes and the co-
expression of phenotypes in the same animals suggests that, in the absence of both
positive and negative regulation through these genes, the Pn.p cells are deregulated.
Cells that in wild type normally adopt vulval fates often adopt nonvulval fates whereas
cells that normally adopt nonvulval fates often adopt vulval fates in these animals (Table
2). It is worth noting that the anchor cell signal has not been eliminated in these animals.
The co-expression of Muv and Vul phenotypes has been reported for lin-8; lin-9
synMuv strains with lin-2, lin-7 and lin-10. However, double mutants between the
synMuv lin-15(n309) mutation and lin-2, lin-7 and lin-lO have been reported to be Muv
(Ferguson et al., 1987). We repeated this experiment using lin-15(e1763). Both of these
lin-15 alleles are molecular null alleles (Clark et al., 1994). The lin-15 double mutants
with lin-2, lin-7 and lin-lO show co-expression of the Muv and Vul phenotypes (Table 4).
These results are consistent with those of the lin-36; lin-15 triples; however, unlike the
lin-36 triple mutants, most animals are either Muv or Muv Vul; few are wild type or Vul.
Since almost all animals express the Muv phenotype and some express the Vul phenotype
in addition to the Muv phenotype, it is likely that in previous studies, the Vul phenotype
was not noticed.
To determine whether the anchor cell signal is responsible for the adoption of
vulval fates by Pn.p cells in which receptor localization is disrupted and the negative
regulatory pathways are eliminated, we removed the anchor cell by eliminating all of the
somatic gonad. This was accomplished by laser ablating Zl and Z4, the precursors of the
somatic gonad (Kimble and Hirsh, 1979). These operations were performed at the early
L larval stage. The ablation of Zl and Z4 prevents germline proliferation and produces
a sterile animal with no gonad (Kimble and White, 1981). This served as an internal
control to confirm the ablation of the somatic gonad. As a further control, we ablated Zl
and Z4 in lin-36; lin-15 A animals; 11/11 of these animals produced ectopic vulval tissue.
This is consistent with the laser ablation of the gonads of lin-8; lin-9 and lin-15 AB
animals which also produce ectopic vulval tissue (Ferguson et al., 1987). We ablated Z
and Z4 in lin-7; lin-36; lin-15 A animals and observed that 14/14 operated animals had
ectopic vulval tissue. Thus, in animals in which the gonadal signal, the receptor
localization system, and the synMuv-mediated inhibitory pathways have been disrupted,
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Pn.p cells can adopt vulval fates. These results, together with those described above, are
consistent with the hypothesis that a ligand-independent and receptor localization-
independent activity of the let-23 signal transduction pathway can lead to the adoption of
vulval cell fates. Presumably, it is this activity which the synMuvs normally inhibit.
Discussion
lin-36 encodes a novel protein and acts cell autonomously
Our results suggest that lin-36 encodes a novel protein which is required in the
Pn.p cells to negatively regulate vulval development. The lin-36 mosaic data are in
marked contrast to the mosaic data for lin-15. Herman and Hedgecock (1990) showed
that lin-15 acts cell non-autonomously in a genetic mosaic analysis experiment.
Specifically, they found that loss of lin-15(+) in PI, AB or AB.p, AB.pl, or AB.pr can
result in a Muv phenotype. hyp7, which derives from these lineages, was postulated to be
the anatomical focus of lin-15 activity. The lin-36 mosaic data are also different from the
mosaic data for lin-37, which was shown by Hedgecock and Herman (1995) to act cell
non-autonomously. Specifically, they found that loss of lin-37(+) in PI, AB.p, AB.pl, or
AB.pr did not cause a Muv phenotype; loss in AB infrequently resulted in a Muv
phenotype. Loss in AB results in many hyp7 nuclei lacking lin-37(+). Hedgecock and
Herman (1995) have postulated that lin-37 is also required in hyp7, but a relatively low
dosage is sufficient for wild-type activity. Our results, which show a requirement for lin-
36(+) only in those lineages leading to the Pn.p cells, suggest that lin-36 acts in the Pn.p
cells and not in hyp7. This is consistent with the lin-36 expression data. Based upon
these mosaic analysis results, we believe that the class B synMuvs encode components of
a signaling system, some of which act in the hypodermis and some of which act in the
Pn.p cells.
Redundancy in the specification of cell fates
lin-36 is a component of one of two redundant pathways involved in the
specification of cell fates during C. elegans vulval development (Ferguson and Horvitz,
1989; Chapter 2). Several other examples of functional redundancy during development
have been observed. The Drosophila genes achaete and scute are functionally redundant
for the specification of larval sense organs but individually required for the specification
of distinct groups of adult bristles (reviewed by Ghysen and Dambly-Chaudiere, 1991).
Several additional examples of functional redundancy have been observed in C. elegans.
The molecularly similar genes lin-12 and glp-1 act in a functionally redundant manner to
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control several aspects of development even though they also have non-overlapping
requirements in certain developmental decisions (Lambie and Kimble, 1991). These
examples each involve functional redundancy between two molecularly similar genes.
Partial functional redundancy between groups of genes or pathways is seen in the cell
corpse engulfment genes of C. elegans. Cell corpse engulfment mutants fall into two
classes; animals carrying mutations in both classes have a more severe phenotype than
animals carrying mutations in only one class. However, an animal carrying one mutation
exhibits a cell corpse engulfment phenotype (Ellis et al.,1991).
The synMuv genes differ from these previous examples in that alone they do not
cause a vulval phenotype and they fall into two classes with multiple members. This
indicates that they encode two pathways, each of which is unnecessary in the presence of
the other for vulval development. Most redundant processes in development are
relatively inaccessible because mutations in the genes of such pathways do not cause a
phenotype in the absence of a second site mutation. The synMuv genes provide a model
system for the analysis of the role of redundant systems in controlling metazoan
development.
lin-36 acts as a component of a signaling pathway
The findings that some of the synMuv genes act outside of the Pn.p cells suggests
that they encode the components of a signaling system that regulates the adoption of cell
fates in the vulval equivalence group (Herman and Hedgecock, 1990, Hedgecock and
Herman, 1995). The finding that lin-36 acts in the Pn.p cells suggests that some of the
class B genes encode the components of a negative regulatory signal transduction cascade
within the vulval precursor cells. Thus the negative signal from the class B pathway is
interpreted within the cytoplasm or nucleus of the Pn.p cell rather than on its surface.
Sequence and expression data suggest that lin-36 may be a nuclear protein. Thus lin-36
may regulate transcription directly or indirectly. If this is indeed the case, then the class
B synMuv pathway regulates vulval fate specification through an effect on transcription.
Since lin-36 likely acts in the nuclei of the Pn.p cells, it may encode a protein that acts
near the end of the class B signal transduction pathway.
The negative signal produced by the components of the class A pathway may be
interpreted on the surface of the Pn.p cell or in its interior (Figure 5). The number of
components of the class A pathway is significantly smaller than that of the class B
pathway (Ferguson and Horvitz, 1989; Chapter 2). This is not inconsistent with the class
A signal acting at the Pn.p cell surface.
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Negative regulation of inductive signaling pathways
lin-36 and the class B synMuvs may negatively regulate vulval development at
any number of points. The class B synMuvs may directly negatively regulate the let-23
receptor by preventing dimerization, by blocking access to downstream signaling
molecules, or by phosphatase activity. Another protein in the inductive signal
transduction cascade may be the target of negative regulation. For example, the synMuvs
may inhibit let-60 ras through a ras-GTPase Activating Protein. They may inhibit
positive regulators of the pathway that are required for the activity of the pathway, but are
not a direct link in the transduction cascade. The class B synMuv genes may not directly
affect the inductive signal transduction system, but instead inhibit the adoption of vulval
cell fates at the level of transcription. The nuclear subcellular localization of the lin -
36::gfp reporter suggests that this is the most likely possibility. However, some class B
synMuv genes may regulate the transcription of a protein, possibly encoded by a class B
synMuv gene, that negatively regulates the let-23 pathway via one of the mechanisms
described above.
The class A and class B genes need not have the same biochemical activities.
Neither must they act at the same point in the inductive pathway. Epistasis experiments
show that let-23 is epistatic to the synMuvs. Since the two classes of synMuv genes are
functionally redundant, only one class needs to act at the level of the let-23 receptor. In
the triple mutant, let-23 bypasses at least one class; this suppression of one class masks
the activity of the other since they are functionally redundant. The suppression of one
class of synMuvs is genetically similar to having a mutation in only one class of synMuv
genes; such animals display no vulval defects. Thus let-23 need be epistatic to only one
of the two classes of synMuv genes.
Epistasis experiments show that the synMuvs are epistatic to lin-3 and that let-23
is epistatic to the synMuv mutations (Ferguson et al., 1987; Huang et al., 1994). These
results indicate that the inductive signal transduction system is required for the adoption
of vulval fates in the absence of negative regulation by the synMuvs. These results,
coupled with the finding that the synMuv mutants are Muv in gonad-ablated animals
(Ferguson et al., 1987), also indicate that activation of the inductive signal transduction
cascade by ligand is not necessary for the adoption of vulval fates in the absence of
negative regulation by the synMuvs. These results are consistent with a model in which
the synMuv genes inhibit (possibly via two distinct methods) the basal (ligand-
independent) activity of the inductive pathway, whose activity is necessary for the
adoption of vulval fates by the Pn.p cells. This inhibition is overpowered by the
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activation of the inductive pathway by the binding of ligand to receptor in the subset of
Pn.p cells nearest the anchor cell.
The synMuv phenotype is co-expressed with the Vul phenotype of lin-2, lin-7 and
lin-lO, genes which positively regulate the inductive signal transduction cascade by
localizing the LET-23 receptor to the Pn.p cell junctions (Ferguson et al., 1987; Kim and
Horvitz, 1990; Hoskins et al., 1996; Simske et al., 1996). Thus, the synMuv genes act to
negatively regulate the let-23 pathway independently of the lin-2, lin-7, lin-lO regulatory
system. The synMuv genes do not act through the lin-2, lin-7 and lin-lO receptor
localization process; they do not inhibit receptor localization. Likewise lin-2, lin-7 and
lin-lO do not act by negatively regulating the synMuv genes. The absence of either of
these modes of regulation can partially bypass the requirement for the other: they
function at equivalent hierarchical steps. Neither takes precedence over the other. In the
absence of both positive and negative regulation, the fate of the Pn.p cells becomes
somewhat deregulated.
With the exception of pattern formation in the vulva, the fates seen in animals
lacking positive regulation by lin-2, lin-7, lin-lO genes and lacking negative regulation by
the synMuv genes are similar to fates seen in animals lacking the stimulatory anchor cell
signal as well as the positive and negative regulatory pathways. The expression of vulval
fates in the absence of receptor localization is not due to the influence of the anchor cell
signal; elimination of this signal still allows the adoption of vulval cell fates in synMuv
mutants with a disabled receptor localization system. Not all Pn.p cells adopt vulval cell
fates, however. In the absence of both inductive signal and receptor localization, the
elimination of negative regulation by the synMuv genes is not sufficient to allow all Pn.p
cells to adopt vulval cell fates. Thus, the activities of the synMuv pathways and the lin-2,
lin-7, lin-lO pathway are necessary to allow tight control over the adoption of vulval and
nonvulval cell fates by the Pn.p cells.
The data described above suggest the following model. The six Pn.p cells are
predisposed to adopt vulval fates by the unstimulated activity of the let-23 signal
transduction pathway. In the absence of this pathway, the Pn.p cells are incapable of
adopting vulval fates. This predisposition to adopt vulval fates is inhibited through the
action of the two functionally redundant signaling pathways encoded by the synMuv
genes. The synMuv genes normally act to downregulate the unstimulated activity of the
let-23 signal transduction pathway. The action of the synMuv genes changes the inherent
tendency of the Pn.p cells to adopt vulval cell fates to a tendency to adopt nonvulval cell
fates. The inductive signal from the anchor cell stimulates the let-23 pathway in the cells
nearest it, instructing them to adopt a vulval cell fate. This stimulation overcomes the
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effect of the two inhibitory pathways either by overriding or inhibiting negative
regulation by the synMuv genes (Figure 5).
Multiple signaling pathways allow a more precise control over developmental
events. It is likely that positive and negative signaling pathways that act together are
common in the specification of cell fates in metazoa. Negative regulation of signaling
pathways by other signaling pathways may be a common mode of regulation. Such
systems are most readily studied in vivo where various tissue types are in contact; the
homogeneous populations in tissue culture experiments are not likely to reveal such
negative regulation.
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Table 1. The percentage of Muv animals of each genotype was determined at 200.
Complete genotypes are shown. Percent Muv, percent of animals having ventral
protrusions. n, number of animals scored.
a data from Ferguson and Horvitz, 1989.
b data from Chapter 2.
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Table 1. Penetrance of the Muv phenotype in strains carrying lin-36 mutations
Genotype Percent Muv n
lin-8(nl11); lin-36(n747) a 98 177
lin-8(nl11); lin-36(n750)a 75 357
lin-8(n 11); lin-36(n766)a 98 207
lin-36(n766); lin-15(n767)a 100 226
lin-36(n772); lin-15(n767)a 99 369
lin-8(nl11); lin-36(n2235) b 79 313
lin-8(nl11); lin-36(n2240) b 79 373
lin-8(n 11); lin-36(n2243) b 94 593
lin-8(nl11); lin-36(n3090) 81 265
lin-8(nl11); lin-36(n3093) 96 320
lin-8(nl11); lin-36(n3094) 53 278
lin-8(nl11); lin-36(n3095) 94 420
lin-8(n111); lin-36(n3096) 97 456
lin-36(n3096); lin-15(n767) 99.7 317
lin-8(nl11); lin-36(n3097) 57 334
lin-36(n3097); lin-15(n767) 99 309
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Table 2. Pn.p cell lineages follow the nomenclature of Sternberg and Horvitz (1986;
1989). This nomenclature describes nuclear division and morphology: S, the nucleus
adopted a characteristic morphology and fusion with the hypodermis; T, the nucleus
divided transversely (left-right); L, the nucleus divided longitudinally (anterior-posterior);
0, the nucleus divided obliquely; N, the nucleus did not divide and adopted a distinct
morphology; ?, the nucleus had not divided four hours after the last divisions but did not
adopt the distinct morphology of an N fate. Underlining and bold face type indicate that
the daughter nuclei adhered to the cuticle. Gross phenotype is described in terms of
pseudovulval invaginations in larvae and subsequent pseudovulval protrusions in adults.
The number of pseudovulval invaginations anterior to the vulva is indicated by the
number preceding the letter a; the number of pseudovulval invaginations posterior to the
vulva is indicated by the number preceding the letter p. WT indicates that no
pseudovulval invaginations formed. Vul, indicates that no functional vulva was formed;
in the case described here, the vulval tissue protruded. Unless otherwise noted, in all
animals, mutant and wild-type, a functional vulva formed. Pn.p cell lineages of lin-
7(e1413) mutants show no vulval induction or partial vulval induction (Sternberg and
Horvitz, 1989). 2' cell fates are defined by division to produce seven or eight great
granddaughter cells that are polarized such that four cells in one half of the lineage adhere
to the cuticle. Note that all but one of the Pn.p cells adopting ectopic 2' cell fates show
polarity similar to that of the nearest Pn.p cell adopting a 2' cell fate and participating in
the formation of the vulva.
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Table 2. Pn.p cell lineages in lin-36 mutants
Gross
Genotype n P3.p P4.p P5.p P6.p P7.p P8.p Phenotype
N2 many S SS LLTN TTTT NTLL SS WT
many SS SS LLTN TTTT NTLL SS WT
lin-15(n767) 5 S SS LLTN TTIT NTLL SS WT
4 SS SS LLTN TTTT NTLL SS WT
1 SS SS LLTN 7 TT NOLL SS WT
lin-36(n766) 5 S SS LLTN TMTI NTLL SS WT
5 SS SS LLTN TITT NTLL SS WT
lin-36(n766); lin-15(n767) 1 LOLL LLTT LLON TTTL NOLL OTOL 2alp
1 OTLO LLOO LLTN TMT NTLL LLTO 2alp
1 LSOO LLTL LLON TMT NTLL LTOT 3alp
1 TOOT LLON LLON TITT NTLL LITT 2alp
1 LLTT LLTN LLON TITT NTLL OOLO 2alp
1 OOLO LLLT LLON TMT NLLL OOS 2alp
1 TILL LOTO LLON TTT NOLL 0000 2alp
1 LLON TTFTL LLLN TITT7 NTLL LTOO lalp
1 LLTN TT70O LLTN TTT NLLL OTTO lalp
1 LLTO TOOO LLTN TITT NLLL TOTO lalp
lin-7(e1413); lin-36(n766);
lin-15(n767) 1 LLTN ??OO LLON LOTO NOLL SOS 2alp
1 S LLON LLTT TTOO LOOL LLTL lalp
1 SOT LLLN LTTTF NTLL SS SS la
1 LLLL OOOT LLTN TTITT NTLL SSS la
1 LTTN OOON SOT LONO SS SS 3a, Vul
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Table 3. Exon sequences are shown in capital letters and intron sequences are shown in
lowercase letters. The C. elegans concensus splice donor and acceptor sites are
RAG/gtaagttt and wwtttcag/NNN where R is A or G, W is A or T, and N is any
nucleotide (Fields, 1990). Amino acid substitutions are shown as wild-type residue
identity, residue number, predicted mutant residue. All mutations with the exception of
n3090 were generated with EMS. Twelve out of the thirteen changes observed in these
the mutations generated with EMS are G:C to A:T transitions, consistent with the known
specificity of EMS (Coulondre and Miller, 1977). The mutation in n766, generated by
EMS, is a transversion (T:A to A:T). The remaining mutation, n3090, is also a
transversion (T:A to A:T). This mutation was generated using TMP, which usually
produces small deletions. In one mutant allele, n747, two lesions were observed. One
produces a predicted missense mutation (identical to that found in n2240); the other
produces a predicted novel splice donor site early in exon 3. Both the wild-type and
mutant codons encode glycine.
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Table 4. The vulval phenotype of strains of various genotypes is described. The complete
genotype is shown. Triple mutants containing lin-36(n766) and double mutants
containing lin-15(e 763) contain no markers; the construction of these strains is
described in Materials and Methods. Phenotypic catagories were assigned as follows:
Muv, animal had a Multivulva phenotype characterized by ectopic ventral protrusions;
Vul, animal had a Vulvaless phenotype such that it was bloated with eggs or contained
many internally hatched larvae (bag of worms); Muv Vul, animal co-expressed both a
Multivulva and a Vulvaless phenotype, that is it was bloated with eggs or internally
hatched larvae and had ectopic protrusions characteristic of a Muv phenotype; WT,
animal had a functional vulva and was nonMuv. n, the number of animals scored.
Several animals displayed a Hyperinduced (Hin) phenotype in addition to the phenotype
described. These animals were assigned a phenotype based upon whether they had
Multivulva-like ectopic vulval tissue (Muv), a nonfunctional vulva (Vul), both (Muv
Vul), or no Multivulva-like ventral protrusions and a functional vulva (WT).
adatum from Ferguson and Horvitz (1989).
bThese animals were not true Muv Vul animals, but were somewhat bloated with
eggs and may have been scored as Muv Vul animals. This number therefore serves as a
measure of the false positive noise in scoring Muv Vul animals in the lin-15(e1763)
double mutants.
Cdatum from Hoskins et al. (1996).
ddata from Ferguson and Horvitz (1985).
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Table 4. Gene Interactions
Genotype Muv Vul Muv Vul WT n
lin-2(n397) c 0% 99% 0% 1% 280
lin-7(el413)d 0% 98% 0% 2% 341
lin-10(n299)d 0% 97% 0% 3% 211
lin-36(n766); lin-15(n767)a 100% 0% 0% 0% 226
let-23(sy97); lin-36(n766); lin-15(n767) 0% 100% 0% 0% 203
lin-36(n766); lin-2(n397) lin-15(n767) 39% 14% 37% 9% 180
lin-7(el413); lin-36(n766); lin-15(n767) 43% 9% 47% 2% 202
lin-10(n299); lin-36(n766); lin-15(n767) 29% 25% 42% 4% 224
lin-15(el763) 97% 0% 3 %b 0% 119
lin-2(n397) lin-15(el763) 52% 0% 48% 0% 106
lin-7(e1413); lin-15(el763) 63% 1% 35% 1% 140
lin-10(n299); lin-15(el763) 56% 2% 42% 0% 113
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Figure 1. Cloning of lin-36. (A) Part of the genetic map of linkage group III showing the
region of lin-36. The deficiency nDf20 failed to complement lin-36 and three factor
mapping positioned lin-36 roughly halfway between egl-5 and unc-36. (B) Physical map
of cosmid clones in the egl-5 to unc-36 region. egl-5 and unc-36 are rescued by cosmids
C37A8 and ZK362, respectively (Coulson et al., 1986; Wang et al., 1993; L. Lobel,
personal communication). These clones formed the endpoints of the molecular region in
which lin-36 lies. The recombination distances shown in (A) suggested that lin-36 lies in
the middle of this region. Cosmids from this region were injected into lin-8(nl11); lin-
36(n747) at a concentration of 80 gg/ml. Cosmids C04H11, F44B9 and E02E3 were
shown to rescue the Muv phenotype (2/2, 5/8 and 3/3, rescued lines respectively). (C)
Subclones constructed from cosmid E02E3. E02E3 F2 rescue data is totaled in the
figure; it consists of: 80 gtg/ml into lin-8(nI 11); lin-36(n747), 3/3; 20 gg/ml into lin-
8(nl11); lin-36(n747), 4/4; 80 jig/ml into lin-36(n766); lin-15(n767), 15/15; 20 gg/ml
into lin-36(n766); lin-15(n767), 17/17. Subcloned insert DNA is depicted by the line
shown adjacent to each subclone plasmid name. Subclones were injected into lin-
36(n766); lin-15(n767) and tested for the ability to rescue the Muv phenotype. A 5.0 kb
minimum rescuing fragment, pJHT16, was defined on this basis. pJHT1, pJHT2, pJHT3
and pJHT4 were constructed by using MluI, NcoI, KpnI, and EagI, respectively, to delete
DNA from the cosmid which was religated. pJHTI and pJHT4 each had one of the
restriction enzyme sites in the vector sequence. From left to right, the following
restriction sites were used in the construction of the subclones: pJHT7: MluI and XbaI,
pJHT8: MluI and SacI, pJHT9: MluI and KpnI, pJHT10: MluI and SalIl, pJHT11: XhoI
and KpnI, pJHT12: SpeI and KpnI, pJHT13: SalIl and KpnI, pJHT14: Clal and KpnI,
pJHT 15: Sall and SacI, pJHT16: SalIl and XbaI, pJHT17: Clal and SacI, pJHT18: ClaI
and XbaI. The following concentrations of DNA were used: pJHT1, 50 gg/ml; pJHT2-4,
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Figure 2. lin-36 cDNA sequence. Nucleotide sequence of the cDNA and predicted
amino acid sequence is shown. Nucleotides are numbered beginning at the first
nucleotide after the EcoRI linker. These first nine nucleotides are the 3' end of the trans-
spliced leader SL1 (Krause and Hirsh, 1987; Huang and Hirsh, 1989). Amino acids are
numbered beginning at the presumptive ATG codon and ending at the residue just before
the presumptive TAA stop codon. Arrowheads indicate the location of intervening
sequences determined by comparison of cDNA sequences with genomic sequence
determined by the C. elegans genome sequencing project (Wilson et al., 1994). The nine
introns are 56, 75, 101, 75, 101, 123, 66, 48 and 215 nucleotides long, respectively.
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AAGITGCAAA GT GATCGA60A~~AAAA AAA 60AAGAACACGAC AGAGAGAGCCAAC~AG CCAAATGAT 1680M S E E L L S T R P S K R D Y N 16 E E H D P T P E S V E R E P T V S P N D 556
GATATCTGACCCAG•• ICACIA 120 CCCGIGITIITCATTCAGA 1740
D I E E P E D S H V T V H S V E Q D S Q 36 P R E R L R L K E R D E Q F A K M V Q K 576
CATIGIGAATCCIAACIGACA 180 AGATWICAGCAAGTAAGCGA CAAACAATIAAGAACAAGAGC1800
H S G E E S S T V D A L Q E T E G D V D 56 R S Q Q V K R L I N A K Q F K K Q E A A 596
G3TABA TCAAOAA T-TAATCAAG 240 AGAAGAAAGGAAAACICT 1860V I G E D E D E H D I P V M P T V T S S 
7
6 T K K P R K A L A Y N L A K G I A A T S 616
C0I0AG AAAAVG3AAAACAA G TACCAACCA 0 cA••3 c CGA AAAAAAAAA=GCACACGAAA 0GT 1920G E V L D E S Q V T P T K Q A S S S Q P 96 S T E P E D K V T S S E Q T P E P T T S 636
AGAGAAGAAATIATCCA GGCGAAAI 360 CAAAAATITCCAATACACATCGAAAACTAA 1980REEIIHGKGESVYSSFPCQV 116QKFIARNTRSKTKESAVQKV 656




AAT 480 CCICTAAAATCATGCGA 2100
YRMSNGRLRIYVVDHFKKFS 156PLKSMLARSFVAGVRPSMAK 696
CCATATCAAC•TIACGGTACATAA 540 TAxCAsA ATAAIc~C I n Cc-Tor T 2160PY S N L T H K P C T V C N R V M K S G 1
76
Y Q I P L E S F T A T A S L G G G R S L 716
EAATCCA-T•GAGAT CA 600 TCIrTGAGATAACAA ACATTCATCCTCrGGCAICTAA 2220EM H L N F P A D L D R R R I W A N LL L1
96 
S S G V I S R P P T S S S P G G I F S Q 736
GGATICAAATACAAGATTTIG CIGTCGCAA~GT 660 AGAGcTIT CCGAAAAAAGcCAAACC~GIGIGC 2280GFKYKDILRSKMGPVSFSIA 216RVMGAVAQEKGPAKRPSVLS 756
GCCAA GA 720 CGAAGACCACIACCITICACCACGAAAAAAAACICCCACII 2340AGPICTEHFAEECFRNHNFN 23 6 RRPLILSPRKKTST P R P T L S 776
AAATCTOCCAAG=IT CCAA 780 CACAACCAGICATC ATAAACPICICAGCAPIC ICIATGA 2400
KSAIEAFGVPVAISPDV K T T 
2
56HHESSPNFSASSPVVVSDEY 796
CCCAGTAAAAAAAGGCAGAGCA AAWACCGTAG~ ATGC 840 CTTCAACGATAAGGAA AcGIATATICETATGG 2460P S K K S S R V P W V C T V C E F H S C 27 6 L I P A T D M E V E M V E E V I D S M G 816
AGi^GCICAGAACEATCACGA 900 AACTCA•CAAG 2520S V V E L Q T H L L N H T E E M L K K K 2 96 N S S S E D V A T S S T S S E R Q P M L 836
GATAATGITGAGAAACA 960 ACGCX GCA GAGATCAGITAAAGATAAGATA 2580
DNVLD VPEAG FMCP F C R K CT 
3
16 TLAEALEMDGSSGTV K D Q DM 856
TArrGIACAAGACAATIC;TGTACTGAATGCCCATTCAT 1020 GAGAAATICAAAATGATGAAAGAACTAGAGCAAAACCT 2640
YGYKTISGYRRHLNAG P I H H 
33
6 E E I S K E M M K D A H Y Y R A M EDA 876
TG~ITCITAGAATAATAATAACICTA 1080 ATCAAAtGICGCACCGITCGAAAA CGCGACIPITIAI-C 2700
CHLRRI Y E F A K M N C R A T E L D 
3
56IKCRTVTKMRADMRLSRHCI 896
CCGCGG TAA GCAACAT ATCACGGCI- 1140 CGGC•AATIGAcoAGACGAcG(cGCTCICTIGCCrsGACIGAGATAT 2760PAESWDNWTRRNVYVAYHGC 3 76 RQIEAARARARLFGERTEDY 916
GAACCA AGlUTAICIACTAC A C TCAAIA1200 CAAATC IACTAACGATCAA CAAAAAAAAPAAA 2820E P P A N E I V L T P S P T K K A Y V Q 3 96 Q I F Y S N D G A Q V L T K K D P K W R 936




ACATIA~ G MI-GAATMC*•GIAOC.AG 1320 TCATGGATITICAACATAIATTTITAATATAAGAp~A 2940T L SF V G K E G G T S V N D L N V M Q 436 S S D SQ Q 962
CACAAGI AGAGAACAGAATACAAAAGCAGAAGAAT1380 ATICAAAAGICAACCGICTAGGATCGCTCATICCATAATC 3000
RQVFLQL R R E A E I N T K A E E S 456
TGTITGATATCCCAG•••A 3060G~ACA~AIUAA•.ATGCAA 1440
A Q G T K E Q E S S Q K K H A E E E S D 476 AAAAACITCGACPAGGATAGATITI CTAATITITAGGATI ACAITACITIT 3120
GA A AU1AACT50CCATC0AG"CACTAGC AGAGTCA 1500 TcCCCATIITACCCCTCCCCCTTxATAATICCAAATAATA~ 3180D V S E L T S H Q S P Q A P M G S G E R 496
CAAA ACACCICCAAC CTACAAATIACCAACAA GIGC 1560 ICATAAGCCCCCGCCCICTCCAAAACCACACITIC ATAAATAAC 3240
R K A T R L A T S A T N S P I K K V A K 516 TGAATTATICACAAAAAArGrAGTCTATAAAC PTTAC 3300
CACGAAG7CIACA CICCATCAACITCAGCTAAGAAA 1620 ATICAAGITIGAAGATAITI CAAATATGACAAAAGICAATAAATAA 3360
H E V P A T A P S T P A K K R K I S H E 536
AT CT AAAAAAAAAAAAAA 3400
Figure 3. Mosaic analysis of lin-36. A partial embryonic lineage (Sulston et al., 1983)
showing the origins of cells involved in vulva development. The gonadal anchor cell is
derived from EMS; P(3-8).p are derived from both AB.plapp and AB.prapp; hyp7, the
main body hypodermal syncytium, is derived from AB.a, AB.p, and C. The number of
nuclei that each of these lineages contribute and the stage at which they are contributed to
hyp7 is noted under the lineage. Only contributions from embryonic through larval stage
3, when Pn.p cells undergo vulval cell divisions, are noted (see Sulston and Horvitz,
1977; Sulston et al., 1983). E, embryonic; L1, larval stage 1; L2, larval stage 2; L3,
larval stage 3. Contributions from P3.p, P4.p and P8.p 30 cell fates are noted in the L3
number even though it is not likely that these hyp7 nuclei play a role in vulval cell
determination. These include two nuclei each from AB.pl and AB.pr and two additional
nuclei from P8.p which descend either from AB.pl or AB.pr. In Muv animals, these cells
often adopt vulval cell fates rather than hyp7 cell fates. Brackets below the lineage
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Figure 4. lin-36:: GFP reporter expression. Scale bar, 20 gm. Anterior is to the left. (A,
C, E) photomicrographs taken under Nomarski optics. (B, D, F) fluorescent images of
the animals seen in (A, C, E) observed using a LP-FITC filter. Animals are Rol. (A, B)
L3 hermaphrodite showing reporter expression in the nuclei of Pn.p cells. P4.p, P5.p and
P6.p are shown. P5.p and P6.p are expected to adopt vulval fates whereas P4.p is
expected to adopt a nonvulval fate. The nuclei of ventral cord neurons adjacent to the
Pn.p cells can also be observed expressing the reporter construct. (C, D) L3
hermaphrodites showing the nuclear expression of the reporter in the descendants of Pn.p
cells during vulval cell division. The lineage relationships of these cells is shown by a
lineage diagram superimposed on the images. The indicated nuclei expressing the
reporter are the daughter and granddaughter cells of P5.p, P6.p and P7.p, the Pn.p cells
which adopt vulval cell fates. (E, F) L4 hermaphrodites during early vulval invagination.




Figure 5. Model for the negative regulation of vulval development by the synMuv genes.
The inductive signal encoded by lin-3 binds the receptor tyrosine kinase encoded by let-
23, activating the signal transduction pathway leading to adoption of a vulval fate by the
Pn.p cell. The two functionally redundant synMuv pathways negatively regulate this
process. The class B pathway has components in both hyp 7 (lin-15 B, lin-37 and
possibly others) and the Pn.p cell (lin-36 and possibly others). It likely that the class B
synMuv pathway may not exert its negative regulation on the adoption of vulval cell fates
until the level of transcription, as suggested by the nuclear subcellular localization of lin-
36. The class A pathway has a component in hyp 7 (lin-15 A) and may or may not have
other components acting in the Pn.p cell. Thus it may act to negatively regulate the
pathway by acting the extracellular surface of the let-23-encoded receptor, by inhibiting
the let-23-encoded receptor tyrosine kinase cytoplasmically, by negatively regulating
another component of the inductive signal transduction cascade (e.g. as a phosphatase, or
a ras-GAP), or in a manner like that proposed for the class B pathway. The class A and
class B pathways may act in biochemically distinct manners. Inductive signal
transduction cascade activity is required for the adoption of vulval fates even in the
absence of negative regulation by the synMuv genes; however, the inductive signal itself
is not required. The ligand-independent activity of the let-23 pathway is necessary for the














Production of Polyclonal Antisera to LIN-36
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Polyclonal antisera to LIN-36 were generated to facilitate the analysis of lin-36.
Western blots identified a 130 kDa LIN-36 protein that was truncated in several nonsense
mutants. LIN-36 did not display any identifiable protein modifications on Western blots
in response to lin-15. Immunoflouresence staining of animals was unsuccessful, so the
expression pattern and subcellular localization of LIN-36 could not be determined.
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Introduction
To determine where lin-36 is expressed, polyclonal antisera were produced. We
planned to produce antisera that would allow us to determine which cells express LIN-36
protein and the subcellular localization of the protein in these cells. It was hoped that the
determination of subcellular localization would provide some insight into the mode of
action of the LIN-36 protein in vulval development.
In addition to providing information on the expression pattern of LIN-36, the
antibodies would serve as a useful reagent for further experiments to elucidate the role of
lin-36. Western blot analysis in synMuv mutant backgrounds may reveal whether LIN-
36 is modified by other class B synMuvs. Modification by phosphorylation or
dephosphorylation should be readily detectable. Detection of the modification of
expression levels by other class B synMuvs through transcriptional or translational means
may be possible. Changes to patterns of LIN-36 cellular expression and subcellular
localization by synMuv mutants may be detectable using the same techniques used to
determine the wild-type expression pattern. The methods described here to analyze
modifications to the wild-type LIN-36 protein can be used to test whether other synMuv
mutants or lin-36 mutants regulate these characteristics. In the case of other synMuv
mutants, these data may reveal regulatory hierarchies; in the case of lin-36 mutations,
these data may reveal important domains of LIN-36 and their function.
LIN-36 antibodies would also provide a useful reagent for further biochemical
studies of synMuv function. Anti-LIN-36 antibodies could be used in
immunoprecipitation experiments to identify interacting proteins. At present, the
identities of any proteins with which LIN-36 interacts are unknown.
Materials and Methods
Production of antisera
Three peptide regions of the lin-36 coding region were selected for antigenic
potential based on hydrophilicity and charge. These included peptide 20,
EERTKMVHDEEKRKKAVR; peptide 21, KEQESSQKKHAEEESDD; and peptide 22,
DPRERLRLKERDEQFAK. These peptides were used to immunize rabbits. ELISA
assays revealed that Ab20 (antisera generated against peptide 20) and Ab22 had high
titers whereas Ab21 had a very low titer (Research Genetics, Huntsville, AL).
Affinity purification of antisera
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The three peptides used for antisera production all map to a small region in the
EcoRI StuI fragment of the lin-36 cDNA. A GST fusion protein was constructed by
cloning this EcoRI StuI fragment into the pGEX-5X-1 inducible bacterial expression
vector (Pharmacia Biotech, Uppsala, Sweden). This fusion protein can be induced at very
high levels in bacteria by IPTG as assayed by Coomassie staining.
To affinity purify anisera, fusion protein expression was induced, proteins
separated by electrophoresis, and transferred to a nitrocellulose filter. 2 ml each of Ab20
and Ab22 were incubated with approximately 1 mg of fusion protein fixed to
nitrocellulose. After washing, affinity purified antisera was eluted from the membrane.
Western blots
Western blots of bacterial expression of fusion protein were analyzed using goat
anti-rabbit alkaline phosphatase-conjugated secondary antibody (BioRad, Hercules, CA).
Western blots of worm protein were analyzed using goat anti-rabbit horseradish
peroxidase-conjugated secondary antibody (BioRad, Hercules, CA). Chemiluminescence
was developed using ECL detection agents (Amersham, Arlington Heights, IL).
Whole mount immunofluorescence
Animals were fixed and prepared for whole mount immunoflouresence essentially
according to the protocol of Finney and Ruvkun (1990). Flourescein-conjugated
secondary antibodies were used to immunolocalize the primary antibodies.
Results and Discussion
LIN-36 is present in worms as a 130 kDa protein that is not obviously modified by
lin-15
Western blots were prepared from protein extracted from mixed stage worms. lin-
36 is expected to encode a protein of molecular weight 108 kDa (Chapter 3). Antibody
Ab22 recognized a protein of 130 kDa from these extracts. That the 130 kDa protein was
actually the LIN-36 protein was supported by the observation that Western blots of
protein extracts from lin-36(n766) worms did not show a 130 kDa protein, but instead
showed a 110 kDa protein. The lin-36(n766) mutation is an ochre stop codon at position
796 of the 962 residue protein (Chapter 3). Thus, the mutant protein encoded by lin-
36(n766) is predicted to be a truncated protein. This is consistent with the supposition
that the 130 kDa protein is LIN-36. Western blots of proteins isolated from lin-
36(n3093) and lin-36(n3095) strains show even smaller proteins and no 130 kDa protein.
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This is consistent with the sequences of these mutations: lin-36(n3093) has an amber
codon at codon position 579 and lin-36(n3095) has an ochre codon at codon position 569)
(Chapter 3).
Proteins extracted from a lin-15(n309) strain were also analyzed by Western blot.
lin-15(n309) is a deletion of most of the lin-15 AB locus and is expected to be a null
allele (Clark et al., 1994). Thus activity of the lin-15 B locus is completely eliminated.
lin-15 has been shown to act in the hypodermis (Herman and Hedgecock, 1990) whereas
lin-36 has been shown to act in the Pn.p cells (Chapter 3). Therefore, we think it is likely
that lin-15 acts upstream of lin-36 in the class B signaling pathway. To test whether LIN-
36 is modified by presumably upstream class B synMuv genes, we conducted a Western
blot of LIN-36 in a lin-15(n309) mutant. No changes in protein size or expression levels
were noted.
LIN-36 antisera has not been shown to usefully stain worms
Both mixed stage and L2 worms were fixed and permeabilized for antibody
staining under various conditions within the parameters of the protocol of Finney and
Ruvkun (1990). None of these various conditions produced any useful staining. Antisera
generated to GOA-1 (M. Koelle, personal communication) were used a positive control
for fixation and immunoflouresence staining. GOA-1 expression was observed in the
expected cells (Mendel et al., 1995; Segalat et al., 1995; M. Koelle, personal
communication). Under certain fixation and staining conditions, Ab22 stains seam cells
whereas Ab20 stains intestinal nuclei. It is thought that this staining is produced by
immunoreaction to contaminating antigens that were not completely removed in the
affinity purified antisera.
Acknowledgments
We thank Michael Koelle for his expert advice on the experiments described in
this Appendix. We also thank Alex Hajnal for providing additional advice on these
experiments. J. H. T. was a predoctoral fellow of the Howard Hughe Medical Institute.
H. R. H. is an Investigator of the Howard Hughes Medical Institute.
156
References
Finney, M. and Ruvkun, G. (1990). The unc-86 gene product couples cell lineage and cell
identity in C. elegans. Cell 63, 895-905.
Herman, R. K. and Hedgecock, E. M. (1990). Limitation of the size of the vulval
primordium of Caenorhabditis elegans by lin-15 expression in the surrounding
hypodermis. Nature 348, 169-171.
Koelle, M. R. and Horvitz, H. R. (1996). EGL-10 regulates G protein signaling in the C.
elegans nervous system and shares a conserved domain with many mammalian proteins.
Cell 84, 115-125.
Mendel, J. E., Korswagen, H. C., Liu, K. S., Hadju-Cronin, Y. M. Simon, M. I., Plasterk,
R. H. A. and Trenberg, P. W. (1995). Participation of the protein GO in multiple aspects
of behavior in C. elegans. Science 267, 1652-1655.
Segalat, L., Elkes, D. A. and Kaplan, J. M. (1995). Modulation of seratonin-controlled




Jeffrey H. Thomas and H. Robert Horvitz




This appendix describes prospects for the continued study of the synMuv genes as
well as some perspectives and speculations on a few issues raised by the study of the
synMuv genes. The first section defines a strategy for the future analysis of synthetic
Multivulva genes. The rest of this appendix presents several thoughts and speculations
prompted by the study of redundant systems in development. The nature of redundant
systems is discussed briefly. Evolutionary considerations raised by the existence of
redundant systems are addressed and several models are proposed to account for the
existence of such systems.
159
Strategy for the future analysis of the synthetic multivulva genes
In this section a strategy for the future analysis of the synthetic multivulva genes
is outlined. The strategy focusses on experiments that extend our understanding of the
signaling pathways modulated by the synMuv genes and how they regulate vulval
development. Many of the experiments described involve the use of reagents developed
over the course of the work described in this thesis.
Genetic analysis of the synMuv genes suggests that mutations in several class B
genes may not have been isolated. There may be several unidentified class B genes that
have not yet been identified because of pleiotropies that interfere with their isolation in
the screens conducted to date. This is suggested by the observation that animals carrying
strong lin-9 alleles are sterile and by the observation that animals trans-heterozygous for
lin-55(n2994) and a deficiency spanning the lin-55 locus are sterile and maternal effect
lethal (Ferguson and Horvitz, 1989; Chapter 2). Mutations with these pleiotropies were
not expected to be isolated in the screens described in Chapter 2. These screens
demanded that the synMuv mutations isolated produce a viable, fertile, Muv animals.
To isolate class B synMuv mutations that produce sterile or maternal effect lethal
phenotypes, a screen must be conducted that allows the recovery of heterozygous siblings
that are viable and fertile. Such a screen can be readily conducted by mutagenizing a
class A strain and picking Fl progeny individually to single plates. F2 progeny are
screened for Muv animals that are sterile or segregate only dead progeny. From plates
that contain such animals, nonMuv animals would be isolated, 2/3 of which are expected
to be heterozygous for the class B mutation. The new mutations would be maintained as
balanced heterozygotes. The new mutations would then be tested to see if they are alleles
of known genes or are alleles of hitherto undiscovered genes.
To extend the molecular characterization of the synMuv genes, additional genes
should be cloned. This will provide molecular reagents for biochemical and expression
studies. The expression studies will allow the synMuv genes to be partitioned into groups
based on the cells in which they are expressed and on the subcellular localization within
these cells. This data may suggest that certain synMuv gene products interact more
closely with certain other synMuv gene products to effect negative regulation of vulval
development.. Of particular interest are data on the similarity of synMuv genes to other
genes with known biochemical functions. Strong similarity may reveal the mechanism
by which a class of synMuv genes acts to regulate vulval development. Such data could
lead to further experiments which are beyond the scope of this discussion.
Cloning many of the newly isolated synMuv genes described in Chapter 2 should
be fairly easy. These genes have been well mapped, often to the point where they have
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been positioned such that they have been locatalized to about a hundred kb of cloned
DNA. The newly isolated class B genes that should be this easy to clone are lin-55 II,
lin-52 III, and lin-54 IV. lin-37 III also falls into this category. Several other class B
genes should be relatively straightforward to clone, these include lin-53 I and lin-35 I.
The class A gene lin-56 II should be as easy to clone a member of the most accessible
group of class B genes. These genes are thus readily amenable to molecular analysis and
should be studied at the first opportunity. If these genes are cloned, nine out of the ten
known class B genes and two out of the four known class A genes will have been cloned.
This will provide an almost complete preliminary analysis of the synMuv genes.
Several strategies exist for placing the synMuv genes into well-ordered pathways
within each class. Since mutations in the synMuv genes all have identical phenotypes,
they cannot be ordered by conventional epistasis experiments. Therefore, non-genetic
strategies must be used to order the pathways. Similar strategies may enable us to
determine the identities of other molecules with which synMuv gene products interact.
These molecules may be key elements involved in vulval development that are regulated
by the synMuv genes. The methods that should be used for this analysis are yeast two-
hybrid experiments and coimmunoprecipitation experiments.
Yeast two-hybrid experiments to order the synMuv genes into a pathway within
each class can be conducted in two ways. The first is to test all pairwise combinations of
cloned synMuv genes of the same class. If the genes noted above are cloned, this will
allow most of the synMuv genes to be tested and ordered into a pathway. In the absence
of any other data, it would only be possible to determine sequence of action without
direction, i.e. without determining the beginning and end of the pathway. However, the
the genetic mosaic results of lin-15, lin-37 and lin-36 should allow the direction of the
pathway to be determined. This of course presupposes the most parsimonious pathway:
signaling from hyp7 to the Pn.p cell. The second method is to use each of the cloned
synMuv genes as bait to trap other genes in a two-hybrid screen. This method, although
much slower than the first, has several advantages. These are that uncloned synMuv
genes may be cloned, that new synMuv genes may be identified and cloned, and that
genes that are not mutable to a synMuv phenotype, but are targets of synMuv gene
regulation or are regulators of synMuv genes may be identified and cloned. In this latter
case, it may be possible to determine if a class of synMuv genes acts to regulate a
particular component of the vulval induction pathway, and if so, which one. Thus, the
potential reward for inferring how synMuv genes work is enormous.
Coimmunoprecipitation experiments offer another approach to address these
issues. Antibodies have been raised to LIN-36 (Appendix 1). These may be capable of
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immunoprecipitating LIN-36 protein from worm extracts.. If so, other proteins may
coimmunoprecipitate with LIN-36. These proteins could be microsequenced so that
probes can be made and clones isolated to determine the identities of these proteins. In
addition to determining which, if any, synMuv genes physically interact with LIN-36, it
may be possible to isolate a target protein of LIN-36 that is not a synMuv if such a
protein exists. A portnetially easier way to identify coprecipitating proteins is to
immunoprecipitate LIN-36 from the extracts of worms carrying mutations in any of the
various class B synMuv genes. The absence of a particular band in a particular extract
may indicate a correspondence between mutant gene and missing protein. Together with
the yeat two-hybrid experiments, these studies may define much of the logic of the
synMuv pathways and posssibly even their targets.
Other biochemical experiments may provide insight into the mechanisms of
synMuv gene regulation of vulval development. Unfortunately, by their nature, these
experiments are not comprehensive searches for biochemical mechanisms but are instead
merely tests of certain potential mechanisms amenable to experimental analysis with the
reagents at hand. The MAP kinase active in vulval development has been cloned
(Lackner et al., 1994; Wu and Han, 1994). This cloned gene can be used in a
phosphorylation assay to see if the synMuv genes can negatively regulate MAP kinase
activity either at the level of the MAP kinase or upstream. This would be done by
comparing the relative activities of MAP kinase in the presence of extracts from wild-
type and synMuv mutant worms. Kinase activity would be expected to be higher in
synMuv mutant extracts if the synMuv genes encode negative regulators of kinase
activity. Similar experiments can be conducted using GTPase assays and the cloned let-
60 ras gene (Beitel et al., 1990; Han and Sternberg, 1990). MAPK::GFP nuclear
transport could also be observed in vivo and tested in the presence of synMuv mutants to
see if the process is inhibited by synMuv genes. Purified LIN-36 protein could be tested
for DNA binding activity. Such activity may suggest that LIN-36 directly modulates
transcription and may define a specific binding sequence for LIN-36. A let-23::GFP
reporter (Hoskins et al., 1996; Simske et al., 1996) could be used to determine if synMuv
genes partially control the transcription of let-23. However, since LET-23 must be
present to receive the LIN-3 signal, the synMuv genes cannot be wholly responsible for
let-23 transcription but may downregulate its expression. Whereas these biochemical
experiments are risky and can only specifically test a few mechanisms of synMuv
activity, they may provide a useful insight into synMuv gene function.
The strategy for future analysis of the synMuv genes described here is relatively
straightforward and requires no unusual effort. Many of these experiments are essentially
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assured of success and would yield important findings. The plan outlined above stands a
good chance of defining the biochemical mechanisms that the two classes of synMuv
genes use to regulate vulval development. If not, these experiments may eliminate
several models and provide a more detailed description of the genetics and molecular
biology of the synMuv genes and vulval development.
Redundancy in development
Redundancy in development has long been an issue which has bedevilled
developmental biologists. Experimentalists have always been concerned about the
implications of redundancy for the analysis of development. Redundant genes and
functions present a distinct dificulty for the analysis of development. The geneticist who
wants to analyze a certain aspect of development through the isolation of mutants in
which this process is perturbed must always bear in mind that some or all of the process
may be controlled by redundant genes. In such a case, a mutation in such a gene is
unlikely to be isolated because a redundant gene masks the mutation. The probability of
finding a double mutant affecting the process is extremely low: the product of the
frequencies of isolation of the two genes times the Poisson probability that two mutations
will be induced in the same animal. Molecular biologists who are able to make a deletion
mutation in a cloned gene of interest by homologous recombination in yeast or mice are
often disappointed to isolate homozygous mutants with no phenotype. Often this is
because of redundant gene is present in the organism. Similar examples are seen when a
geneticist attempts to revert a dominant phenotype and isolates a loss-of-function
mutation in the gene of interest that produces a wild-type phenotype. This may often be
the result of redundant gene activities.
Redundant genes and their functions are usually identified in only a few ways.
One method is the construction of double mutants between genes that control similar
processes. The double mutant often has additional phenotypes not seen in the single
mutants. Double mutants between genes that encode similar proteins are also often
constructed because the genes are hypothesized to perform the overlapping function.
These double mutants often have additional or more severe phenotypes than the single
mutants. If neither single mutant has a phenotype, then a phenotype is often observed in
the double mutant (for examples see Hadwiger et al., 1989; Richardson et al., 1989;
Ghysen and Dambly-Chaudiere, 1991; Lambie and Kimble, 1991). In other cases, weak
phenotypes are seen in single mutants and these phenotypes are enhanced in double
mutants between weaker mutants with the same phenotype. Often this enhancement, in
the case of null mutations, is the result of redundancy (for example, see Ellis et al., 1991).
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The synMuv genes are distinct from these more common examples in that they have no
vulval phenotype as single mutants. Some class B mutants have defects in viability and
fecundity. It is notable that the synMuv genes were isolated by a fortuitous double
mutant (Horvitz and Sulston, 1980).
Genetic redundancy can take two distinct forms: duplicated genes and functional
redundancy. Redundant duplicated genes are of course functionally redundant, but they
are functionally redundant by virtue of having essentially identical biochemical functions.
Duplicated genes are genes that are molecularly similar and perform the same
biochemical function. Often these sytems arose from the duplication of an ancestral gene
or genes. In these cases, the control elemmts of the gene as well as the structure and
function of the gene are very similar. In other cases, the genes are more distantly related.
Such genes may have the same basic biochemical function, such as kinase activity, but
differ profoundly in control and structure. Despite these differences, the encoded proteins
are able to perform the same biochemical role and thus act redundantly.
In the case of purely functional redundancy, the genes do not necessarily have to
have similar biochemical functions, they only have to have similar biological functions.
This biological function can be provided by different biochemical means. For example,
two genes may act to increase the activity of a target gene above a certain threshold. One
may be a transcriptional activator that leads to increased expression of the target protein,
and the other may be a cofactor that increases the activity of the target protein. Either
gene is sufficient to increase the activity of the target. Another example could involve the
acquisition of a metabolite. One gene may act as a transporter of this metabolite from the
environment whereas a functionally redundant gene may act to catalyze the production of
this metabolite from another molecule in the cell. In this example, the redundant genes
play the same biological role, but do so by very different biochemical means. These
hypothetical examples serve to show how functional redundancy need not imply
molecular or biochemical similarity.
Redundancy and evolution
The fundamental questions with regard to redundancy and evolution are how is
redundancy evolutionarily feasible and why does it exist? Because evolution occurs by
mutation and natural selection, these questions are inextricably linked. By answering the
question why does redundancy exist, it is straightforward to determine how it is feasible.
Knowing how redundancy is feasible may well indicate why it exists. One must bear in
mind that organisms are not engineered, they are evolved. Redundancy is a common
element in designed systems; such redundancy provides some insurance against failure.
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For instance, the space shuttle is designed with many backup systems so that if the
primary system fails, the backup system can take its place. This is a very safe design.
However, such systems cannot be maintained throughout evolution where natural
selection and mutation interact to determine the "design" of an organism. There is no
selective advantage for a backup system. Since the system is redundant, there is no
selective pressure to maintain two parallel systems. Random mutations that disable one
or the other of the redundant systems are nondeleterious. In the absence o selective
pressure to eliminate these mutations from the gene pool, it is likely that the redundant
system will decay over time so that one redundant element is disabled in a brief time and
the process is no longer redundant.
The argument cited above applies only to strictly redundant systems. In the case
of incompletely redundant systems, selective pressure can maintain both components of
such a redundant system. This is because both components are required; neither
component is sufficient for complete function. However, the synMuv genes appear to be
completely redundant for vulval development as seen by the absence of any defects in
single mutants (Capter 3). I propose several models which may account for the presence
of a redundant system in the control of C. elegans vulval development.
The first model is relatively trivial. It is that the two classes of synMuv genes are
not truly redundant in the wild. These genes have been analyzed under laboratory
conditions in which much of the selective pressure on nematodes has been eliminated.
Thus, these genes may not be redundant for vulval development under narural conditions,
or these genes may be required for functions necessary for survival in the wild that are
not present in the laboratory and therefore not observable.
In the second model, the synMuv genes are redundant by virtue of accidental
expression. The two classes of synMuv genes each play a distinct role in the biology of
the organism. The reduced fecundity and viability of many class B synMuv mutants
suggest a distinct biological role for these genes. The class A genes may be required for a
process that has so far escaped notice or is not essential in the laboratory enviroment.
Thus selective pressure maintains these two systems independently of each other. One of
these processes controls vulval development and the other is expressed at the right time
and place to do so as well. This expression may be the result of the pathway's
requirement in another process at the same time and place or may be the result of the
interaction of controls that express this system in several other locations at other times.
In this model, one of the pathways just happens to be in the right place at the right time
and can functionally substitute for the other pathway in terms of ultimate biological effect
on vulval development. It is important to note that in this case there is no selective
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pressure to maintain this overlap of expression and function except as an artifact of
maintaining the proper expression and function of the two classes of genes for their
primary functions.
The third model involves direct selective pressure acting to maintain a redundant
system for the negative regulation of vulva development. In this model, the redundancy
itself has some selective advantage over nonredundancy. Higher efficiency is a likely
reason for such selective pressure. A slight growth advantage would be favored by
natural selection. Over many generations, this slight advantage would be sufficient to
favor animals which possessed it. Such a growth advantage would be predicted to be
particularly advantageous to an organism such as C. elegans that has a short lifespan
characterized by rapid growth. Note that this increased efficiency is not the result of a
backup system in case something goes wrong, but an actual improvement in performance
because of the operation of two systems. In such a case, it seem that there would have to
be cross talk and back regulation between the synMuv genes and other components of the
vulal development system in order to obtain the greater efficiency; there has to be a way
for two pathways performing the same function to use less resources or take less time
than having only one pathway perform this function. The situation postulated in this
mode is one in which redundancy is actually favored by selection.
In this section I have attempted to address the vexing conundrum of how a
redundant system is maintained during evolution. For this to be the case, there has to be
some selective pressure, whether direct or indirect, to maintain such a system. Several
possible models to explain how redundant systems are feasible and why they exist have
been proposed and explored.
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